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Trap by Pain
ACTIONS
Oxycodone is a semi-synthetic narcotic analgesic with actions qualitatively 
similar to those of morphine, particularly involving the central nervous 
system and organs composed of smooth muscle. The principal therapeutic 
actions are analgesia and sedation. Oxycodone retains at least one half of 
its analgesic activity when administered orally. In addition to caffeine. 
Percocet and Percocet-Demi also contain the non-narcotic antipyretic anal­
gesic acetaminophen, which exerts its effects in a manner similar to the 
salicylates, but without the anti-inflammatory or uricosuric properties. 
Acetaminophen is rapidly and almost completely absorbed in the gastro­
intestinal tract: peak plasma levels are reached within ten minutes to 
one hour.
INDICATIO NS
Relief of moderate to moderately severe pain (Percocet), or relief of mild to 
moderate pain (Percocet-Demi), with or without fever, especially in patients 
who are allergic to acetylsalicylic acid or for whom acetylsalicylic acid is 
contraindicated.
CONTRAINDICATIO NS
Status asthmaticus, pre-existing respiratory depression or convulsive states, 
hypersensitivity to oxycodone, acetaminophen, or caffeine.
Unlike acetylsalicylic acid, acetaminophen is not contraindicated in pa­
tients with peptic ulcer or gout.
W ARNINGS
Oxycodone can produce drug dependence of the morphine type and has the 
potential for being abused. Psychic dependence, physical dependence and 
tolerance may develop upon repeated administration, as with other oral nar­
cotic medication. May impair the mental and/or physical abilities required 
for the performance of potentially hazardous tasks, such as driving a car or 
operating machinery. Patients should be cautioned accordingly. Additive 
CNS depression may occur in patients receiving other narcotic analgesics, 
general anesthetics, monoamine oxidase inhibitors, tricyclic antidepres­
sants, phenothiazines or other tranquilizers, sedative-hypnotics or alcohol.
If combined therapy is contemplated, the dose of one or more of the agents 
should be reduced. Safe use in pregnancy has not been established 
relative to possible adverse effects on fetal development, therefore Per­
cocet or Percocet-Demi should not be used in pregnant women unless, in 
the judgment of the physician, the potential benefits outweigh the possible 
hazards. The administration of Percocet or Percocet-Demi to obstetrical 
patients in labor may be associated with respiratory depression of the new­
born. Percocet should not be administered to infants or children, although 
Percocet-Demi may be considered for children of six years or older. 
PRECAUTIONS
The respiratory depressant effects of narcotics and their capacity to elevate 
cerebrospinal fluid pressure may be markedly exaggerated in the presence 
of head injury, other intracranial lesions or a pre-existing elevated in­
tracranial pressure. The diagnosis or clinical course in patients with head 
injuries or with acute abdominal conditions may be obscured by narcotic 
drugs. Give cautiously to elderly or debilitated patients due to the risk of 
cardiac or respiratory depression, as well as to patients with hemorrhage, 
severe impairment of hepatic, respiratory or renal function, hypothyroidism, 
Addison’s disease, prostatic hypertrophy or urethral stricture. Narcotic 
analgesics should only be employed for the treatment of headaches when 
no other treatment is effective, in order to minimize risk of psychological 
and physical dependence.
ADVERSE REACTIONS
Light-headedness, dizziness, sedation, nausea and vomiting may occur, as 
well as euphoria, dysphoria, constipation and pruritus.
DRUG INTERACTIONS
May be additive with other CNS depressants.
M ANAG EM ENT OF OVERDOSAGE  
Signs and symptoms: Respiratory depression, extreme somnolence progress­
ing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, and 
sometimes bradycardia and hypotension. In severe cases, apnea, circulatory 
collapse, cardiac arrest and death may occur. Acute acetaminophen intoxi­
cation is characterized by anorexia, nausea, vomiting and sweating within 
two or three hours of ingestion, and possibly cyanosis with methemo­
globinemia; enlargement and tenderness of liver, accompanied by 
abnormally high liver function tests, occur within 48 hours, followed by 
jaundice, coagulation defects, myocardiopathy, encephalopathy, renal 
failure and death due to hepatic necrosis. A dose of 10 g of acetaminophen 
is intoxicating, possibly fatal in excess of 15 g. Hepatic toxicity occurs when 
the plasma levels reach 300 pg /m l within four hours of ingestion. 
Treatment: Re-establish adequate respiratory exchange. Naloxone, nalor­
phine or levallorphan are specific antidotes against narcotic-induced 
respiratory depression. An appropriate dose of antagonist should be ad­
ministered preferably intravenously, and repeated as needed to maintain 
adequate respiration; the patient should be kept under continued 
surveillance. Instructions in the package insert provided by the manufac­
turer should be carefully followed. Do not administer an antagonist in the 
absence of clinically significant respiratory or cardiovascular depression. 
Employ oxygen, intravenous fluids, vasopressors and other supportive 
measures as indicated. Gastric emptying by emesis or lavage may be 
helpful. Hemodialysis carried out within ten hours of ingestion may be of 
some value. Plasma levels of acetaminophen should be determined.
Only Percocet combines acetaminophen with the 
effectiveness of oxycodone, to provide relief of moderate 
to moderately severe pain.
A single dose of Percocet begins to act within 15—30  
minutes, and may provide up to six hours of soothing relief.
Oldo
£ndo Laboratories
7000 Park Avenue, 
Montreal, P.Q. H3N 1X1
PRECAUTION This product has 
the potential for being abused.
Subsidiary of E.l. Dupont de Nemours Co. (Inc.) * Registered
DOSAGE AND ADMINISTRATION
Percocet Tablets: Usual adult dose is one tablet every six hours, as needed 
for pain.
Percocet-Demi Tablets: Usual adult dose is one or two tablets every six 
hours. Children twelve years and older: half a tablet every six hours. 
Children six to twelve years: a quarter of a tablet every six hours. Not in­
dicated for children under six years of age.
Dosage should be adjusted according to the severity of the pain and the 
patient's response.
DOSAGE FORMS
Percocet Tablets: Bottles of 40,100 and 500 white, scored tablets, each 
containing oxycodone hydrochloride 4.5 mg, oxycodone terephthalate 0.38 
mg, acetaminophen 325 mg, caffeine 32 mg.
Percocet-Demi Tablets: Bottles of 40,100 and 500 blue quadrisected 
tablets, each containing oxycodone hydrochloride 2.25 mg, oxycodone 
terephthalate 0.19 mg, acetaminophen 325 mg, caffeine 32 mg.
Complete prescribing information available on request.
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The Canadian Journal of Surgery 
Le journal canadien de chirurgie
(613) 731-9331
The Canadian Journal of Surgery is published by the Cana­
dian Medical Association and sponsored by the Royal Col­
lege of Physicians and Surgeons of Canada. The establish­
ment of editorial policy is the responsibility of the Royal Col­
lege. The objectives of the Journal, endorsed by the Council 
of the College, are: (1) to contribute to the effective continu­
ing education of Canadian surgical specialists, using in­
novative techniques when feasible and (2) to provide Cana­
dian surgeons with an effective vehicle for the dissemination 
of their observations in the area of clinical research.
Published every 2 months by the Canadian Medical Associa­
tion, PO Box 8650, Ottawa, Ont. K1G 0G8. Printed by 
Harpell’s Press Cooperative, Gardenvaie, PQ HOA 1B0. 
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($10.50 per year for trainees in surgery in Canada only), for 
all other countries $26.00 per year. Single copies (current 
issue) available at $4.00 each, back issues at $5.00 each.
Instructions to Contributors
The Journal invites contributions of original and review ar­
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surgery. Short contributions, letters to the editor and case 
reports will also be considered.
Manuscripts should be submitted to: The Coeditors, The 
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be submitted in triplicate, double spaced with wide margins. 
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4His body has been hit hard.
A t a tim e like this, do you really want to  subject 
him to  a narcotic?
W ith  Marcaine, you don’t  have to.
Marcaine, injected as a nerve block prio r to  
closure, provides up to  twelve hours o f pain-free 
recovery tim e /1)
That’s tw o  to  three times longer than lidocaine.P)
It gives complete sensory block with o r w ithout 
significant m otor block depending upon the con­
centration used. It means you can delay using a narcotic 
during that critical stabilizing post-op period.
Because Marcaine lets your patient come around 
long before the pain.
W inthrop Laboratories
Division o f Sterling Drug Ltd., Aurora, Ontario L4G 3H6.
Delay the pain, delay the need for narcotics.
QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Surgery for Intractabl
Three operative procedures are cur­
rently used to treat intractable duo­
denal ulcers: vagotomy with drainage, 
vagotomy with antrectomy and 
parietal cell vagotomy. Each proce­
dure has its proponents and anta­
gonists, and at almost every surgical 
meeting the “pros and cons” of each 
operation are vigorously debated.
Assessment of the merits of the 
different operations must include (a) 
operative mortality, (b) incidence of 
recurrent ulcers and (c) side effects. 
This discussion will summarize the 
available data on each of the three 
operative procedures and will outline 
an appropriate approach to surgery 
for intractable duodenal ulcer.
In 1943, Dragstedt and Owens' de­
monstrated that supradiaphragmatic 
truncal vagotomy abolished gastric 
hypersecretion and inappropriate noc­
turnal secretion of acid in patients 
with duodenal ulcer and also that it 
healed the ulcers. Dragstedt2 later 
added gastrojejunostomy because gas­
tric stasis and formation of gastric 
ulcers had resulted from use of vago­
tomy alone. This was the begin­
ning of the “vagotomy era” in duo­
denal ulcer surgery. But Dragstedt was 
not the first to perform vagotomy for 
duodenal ulcers. Latarjet3 in 1922 
performed vagotomy and gastrojeju­
nostomy, but because of the populari­
ty of gastrectomy was at its zenith, 
this lesser surgical procedure was not 
accepted by the surgical community.
In the 1950s Farmer and associates4 
conclusively demonstrated that truncal 
vagotomy with limited gastric resec­
tion (antrectomy) would successfully 
treat duodenal ulcers. Since then this 
procedure has become the standard 
operation in many North American 
centres.
Griffith and Harkins5 in 1957 re­
ported that acid secretion in the dog 
was substantially reduced by denerva- 
ting the fundic glands but main­
taining the innervation of the an­
tral-pyloric pump. Thus, the concept 
of “parietal cell vagotomy” was born. 
In 1969 Hoile and Hart6 performed 
the first parietal cell vagotomy in man 
and they added a drainage procedure. 
One year later Johnston and Wil­
kinson7 in England and Amdrup and 
Jensen8 in Denmark, independently 
performed parietal cell vagotomy 
without a drainage procedure. Since 
then, parietal cell vagotomy has been 
performed world wide.
There are many well controlled 
studies comparing truncal vagotomy
and antrectomy with truncai vagotomy 
and drainage or with parietal cell 
vagotomy.8-16 Table I illustrates the 
overall operative mortality and rate of 
recurrent ulceration in all available 
controlled and well designed studies 
in the literature. The lowest operative 
mortality is for parietal cell vagotomy. 
The occurrence of stomal ulcers is 
lowest after vagotomy and antrectomy 
but is similar in patients who have 
vagotomy with drainage or parietal 
cell vagotomy.
With respect to side effects result­
ing from the three surgical procedures, 
parietal cell vagotomy had the lowest 
rate for every side effect but epigas­
tric fullness (Table II).
Thus it is apparent that parietal cell
Table 1— Operative Mortality and Rate of R ecu rren t U lce ra tion  in E lective  
Surgery for Duodenal U lce r Reported in the L ite ra tu re
Truncal vagotomy 
and drainage
Trunca l vagotomy 
and antrectom y
Pa rie ta l 
ce ll vagotomy
Total no. of patients
reported
M orta lity
>15 000 >8000 >6000
Rate, % 0.8 2.7 0.29
No. of patients 
Rate of recurrent or 
pers istent ulcer, %
>5000 >5000 >5000
5-yr fo llow -up 8 0.8 6.8
10-yr fo llow -up 15 0.9
Table II- Rate of Side Effects (% ) a fte r Surgery fo r Duodenal U lce r
Truncal vagotomy Trunca l vagotomy Pa rie ta l
Side effect and drainage and antrectom y cell vagotomy
Diarrhea 22 15 2
Dumping 10 15 4
B iliou s vom iting 10 12 2
Nausea 12 15 8
Epigastric fu llness 11 10 25
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vagotomy is superior to vagotomy with 
drainage as an elective procedure for 
intractable duodenal ulcer. What 
about vagotomy with antrectomy? 
There is no doubt that this procedure 
is associated with a lower rate of 
stomal ulcers than parietal cell vago­
tomy but it carries a higher operative 
mortality. Moreover, stringent atten­
tion to technical detail is of para­
mount importance in performing 
parietal cell vagotomy. In several pub­
lished series parietal cell vagotomy 
resulted in 5-year rates of recurrent 
ulcer of less than 2%.17 The impor­
tance of denervating at least 5 cm 
of the distal esophagus, has been de­
monstrated by several authors17-18 who 
were able to reduce appreciably the 
number of stomal ulcers when they 
extended their dissection to the lower 
esophagus.
Duodenal ulcer surgery has 
changed rapidly since the introduc­
tion of procedures such as vagotomy. 
Parietal cell vagotomy is now the 
procedure of choice for the uncom­
plicated case of duodenal ulcer, pro­
vided the surgeon has completely mas­
tered the operative technique.
H.S. H imal] md, f r c s [c]
Department of surgery 
Toronto Western Hospital,
Toronto, Ont.
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proven in burns
Flamazine
now indicated for leg ulcers 
Abridged Product Information
Chemical Name
Silver 2- (4-ammobenzenesulfonamide) -pyrimidine.
Description
Silver sulfadiazine is a light-stable white powder, very slightly soluble in 
water and most organic solvents, but readily dissolved in nitric acid and 
concentrated ammonia solutions.
Composition
Silver sulfadiazine 1% in a cream base.
Action
The action of silver 2- (4-aminobenzenesulfonamide)-pyrimidine is 
bactericidal. Little of the active ingredient is absorbed; the silver 
sulfadiazine acts as a drug depot which reacts slowly with cellular debris 
and microorganisms on the burn wound to release that amount of 
sulfadiazine which is absorbed. The silver remains largely at the wound 
surface.
There is little delay in the bactericidal activity of silver sulfadiazine, and 
the experimental evidence suggests that its site of action is the bacterial 
cell membrane. Silver sulfadiazine inhibits DNA. RNA, and protein 
synthesis which may explain its bactericidal activity.
Silver sulfadiazine has been shown to be effective in vitro against various 
strains of the following pathogens isolated from infected burn wounds: 
Pseudomonas aeruginosa, Aerobacter aerogenes, E. coli, Proteus mirabilis, 
Candida albicans, Proteus vulgaris, Staphylococcus aureus, Klebsiella 
spp., Aspergillus mger.
Indications and Clinical Uses
Flamazine is indicated for the adjunctive treatment and prevention of 
infection in severe burns and leg ulcers. Flamazine is particularly effective 
against Gram negative organisms, such as Pseudomonas aeruginosa. 
Flamazine has not caused electrolyte disturbance, acidosis or subsequent 
hyperventilation. It causes very little skin sensitization and there is no 
lain on application. Flamazine does not cause argyria and does not cause 
staining of the skin or bedclothes. The development of bacterial resistance 
to Flamazine would seem to be slight.
A disadvantage that has been noted, in burn therapy, is a delay in the 
separation of slough from the burn wound, due to the absence of bacteria 
which contribute to slough separation by producing proteolytic enzymes 
and by stimulating leucocytosis.
Contraindications
Flamazine is contraindicated in women of child-bearing age, unless the 
burnt area is more than 20% of the total body surface, or in the 
investigator's judgment benefit outweighs risk. Further, because 
sulfonamide therapy is known to increase the possibility of kermeterus, 
Flamazine should not be used in pregnant females at term, in premature 
infants, or in newborn infants in the first month of life.
Warnings
Flamazine should not be used in patients with a known, or suspected, 
sensitivity to sulfonamides.
Precautions
Flamazine should be used with caution if hepatic or renal function is im­
paired. The cream should be applied with a sterile gloved hand or spatula. 
Each jar and tube of Flamazine cream should be reserved for the exclusive 
use of a single patient, and any remaining cream should be discarded on 
completion of treatment. Flamazine should be stored in a cool place. 
Adverse Reactions
Sensitivity has been observed, but the incidence is lower than with other 
sulfonamides. A fall in white blood count has been demonstrated occa­
sionally, but this is not thought to be associated with the treatment per se 
and more likely reflects the condition of the burned patient.
Symptoms and Treatment of Overdosage
As a topical preparation, Flamazine does not lend itself to overdosage by a 
systemic route; topically applied it has shown little evidence of toxicity in 
experimental animals, and the clinical situations in which it has been 
studied are such that evidence of systemic toxicity, if any, is unlikely to be 
revealed.
The absorption studies which indicate that only a small percentage of 
sulfadiazine and virtually no silver are absorbed suggest that overdosage 
following topical administration, even on burned skin, is unlikely to be a 
problem.
Dosage and Administration
Flamazine should be applied topically in a layer approximately 3-5 mm 
thick with a sterile gloved hand or spatula, daily, or more often as 
required. The wound may be dressed or left open.
Duration of administration can be from a few days to several months, 
depending upon the nature and severity of the wound. Treatment should 
be continued until satisfactory healing has occurred or until the burn site 
is ready for grafting. The drug should not be withdrawn from the 
therapeutic regimen while there remains the possibility of infection 
except if a significant adverse reaction occurs.
Dosage Forms
Flamazine is presented as a cream containing 1% w/w  silver sulfadiazine 
in containers of 500 g and tubes of 50 g.
Complete product monograph available on request.
, - - - N Smith & Nephew Inc.
| |  >, 2100, 52 Avenue
v Lachine, Que., Canada
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They should share the 
same treatment.tnazine
The antibacterial of choice 
for burns is also the logical 
choice for leg ulcers.
Flamazine
has met one of the toughest challenges of 
topical antibacterial therapy. Major burns 
And the reasons that have made it the 
number one antibacterial in burn 
therapy make it the logical anti­
bacterial for the treatment of 
leg ulcers.
Unsurpassed effectiveness.
Flamazine is bactericidal and 
fungicidal. Its exceptionally 
broad spectrum covers most 
major pathogens, including 
Staph, aureus, Pseudomonas 
aeruginosa and Candida 
albicans.
And the dual bactericidal action of silver and sulfadiazine prevents the 
emergence of resistant strains.
Unsurpassed safety. Flamazine has been used extensively on full­
thickness burns, yet the incidence of systemic effects and sensitization 
was reported to be less than lU of 1 %!1 Sensitization to topical anti­
biotics or antiseptics often disrupts the 
treatment of leg ulcers. This problem 
is unlikely to occur with Flamazine.
1. Data on File. Smith &  Nephew Inc.
Sm ith & Nephew  Inc.
2 1 0 0 ,  5 2  A v e n u e  
L a c h in e ,  Q u e .,  C a n a d a  
H 8 T  2 Y 5
Soothing pain relief.
Flamazine actually relieves 
the pain and itching of leg 
ulcers. And its water-miscible 
base allows it to be removed 
easily and painlessly.
CORRESPONDENCE
Myocutaneous Pectoralis Flaps 
versus Revascularized 
Free Flaps in Head 
and Neck Reconstruction
To the coeditors.—The article “Mic.ro- 
vascularfre^JJaggjnheadan^^eck  
reconstructionUJiv Zuker and associa­
tes (Can J Sure 23: 157. 1980) is com­
mendable in many ways, but there is 
one major misconception that must 
be corrected for the readership. On 
page 159, under case 1, it is made 
quite clear that the myocutaneous 
pectoralis flap technique is included 
in reconstructive procedures that 
“usually have greater morbidity and 
require longer hospitalization than 
the single-stage free flap procedure”. 
This is erroneous on all counts. The 
myocutaneous flap transfer, includ­
ing the pectoralis major, is a single- 
stage procedure and does not require 
longer hospitalization. It also has the 
advantage of taking much less time 
to perform than the revascularized 
frce-flap transfers with which 1 have 
had a great deal of experience.
The myocutaneous flap now has 
replaced the free-flap microvascular 
transfer for most reconstructive head 
and neck procedures because it is 
faster, easier and as efficient. There 
are a few procedures, such as repair 
of anterior mandibular defects, that 
are exceptions to this statement.1,2 
Microvascular surgery is important 
for many reasors, but its use in head 
and neck reconstructive surgery is 
limited.
J(»nt*«M. F redricksoni\MDFRCSfC]
Department of otolaryngology, 
University of Toronto, 
Toronto, Ont.
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Contributions to the Correspondence sec­
tion are welcomed. They should be type­
written and double spaced.
To the coeditors.—Dr. Fredrickson 
has pointed out some of the advan­
tages of the pectoralis major flap for 
head and neck reconstruction. Our 
group has also found this to be an 
extremely useful flap holding great 
promise. However, Dr. Fredrickson’s 
statement that “the myocutaneous flap 
has now replaced the free-flap micro­
vascular transfer for most reconstruc­
tive head and neck procedures” is a 
somewhat narrow view.
We presented our experience with 
free flaps as a new development 
worthy of evaluation and discussion. 
This experience has shown that there 
are situations in which a free flap has 
substantial advantages over pedicle 
flaps. In fact use of a free flap in 
certain complex situations is cur­
rently our method of choice. To claim 
that an even newer procedure is ac­
cepted surgical practice is unwise.
Dr. Fredrickson has had a great 
deal of clinical experience with free- 
flap transfers and we would welcome 
a summary of his results with this 
procedure.
: Rewrfep  M, Zu k e rJ m d , fr c s[c]
Division of plastic surgery,
The Hospital for Sick Children, 
Toronto, Ont.
Menis
^Tempore
cectomyj>f the 
emporomandibulaFJointN
To the coeditors.—-In his review of 
214 patients who underwent temporo­
mandibular joint meniscectomy (Can 
J Sura 23: 30, 19801. Dr. Brown’s sta­
tement that “meniscectomy . . .  is the 
surgical treatment of choice for pa­
tients with persistent intermittent 
symptoms of internal derangement of 
the joint, when nonoperative conser­
vative methods of management have 
failed,” is highly controversial and 
must not go unchallenged.
Since establishing a temporoman­
dibular joint clinic at the Ottawa 
Civic Hospital in early 1971 I have 
seen approximately 2000 patients, 
most of whom had the symptoms that 
Dr. Brown suggests are indications for 
meniscectomy. These patients, like the 
ones in his surgical series, have been 
predominantly female and under 30 
years of age. During that time I have 
performed approximately 15 me­
niscectomies. To my knowledge, no 
other surgeon in this referral area is
performing similar surgery and I 
can only assume either that I am not 
doing enough meniscectomies or that 
Dr. Brown is doing too many.
Perhaps it would be appropriate to 
outline the program that I have de­
veloped in Ottawa with the coopera­
tion of local members of the dental 
profession. After initial assessment, in­
cluding history-taking, a physical 
examination and careful evaluation of 
the patient’s occlusion, those with a 
diagnosis of temporomandibular joint 
dysfunction are placed on a conserva­
tive regimen. Restricted opening of the 
mouth is emphasized and patients are 
asked to avoid such habits as clen­
ching the jaw, grinding the teeth, bit­
ing the lips, cheeks, tongue or nails 
and chewing gum. Patients are given 
an instruction sheet explaining the 
nature of their problem and suggest­
ing how they can alter their lifestyle, 
particularly their jaw habits, to obtain 
relief of pain. Those with particularly 
severe symptoms are treated with anal­
gesics, anti-inflammatory agents and 
occasionally injection of local anes­
thetic and Depo-Medrol into the af­
fected joint or joints. Roentgenograms 
are obtained only when there are spe­
cific indications such as a history of 
injury, particularly long-standing 
symptoms or suggestion of an arthritic 
process. Plain films and tomograms 
have been of no value in diagnosis or 
treatment.
In the past 9 years, a few patients 
who have failed to respond to this 
regimen have undergone meniscec­
tomy. The major indication for such 
an operation, however, was not pain 
or clicking, both of which usually re­
spond to conservative measures, but 
severe, persistent trismus interfering 
with routine dental care and diet.
It is regrettable that Dr. Brown’s 
article appeared in the Canadian Jour­
nal of Surgery, a journal widely read 
by surgeons across Canada. It con­
veys to the readership an unjustified 
enthusiasm for a procedure that has 
been severely criticized in the world 
literature. Of particular interest is Dr. 
Brown’s inclusion of patients in the 
10- to 12-year age group. His sug­
gestion that these patients have sur­
gical removal of their meniscus on 
such tenuous indications as pain and 
clicking is without support in the liter­
ature. He should be called upon to
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Sulcrate
(sucralfate)
Gastro-duodena I
Cytoprotective
Agent
Binds to the ulcer to protect it 
from acid, pepsin, and bile, 
up to six hours.
ACT IO NS Sulcrate® (sucralfate) produces an adher­
ent and cytoprotective barrier at the ulcer site. This 
barrier protects the ulcer site from the potential ulce­
rogenic properties of acid, pepsin and bile. Further­
more, sucralfate blocks acid diffusion across the 
sucralfate protein barrier and also complexes directly 
with pepsin and bile.
The action of sucralfate is non-systemic as the drug 
is only minimally absorbed from the gastrointestinal 
tract. The minute amounts of the sulfated disaccha­
ride which are absorbed are primarily excreted in 
the urine.
Experiments have show n that sucralfate is not an 
antacid.
IND ICAT IO NS Sulcrate® (sucralfate) is indicated for 
the treatment of duodenal and non-malignant gastric 
ulcer.
CLINICAL EXPER IENCE IN  D U O D E N A L  ULCER
The safety and efficacy of sucralfate in duodenal ulcer 
has been demonstrated in a number of controlled as 
well as non-controlled studies involving 9 00  patients. 
The drug was compared under double-blind condi­
tions to a placebo or cimetidine.
Diagnosis and clinical findings were controlled with 
endoscopic examinations. The average daily dosage 
utilized was 3 to 4 g  a day and the duration of the 
treatment varied between 4 to 12 weeks.
Over 83% of duodenal 
ulcer patients healed on 
Sulcrate® regimen.
Complete healing of duodenal ulcer was observed in 
83.9% of patients treated with Sulcrate® compared 
to 57.2% of patients treated with a placebo.
In a comparative study of Sulcrate® and cimetidine 
in 46 patients, the healing rate was not statistically 
different for both drugs.
CLINICAL EXPER IENCE IN  GASTRIC ULCER The
effect of sucralfate in gastric ulcer w as evaluated 
under double-blind conditions in approximately 450 
patients. The healing rate for patients receiving 
sucralfate was 74.1% as compared to 53.1% in 
patients receiving a placebo.
In a comparative study of sucralfate and cimetidine 
in 41 patients, the healing rate was comparable in 
both groups of patients.
CO NTRAIND ICATIONS There are no know n contra­
indications to the use of sucralfate. However, the 
physician should read the Precautions section when 
considering the use of this drug in pregnant or pedi­
atric patients, or patients of child-bearing potential. 
W A RN IN G  Proper diagnosis is important since symp­
tomatic response to Sulcrate® (sucralfate) therapy 
does not preclude the presence of a gastric malignancy. 
PRECAUTIONS Recurrence may be observed in 
patients with gastric or duodenal ulcers. While 
treatment with sucralfate can result in complete 
healing of the ulcer, a successful course of treat­
ment with sucralfate should not be expected to alter 
underlying cause of ulcer disease. Use in pregnancy: 
There has been no experience to date w ith the usage 
of sucralfate in pregnant women. Therefore, sucralfate 
should not be used in pregnant women or women of 
child-bearing potential unless, in the judgement of 
the physician, the anticipated benefits outweigh the 
potential risk. Pediatric use: Clinical experience in 
children is limited. Therefore, sucralfate therapy can­
not be recommended for children under 18 unless, in 
the judgement of the physician, anticipated benefits 
outweigh the potential risk.
Exceptional safety— 
non-systemic action.
A D V ERSE  REACTIONS Very few side effects have 
been reported with Sulcrate® (sucralfate). They are 
mild in nature and have only exceptionally led to 
discontinuation of therapy.
The main complaint has been constipation in 1.7% 
of patients.
Other side effects reported included diarrhea, nausea, 
gastric discomfort, indigestion, dry mouth, skin rash, 
pruritus, back pain, dizziness, sleepiness and vertigo.
O V E R D O SA G E  Overdosage has never been ob­
served and appears to be unlikely since, using 
maximal doses of up to 12g/kg/bocfy weight in a 
variety of animal species, a lethal dose could not 
be established.
Sulcrate® protects ulcers 
three ways; without altering 
digestive system function.
M E C H A N ISM  O F  ACT IO N  Results of in-vivo and 
in-vitro studies show  that Sulcrate® (sucralfate) pro­
duced an adherent and cytoprotective barrier at the 
ulcer site which resisted degradation by acid and 
pepsin.
Laboratory and clinical studies indicate that sucralfate 
promotes the healing of gastric and duodenal ulcers 
by a three-way action: ( I ) Formation of a chemical 
complex that binds to the ulcer site to establish a 
protective barrier: (2) Direct inhibition of the action 
of pepsin and bile; (3) Blockage o f the back diffusion 
of gastric acid across the barrier.
The binding of sucralfate w as demonstrated in rats 
with experimentally-induced ulcers. After a single 
dose of sucralfate, the ulcerated organs were excised 
and washed with a fluorescent compound that w as 
taken up by sucralfate. Under ultraviolet light, the 
sucralfate showed affinity for the areas of ulceration, 
substantiating the binding action.
The affinity of sucralfate for the ulcer site was further 
substantiated in a study where patients were 
scheduled for gastric resection. Each patient received 
the same daily dose of sucralfate, with the interval 
from the last dose to operation time varying from 2 to 
16 hours. A t  all of these intervals, the concentrations 
of sucralfate in ulcer craters were 4 to 30 times higher 
than the concentrations in tissue specimens from the 
normal mucosa in the same patients.
The antipepsin activity of sucralfate has been demon­
strated in several in-vitro and in-vivo studies.
In in-vitro studies and on pylorus ligated rat models, 
the presence of sucralfate inhibits pepsin activity of 
the gastric juice, reduces the total acidity and is 
associated with an elevation of gastric fluid pH.
In a clinical study, sucralfate w as administered to 
ulcer patients and the effects on  pepsin activity was 
monitored for 30 minutes after ingestion of the drug. 
Sucralfate doses of 1, 1.5,2,2.5 and 3g reduced pepsin
activity by 32%, 34%, 32% , 4 4 %  and 5 5 %  respectively 
Sucralfate w as show n  to reduce bile salt concen­
tration in-vitro by adsorbing the bile salts onto 
sucralfate in suspension. Glycocholic acid in a buf­
fered solution w as used in the test. The maximum 
amount adsorbed w as approximately 112 m g per 
gram of sucralfate.
Sucralfate's capacity to block the diffusion of acid 
w as demonstrated in an in-vitro diffusion-cell experi­
ment. Sucralfate w as bonded to an albumin film and 
placed between tw o solutions of equal acidity. W hen  
the acidity on  the sucralfate side of the film w as 
increased, a lowering of p H  on  the other side w as 
delayed. Sucralfate delayed the change more than 
twice as long as albumin alone and nearly twice as 
long as albumin plus an antacid. The capacity of 
sucralfate to block acid diffusion w as further sub­
stantiated in a clinical study. Gastric transmural 
potential difference w as measured in normal volun­
teers after the administration of either glycocholic 
acid or sucralfate followed with glycocholic acid. 
The drop in potential difference produced by the 
administration o f glycocholic acid w as reduced w hen  
sucralfate w as administered before glycocholic acid, 
indicating a reduction in the back diffusion of acid. 
During therapy, the physiological functions o f the 
digestive system remain virtually unchanged.
Healing of duodenal 
ulcers often within two 
to four weeks.
D O SA G E  A N D  A D M IN IST R A T IO N  The recom- 
mended adult oral dosage of Sulcrate® (sucralfate) 
for duodenal and gastric ulcer is one tablet of 1 gram 
four times a day, one hour before meals and  at bed- 
tirrte, preferably on  an empty stomach.
For relief of pain, antacids may be added to the 
treatment. However, antacids should not be taken 
within one-half hour before or after sucralfate intake. 
In duodenal ulcers, while healing w ith sucralfate 
often occurs within tw o to four weeks, treatment 
should be continued for 8  to 12 weeks unless healing 
has been demonstrated by X-ray and/or endoscopic 
examinations.
In the case of gastric ulcers, an alternative treatment 
should be considered if no objective improvement is 
observed following 6  weeks of sucralfate therapy. 
However, patients w ith a large gastric ulcer that 
has demonstrated a progressive healing tendency 
may require a longer period of time of treatment.
AVAILABILITY Each white, capsule-shaped com­
pressed tablet contains 1 gram of sucralfate.
To be kept and dispensed in a well-closed container.
Bottles of 100 tablets. ._________ .
Product M onograph  available on request. 1 PA A B ]
"Reg. Trademark, N O R D IC  LABORATORIES, Inc., 
authorized user.
JTJ &0®K®0©
V _ A J  NORDIC LABORATORIES INC
Laval, P.Q. H7S 2A4
defend his recommendations with 
statistical evidence.
[ G. Am w  Taylor , |dds. m d , fr c s[c]
Chief, division of plastic surgery,
Ottawa Civic Hospital, ,
Ottawa, Ont.
To the coeditors.— In response to Dr. 
Taylor’s letter, 1 am quite aware of 
the controversy that rages over the 
management of internal derangement 
of the temporomandibular joint. The 
frequency with which this syndrome 
occurs is indicated by the 2000 pa­
tients that Dr. Taylor has seen in his 
clinic over a 9-year period. All my 
patients have been referred, not only 
within Toronto but from at least a 
dozen other cities and towns as far 
away as Thunder Bay. This shows 
how desperate some patients become 
when conservative methods have 
failed and I can see no reason why 
the surgical correction should be 
withheld from them.
The conservative management to 
which these patients had been sub­
jected included limitation of jaw fun- 
tion, limitation of diet in some pa­
tients to the point of weight loss, 
application of bite blocks and night 
splints, dental spot grinding, inter­
dental wiring, sedation, use of anti­
inflammatory drugs, intra-articular 
injection of cortisone and hypnosis; 
one patient had even been managed 
for 3 months by a herbalist in British 
Columbia.
The referrals have come from fam­
ily physicians, neurologists, neurosur­
geons, orthopedic surgeons, dentists, 
oral surgeons, psychiatrists and other 
plastic surgeons.
In my series the referrals began in 
1952. Dr. Taylor has seen 2000 pa­
tients in 9 years; my patients have 
been carefully selected for surgical 
management out of many thousands. 
I don’t believe that I have done too 
many meniscectomies but too few. 
Having now done about 40 condylec- 
tomies for destroyed joints (the worst 
case of which was in a 29-year-old 
woman in whom the head of the 
joint became fused to the fossa by 
bone in the closed position after pro­
longed hypnosis) I think I should have 
done 40 meniscectomies before the 
onset of degenerative arthritis.
In the world literature on this sub­
ject there is a singular lack of follow­
up presentations, and biased opinions 
excluding surgical correction. I would 
be interested in follow-up statistics of 
Dr. Taylor’s 2000 patients, including 
rates of cure, persisting symptoms and 
the occurrence of destructive arthritic 
changes.
W.A. Br o w n , m d , fr c s[a], facs
V
Division of plastic surgery, , ,
Toronto Western Hospital. /_':Y__
Retained)Calculi ^  
in the Common Bile Ducts)
To the coeditors.— It may be of value 
to report my recent experience with 
retained calculi in the common bile 
duct.
The patient was operated upon because 
of obstructive jaundice. Several calculi 
were removed from the bile duct and 
cholecystectomy was carried out. The 
usual measures of irrigation, exploration 
with stone forceps and sweeping with a 
Fogarty bile duct catheter indicated that 
no further fragments were present. A no. 
14 T tube was sutured into place and 
brought out by the most direct route to 
the skin. An operative cholangiogram 
showed that the bile duct was clear and 
that drainage into the duodenum was 
adequate.
After a smooth postoperative course, 
another cholangiogram disclosed the 
presence of two small stones in the lower 
end of the bile duct.
A small stone basket, which normally 
is used in conjunction with duodenoscopy 
for a transpapillary approach to this 
problem, was threaded easily through the 
T tube with a pre-existing bend in it, so 
that it was seen, fluoroscopically, to 
curve distally into the lower portion of 
the common bile duct.
With three blind passes, manipulation 
of the stone basket and occasional use 
of the image intensifier, both stones were 
removed without dislodging the T tube. 
An immediate T-tube cholangiogram 
showed that the bile duct was clear.
Obviously this technique would not 
be adequate for larger stones but it 
is certainly useful for removing cal­
culi that are small enough to pass 
through the largest T tube. This un­
derlines the importance of inserting 
the largest possible T tube at the time 
of operation.
It is noteworthy that the patient re­
quired no sedation and experienced 
almost no pain.
W. H u r s t , | m d . c m , fr c s[c],DWTTO
FACS
Department of surgery,
Welland County General Hospital, 
\yelland, Ont.
ISX-O
To the coeditors.—I am compiling a 
biography of the late Dr. Harold 
Benge Atlee who was professor of 
obstetrics and gynecology at Dal- 
housie University in Halifax, Nova 
Scotia. If any readers have—or know 
of people who have—photographs,
letters, publications (medical or non­
medical), anecdotes, reminiscences, 
impressions or personal opinions, 
would they please contact me. Too 
often, valuable material is lost be­
cause it is considered insignificant or 
unimportant. On the contrary, every 
scrap of information is valuable.
H*WW OXQRl/ MD, FRCS[C]
Department of obstetrics and gynecology, 
Ottawa Civic Hospital,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
The
To the coeditors.—There comes a 
time in our lives as surgeons, those 
of us who have reached three score 
years and ten, to consider laying 
down the scalpel. At that age we 
have an honorary position in our hos­
pital and are definitely on the descent 
in our profession. What do a few 
more gallbladders, colons, hearts or 
hernias matter? Our keenness has 
diminished from the days when our 
aspirations were great. We are simply 
going through the routine of many 
years past because we have not found 
anything more stimulating.
Surgeons are the worst of all people 
in organizing and preparing for retire­
ment. There is good reason for this. 
To be a competent surgeon, espe­
cially in a university milieu, demands a 
life of dedication. There were 8 years 
of college education with examina­
tions hanging over our heads, 4 to 8 
years of residency training when 
there was hardly enough time to find 
a wife, then the long hours and hard 
work in building up a practice and 
reputation. If we were appointed to 
a teaching hospital there were many 
hours of student instruction, research 
projects and the chief’s unspoken 
command to publish. All hospitals 
required us to work on committees 
and, before universal medicare, to do 
our share of supervising, and opera­
ting on, public ward patients.
All of this was intensely interesting, 
challenging, necessary for advance­
ment and exactly what all our peers 
were doing. We got away from the 
routine on occasion with a Caribbean 
cruise or a trip to Europe especially if 
we could find a medical meeting to 
look in on for income tax purposes. 
We belonged to various surgical socie­
ties and attended meetings.
I am sure you have by now grasped 
the point that you had to be so in­
terested and involved in your profes­
sion that you gave no thought to
Retired Surgeon
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what you would be and do in later 
years and consequently made no pre­
parations for retimement. Check on 
some of your older colleagues and you 
will find, by and large, that they are 
still in harness pecking away at the 
remains of their practice. The medical 
specialists and family practitioners are 
more prone to this than surgeons be­
cause they don’t need the surgeon’s 
manual dexterity. One glaring example 
of not knowing when to retire was 
that of a former chief surgeon who 
was still doing operations in his 80s, 
albeit with his son positioned on the 
executive side of the table. Another 
instance was that of a former head 
of medicine still seeing patients up 
until his death in his early 90s. 
During my internship, we had a sur- 
geon-in-chief who was appointed to 
the position mainly for political 
reasons. His surgical repertoire con­
sisted of appendectomies, cholecystec­
tomies and hernial repairs. One oper­
ation at which I assisted was for a 
rectal cancer. When the abdomen was 
opened, the diagnosis was obvious but 
our hero was either unwilling or un­
able to do the required abdominoper­
ineal resection; he hunted about until
he found an enlarged gland in the sig­
moid mesentery, declared the case in­
operable and did a colostomy. He 
wound up his surgical career sitting on 
a chair in the operating room gowned 
and gloved while a younger surgeon 
did the operation for him. Why didn't 
he face reality and give up before this 
ignominious ending?
You may ask what’s wrong with 
this sort of end to your career; you 
may even be doing the same thing. I 
would say that it is a pity to see a 
once vigorous and influential surgeon 
go downhill and in many instances, 
become a professional nuisance. You 
and I know of many examples of the 
older medical specialists in partic­
ular (surgeons die earlier) moseying 
about the hospital seeing one or two 
patients and speaking out at staff con­
ferences in long-winded fashion all 
because they have nothing else to do.
On the financial side, I cannot be­
lieve that any Canadian surgeon has 
not laid away a good nest-egg unless 
he has blotted his copybook in the 
divorce court or on the stock market. 
Consequently the monetary side of 
retirement should not be a factor.
If you go along with my somewhat
brutal assessment of the 70-plus med­
ical man you might well ask, How do 
I avoid a similar fate? You can’t slam 
the office door tomorrow and head 
for retirement in Florida or British 
Columbia because you will become 
the most bored person alive. Such a 
step takes preparation with a gradual 
weaning away from professional ac­
tivities and a gradual assumption of 
the projects of retired life. What these 
activities will be depends on the in­
dividual and there are numerous pos­
sibilities. Dale Carnegie is constantly 
telling us that our potentials are great 
providing we will only cultivate them 
and this advice applies as well to our 
retirement activities. The world is an 
interesting place and holds a lot more 
than surgery.
A number of ingredients make for a 
successful retirement. A happy m ar­
riage and freedom from financial 
worries are important. Your activities 
must include achievement in some 
line of endeavour because this has 
been the backbone of your life and 
it is essential that the years you have 
left are purposeful. If you are sound 
of wind and limb it is likely that you 
continued on page 435
For post-operative pa­
tients, the bowel may need 
a little gentle prompting to 
begin functioning normally 
again, and that's where 
Metamucil can help. Why 
not recommend a laxative 
that works slowly gently 
and effectively That’s the 
Metamucil way
Metamucil is made 
from (gluten-free) gram, 
providing fiber that 
produces soft, fully formed / 
stools to promote regular 
bowel function.
Available as a powder (low in 
sodium) and a lemon-lime flavoured 
Instant Mix (low in calories).
Why not give your patients our 
helpful booklet about constipation?
Metamucil
The laxative most recom m ended by Physicians.
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To lower 
blood pressure 
during 
anesthesia
Nipride reduces excessive blood loss
.
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Frostbite in Saskatoon: a Review of 10 Winters
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In a review of 101 patients suffering 
from frostbite who were admitted to 
hospitals in Saskatoon during 
10 winters, it was found that alcohol 
consumption was a contributing factor 
in 39 patients and a motor vehicle 
accident or breakdown in 33 others.
Sixty-six patients underwent primary 
treatment in Saskatoon, the other 35 
were referred for management of 
demarcated gangrene. Two hospitalized 
patients died, both of causes unrelated 
to the frostbite. The preliminary 
results of bone scanning with radio­
active technetium methylene di- 
phosphonate in frostbitten patients 
suggest that this is not a good 
prognostic indicator of the ultimate 
extent of tissue loss until 5 days have 
elapsed from the time of exposure.
The lesion appeared to decrease in 
extent and increase in depth over 
a 3-week period.
The mainstays of treatment remain 
rapid rewarming and adequate delay 
before conservative debridement or 
amputation. The delay allows healing 
of partial-thickness injuries and 
demarcation of full-thickness injuries. 
One third of patients receiving primary 
care in Saskatoon required amputation.
L’etude de 101 patients souffrant de 
gelures et qui ont ete hospitalises 
a Saskatoon au cours des 10 hivers, 
a permis de decouvrir que la 
consommation d’alcool avait ete un 
facteur determinant chez 39 malades, 
et un accident de la route ou une 
panne de voiture pour 33 autres.
From the department of surgery, 
University of Saskatchewan, Saskatoon, 
Sask.
*Resident in plastic surgery, University 
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'll  cad, division of plastic surgery and 
clinical professor, department of surgery, 
University of Saskatchewan
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Soixante-six malades ont recu ies 
premiers soins a Saskatoon, Ies 35 
autres etant diriges vers un centre 
pour le traitement d’une gangrene 
iocalisee. Deux malades hospitalises 
sont decedes, tous Ies deux de causes 
etrangeres aux gelures. Une scinti- 
graphie des os au methyle diphosphate 
marque au technetium 99m (isotope 
radioactif) n'est pas un bon indice 
previsionnel de I’etendue finale de la 
perte tissuiaire avant Ies 5 jours qui 
succedent I'exposition au froid. La 
lesion a semble perdre en etendue 
mais augmenter en profondeur au 
cours d'une periode de 3 semaines.
Les grands principes de traitement 
demeurent un rechauffement rapide 
et I’attente d'un delai suffisant avant 
de proceder a un debridement 
conservateur ou a une amputation.
Ce delai permet la guerison des lesions 
moins profondes et la demarcation 
des lesions profondes. Un tiers des 
malades qui ont recu les premiers soins 
a Saskatoon furent dans I'obligation de 
subir une amputation.
Frostbite has plagued man for cen­
turies. It may present as a relatively 
minor injury of the extremities or 
give rise to a serious functional handi­
cap or be a life-threatening traumatic 
incident. Most clinical studies of 
frostbite have been carried out during 
military campaigns.1 Winter condi­
tions in Saskatchewan are such that 
some cases occur every year. This 
paper reviews the experience of three 
hospitals in Saskatoon (St. Paul’s Hos­
pital, Saskatoon City Hospital and 
University Hospital) over 10 years.
Average winter temperatures ob­
tained from the Saskatoon weather 
office (Table I) indicate that January 
is the coldest month of the year with 
a daily mean low temperature of 
-24°C. Temperatures at night regu­
larly fall below -35°C. Wind chill 
also is maximal during January.
There are several forms of localized 
cold injury, including chilblains, 
trench foot, immersion foot and frost­
bite. The appearance of each of these
is determined by environmental con­
ditions.2 The pathologic processes are 
similar in all types of injury. Exces­
sive cold may also affect the body 
generally by causing hypothermia. 
We were not primarily concerned 
with hypothermia in this series al­
though several patients with frostbite 
were also hypothermic.
Patients and Methods
In this retrospective study we re­
viewed the charts of patients suffer­
ing from frostbite who were admitted 
to any of the three main hospitals in 
Saskatoon during the winters of 1969/ 
70 to 1978/79. The study comprised 
101 patients (78 males, 23 females) 
who ranged in age from 3 to 85 years 
(average 40 years). The peak inci­
dence was in the third decade (Fig.
1) . Seventy-three patients were Cau­
casian, 26 were North American In­
dians and 2 were of other origin.
The greatest number of cases of 
frostbite occurred in December (Fig.
2) although January is a colder month. 
The incidence by year was highest 
during 1969/70 (15 patients). Re­
cently, eight patients on average 
have been treated each winter.
We could not obtain accurate de­
tails of the temperature, wind chill 
factor and duration of exposure in 
most of our patients. Many were in­
ebriated at the time of injury, making 
any estimate of their own unreliable. 
Generally the temperature ranged
Table I—Saskatoon Weather Statistics
Daily mean
Month
temperature, °C Mean wind 
chill factor, 
W/m2High Low
October +11 -  1 —
November -  1 -1 0 1655
December -  9 -1 9 1530
January -1 4 -2 4 1680
February -  9 -2 1 1530
March -  3 -1 4 1360
April +  9 -  3 —
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from -20 °C to -40 °C and the dura­
tion of exposure from 6 hours to less 
than 1 hour. The quality of attire on 
hands and feet was obviously inade­
quate in many instances, either 
through accident or forgetfulness.
In all but nine patients there was 
an identifiable reason for the frost­
bite (Table II). Alcohol consumption 
before exposure was noted in 39 pa­
tients. Motor vehicle accident or 
breakdown occurred in 33 cases; 
snowmobiles were involved in 6 
cases. Predisposing illness such as 
diabetes, peripheral vascular disease 
or mental disorder was recorded in 
15 patients. Thirteen patients, listed 
under “other”, were neither drunk 
nor previously ill. They were frost­
bitten for such reasons as hitch-hiking 
on lonely roads and staying on the 
hockey rink too long.
Clinical Findings
and M anagem ent
Sixty-six patients were admitted to 
hospital in Saskatoon within hours of 
exposure and received primary care 
in this city. The remaining 35 patients 
were referred an average of 3 weeks 
after the cold injury for definitive 
operations upon areas of demarcated 
gangrene.
The affected extremities of the 66 
patients treated primarily were classi­
fied according to the proximal extent 
and the depth of injury. Grades 1, 
2 and 3 involved the toes and fingers 
to the phalanges while grade 4 in­
juries extended to the dorsum of the 
hand or foot and grade 5 involved the 
whole hand or foot.3 The depth of 
the lesion was designated by degrees 
from one to four as in burn wounds. 
The method of assessment at the time 
of admission was used to tabulate the 
eventual loss of tissue after healing 
and demarcation.
Table II—-Predisposing Factors in 101 
Patients with Frostbite
Factor No. of patients
Alchohol consumption 39
Walking from 
broken-down car 12
Staying in 
broken-down car 6
Head injury 4
Immobilization due 
to accident 11
Mental disorder 10
Diabetes or peripheral 
vascular disease 5
Other 13
None identified 9
Multiple 8
The results of this study are shown 
in Figs. 3 and 4. The initial assess­
ment of injury in 48 patients was of 
first or second degree. Only five of 
these patients required amputation; 
healing was spontaneous in the others. 
Three of the five who required am­
putation had grade 5 lesions on ad­
mission but gangrene involved little 
more than the phalanges.
In 18 patients the initial assess­
ment was of third or fourth degree 
frostbite. The majority appeared to be 
grade 4 or 5 on admission. The even­
tual loss of tissue in these patients 
was usually restricted to the pha­
langes. Only one patient required am­
putation greater in extent that his 
initial assessment had indicated. In 
general the apparent extent tended to 
decrease and the apparent depth to 
increase, during the period of observa­
tion.
At the time of admission, nine pa­
tients had a body temperature below 
32°C, the lowest being 23.5°C. Nor- 
mothermia was restored in all. It was 
our policy to institute rapid rewarm-
FIG. 1— Age incidence of frostbite by 
decade.
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GRADE (EXTENT OF INJURY)
FIG. 3— Injuries in 66 patients 
assessed on admission to hospital for 
primary care. Circles indicate patients 
who required amputation. Squares in­
dicate those in whom healing was spon­
taneous.
ing of frostbitten extremities and 
observe them until nonviable areas 
were fully demarcated.
During the latter part of the 
study radioactive technetium methy­
lene disphosphonate (99mTc-MDP) soft 
tissue and bone scintiscanning was 
performed in three patients to delin­
eate nonviable tissue. Two patients 
had sustained frostbite of the feet 
and one had frostbitten hands. In 
this patient with a grade 4, second 
degree injury, scintiscanning was per­
formed within 48 hours of injury and 
again at 10 days (Fig. 5). The initial 
scan showed perfusion to the tips of 
all fingers. We were not able to 
predict from this scan that he would 
eventually lose the terminal phalanges 
of three fingers of the right hand, 
although the second scan obtained 10 
days after injury clearly demonstrated 
lack of perfusion to those areas. The 
other two patients were scanned 5
FIG. 2— Monthly incidence of frostbite 
over 10 winters.
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FIG. 4—Tissue loss sustained by 66 
patients undergoing primary care in 
Saskatoon. Circles indicate patients who 
required amputation. Hatched area in­
dicates 43 patients in whom healing was 
spontaneous.
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Fig. 5b
Fig. 5d
FIG. 5— (a) Frostbite of both hands 
in young man who had been in airplane 
crash 24 hours previously, (b) Scintiscan 
obtained at 36 hours shows no abnor­
mality. (c) Scintiscan after 10 days shows 
perfusion to tips of middle, ring and 
little fingers of right hand, (d) Patient’s 
right hand just before operation at 21 
days shows that clinical demarcation of 
nonviable areas on same fingertips has 
taken place.
days and 4 weeks, respectively, fol­
lowing injury. In both cases the scans 
demonstrated the clinically nonviable 
digits quite accurately where circum­
ferential soft tissue necrosis was 
present (Fig. 6). These preliminary 
studies suggest perhaps that 99mTc- 
MDP scintiscanning cannot predict 
tissue loss in frostbite until approxi­
mately 5 days after the injury.
Medical or surgical sympathectomy 
was performed in six patients. Low- 
molecular-weight dextran was infused 
in 12 patients. Heparin was used in 
one patient. Finger decompression 
was carried out in two patients and 
amputation was performed in 23 pa­
tients. Two patients died in hospital; 
one was admitted with bronchopneu­
monia and died of this 6 days later. 
The other patient died suddenly of a 
myocardial infarction 21 days after 
bilateral below-knee amputation for 
grade 5 frostbite.
Twenty-four of the 66 patients who 
underwent primary treatment in Sas­
katoon have been followed up for
Fig. 6a
Fig. 6b
FIG. 6— (a) Patient seen 4 weeks after 
transport failure. Medial three toes of 
right foot are gangrenous, (b) Scintiscan 
delineates gangrenous area; clinical situa­
tion by this time was well defined.
periods of 5 months to 8 years. Un­
stable scarring occurred in five pa­
tients and required a variety of re­
constructive procedures including 
gastrocnemius myocutaneous flap to 
the patellar area in one. Lumbar 
sympathectomy was performed in 
two patients who had persistent pain 
and sweating in previously frostbitten 
extremities.
D iscussion
Deaths due to excessive cold are 
not infrequent in Saskatchewan, aver­
aging 11 annually over the past dec­
ade and accounting for 10% of all 
deaths due to cold in Canada since 
1969. This incidence is twice that 
expected for the population of Sas­
katchewan when compared with the 
rest of Canada (Saskatchewan Health, 
Regina; Personal communication, 
March 1979).
The severity of cold injury varies 
with environmental factors such as 
temperature, duration of exposure, 
humidity and wind chill. Host factors 
which may affect the outcome in­
clude immobility, occlusive vascular 
disease, previous cold injury and pre­
existing sensory deficit. Patients with 
Raynaud’s disease and cryoglobuli­
nemia are also more liable to cold 
injury.4 Because of the many vari­
ables in a given injury the contribu­
tion of each is difficult to determine, 
particularly if the history is unreli­
able. Inebriety was a causative factor 
in 39% of our patients; Knize and 
colleagues1 reported an even higher 
rate in their series.
It is still uncertain whether the 
fundamental injury in frostbite is 
freezing and disruption of the cell 
membrane or whether ischemic 
necrosis secondary to vascoconstric- 
tion and capillary thrombosis is the 
primary event. Extracellular forma­
tion of ice with progressive intracel­
lular dehydration is known to occur 
if the extremity is cooled slowly.5 
Many forms of therapy have been de­
veloped with these mechanisms in 
mind, including the use of anti-slud­
ging agents, anticoagulants and vari­
ous types of sympathetic blockade. 
None of these has proved useful in 
all cases. Porter and associates6 pub­
lished their experience with intra­
arterial sympathetic blockade in frost­
bite using reserpine. Some selectivity 
for their method was introduced by 
kakower, Shahgoli and Wong,7 using 
noninvasive blood-flow measurements 
in frostbitten limbs. Those patients 
who already had maximal flow in the 
palmar or pedal arteries were not
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given reserpine. No conclusions can 
be drawn from our own cases as ther­
apy was not applied in a controlled 
fashion. Rapid rewarming remains 
the only certain treatment in the 
emergency care of frostbite. It works 
by reducing both the warm ischemic 
time of the extremity and the period 
of extracellular hypertonicity.5
There is a tendency to overrate the 
extent of the frostbite injury when 
the patient is first seen;8 this was 
confirmed in our studies. An impor­
tant part of management is to allow 
time for the resolution of first and 
second degree injuries before per­
forming debridement or amputation. 
Tetanus prophylaxis should be con­
sidered in all cases.
Lisbona and Rosenthall0 assessed 
bone viability in frostbite by scinti­
scanning. Our limited experience with 
three patients so far suggests that 
delineation of nonviable areas is not 
accurate before 5 days have elapsed 
from the time of injury. Noncircum- 
ferential soft tissue necrosis may also 
make interpretation difficult. In many 
cases it is the soft tissue injury that 
determines the extent of bone resec­
tion.
The reported frequency of a late 
increase in sympathetic tone in previ­
ously frostbitten extremities is 40% .8 
Unstable scarring is another well rec­
ognized complication.10 Neither of 
these entities were prominent in our 
series.
Frostbite may be prevented or re­
duced by taking a few simple precau­
tions when travelling, such as carry­
ing a winter storm kit (extra clothing 
and footwear, a shovel and an axe, 
sand, extra gasoline, a flashlight and 
matches) and staying in the car in the 
event of a breakdown. In parts of the 
country where cold injury is frequent, 
these principles should be impressed 
upon the public.11
Summary
Winters in Saskatchewan are severe, 
and deaths from excessive cold occur 
regularly. The experience with frost­
bite in three Saskatoon hospitals has 
been reviewed. One hundred and one 
patients have been admitted with 
frostbite during the past 10 years. 
Alcohol consumption was probably 
responsible for injury in 39 cases and 
transport failure in 33 cases.
The prevailing temperature was not 
known in most instances, but gen­
erally temperatures were in the range 
—20°C to -40°C. The apparent ex­
tent of injury decreased and the ap­
parent depth increased in most pa­
tients during the observation period. 
After 5 days have elapsed from the 
time of injury, bone scanning using 
99"'Tc-MDP may help in predicting 
the ultimate extent of gangrene.
Rapid rewarming and an adequate 
period of observation remain impor­
tant aspects in the care of the frost­
bitten patient. Twenty-three of the 66 
patients who received primary care in 
Saskatoon ultimately required ampu­
tation. Two patients in the series died 
of other causes while in hospital.
We are indebted to Dr. A.A. Wilkin­
son for his interpretations of the bone 
scans. We thank Kathee Olynik of the 
Policy Research and Management Serv­
ices Branch for providing statistics on 
fatal cold injuries from Saskatchewan 
Health records and Cliff Hannah of 
the Saskatoon Atmospheric and En­
vironment Service for information on 
weather conditions.
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A propos de 25 cas de rupture traumatique 
de I’aorte thoracique: nouveaux elements diagnostiques
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La rupture traumatique de I'aorte 
thoracique est letale en moins de 3 
semaines chez 95% des patients 
qui ne subissent pas d'intervention 
chirurgicale. Dans cette serie de 25 
malades qui ont ete operes, 84% 
survecurent sans sequelle de para- 
plegie. A I'examen d’un traumatise, 
le mecanisme de I'accident est des 
plus important et se doit d'etre 
precise par le questionnaire du 
malade ou de temoins. Une histoire de 
deceleration rapide (plus de 60 km/h) 
consecutive a un accident de la route 
a ete retrouvee chez tous nos cas. 
Soixante-dix pourcent des malades 
furent ejectes de leur vehicule alors 
qu’ils ne portaient pas de ceinture de 
securite. Un impact lateral entrainant 
une deceleration laterale fut la cause 
d'un traumatisme de I’aorte intratho- 
racique dans 45% des cas. Une chute 
d'une grande hauteur (pont, voie elevee) 
resulta en une deceleration verticale 
dans 25% des cas. Les manifestations 
cliniques ayant une importance 
diagnostique furent une hypertension 
arterielle (60%), un souffle systolique 
(35%) et un syndrome de pseudo­
coarctation (25%). A la radiographie 
thoracique, les observations perti- 
nentes presentes dans 95% des cas
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furent I'elargissement du mediastin 
et I'effacement du bouton aortique.
Les auteurs concluent que I’aorto- 
graphie thoracique devrait etre prati- 
quee chez les patients traumatises 
chaque fois que deux ou plus des 
criteres suivants sont rencontres:
(a) une histoire de deceleration 
rapide, d’ejection d'un vehicule ou de 
collision laterale, (b) une hypertension 
et (c) un effacement ou une deforma­
tion du bouton aortique. L'observation 
d'un syndrome de pseudocoarctation 
est une indication absolue d'aorto- 
graphie.
Traumatic rupture of the descending 
thoracic aorta is lethal within 3 weeks 
in 95% of patients who do not 
undergo operation. In this series of 
25 patients who were operated on,
84% have survived for 6 years and 
there have been no cases of para­
plegia. The mechanism of injury is 
most important in the investigation 
of patients with traumatic injuries 
and must be sought either from the 
patient or from witnesses. A history 
of rapid deceleration (more than 
60 km/h) following a highway collision 
was present in all our cases. Failure to 
wear seat-belts resulted in 70% 
of patients being ejected from a 
vehicle. A side-on collision resulting 
in lateral deceleration caused trauma 
to the intrathoracic aorta in 45% of 
cases. Vertical deceleration resulted 
from falls from great heights 
(bridge, overpass) in 25% of cases. 
Clinical signs of diagnostic importance 
were: arterial hypertension (60%), 
systolic murmur (35%) and the 
pseudocoarctation syndrome (25%). 
Pertinent signs on chest roentgeno­
grams were present in 95% of cases 
and included widening of the medi­
astinum and blunting of the aortic 
knob.
The authors conclude thoracic 
aortography should be carried out in
trauma patients when two or more 
of the following are present: (a) 
history of rapid deceleration, ejection 
from a vehicle or lateral collision,
(b) hypertension and (c) blunting 
or modification of the aortic knob. 
The presence of a pseudocoarctation 
syndrome is an absolute indication 
for aortography.
La rupture traumatique de I’aorte 
thoracique represente une lesion ex- 
tremement letale mais paradoxale- 
ment peu facile a diagnostiquer chez 
certains malades. Seule l’aortographie 
la demontre avec certitude (Fig. 1). 
Cet examen peut s’averer cependant 
tres penible, necessitant le transfert 
souvent mal tolere d’un polytrauma- 
tise en instabilite hemodynamique ou 
respiratoire. Ce risque peut meme se 
reveler injustifie dans certains cas, 
considerant qu’a peine 10% a 15% 
des aortographies demontreront la 
lesion aortique, lorsque Vindication 
angiographique est basee sur les cri­
teres radiologiques classiquement de- 
crits. Faut-il, comme certains auteurs1 
le suggerent, ignorer les manifesta­
tions radiologiques et soumettre a
FIG. 1— Aortographie demontrant le 
faux anevrisme et la fuite de colorant 
dans le mediastin chez un jeune poly- 
trauniatise de 20 ans.
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une angiographie tous les polytrauma- 
tises ayant subi a une deceleration 
rapide? 11 reste encore a demontrer 
la pertinence d’une telle liberalisation 
de l’aortographie. Ce gros probleme 
sera sans doute resolu lorsqu’on pour- 
ra a l’aide de methodes non invasives 
(telle Fechographie) trier sur place les 
malades qui devraient etre soumis a 
une aortographie. Dans le souci im- 
mediat d’adopter une mesure plus 
realiste, 25 cas de rupture aortique 
trades chirurgicalement ont ete re­
vises afin d’en extraire les elements 
de suspicion diagnostique les plus 
pertinents, justifiant une aortographie.
Experience clinique
Du ler juillet 1974 au 30 juin 
1979, a FHopital du Sacre-Coeur de 
Montreal, nous avons opere 28 cas 
de rupture de l’aorte thoracique et de 
ses branches intrathoraciques. La sur- 
vie globale a long terme de nos ma­
lades est de 86% sans aucune se- 
quelle de paraplegie. Ces resultats 
contrastent avec la survie moyenne 
de 5% a 3 semaines telles que rap- 
portee dans la litterature pour des 
patients non operes.2 Nous avons 
lirnite notre etude aux 25 cas de rup­
ture aortique excluant les trois lesions 
traumatiques des vaisseaux de la base. 
Nos observations reposent sur trois 
points essentiels: a) le mecanisme de 
Faccident causal, b) les signes clini- 
ques, et c) les signes radiologiques.
Le mecanisme de I’accident causal
Une tragediq routiere avec decele­
ration rapide est toujours retrouvee 
rnais la vitesse initiale du vehicule 
n’est pas necessairement excessive. 
Dans certains accidents observes a 
des intersections de ville, la vitesse 
ne pouvait pas depasser 50 a 70 
km/h. Le questionnaire du malade, 
des temoins de l’accident, des ambu- 
lanciers ou des policiers devient d’une 
extreme importance si l’on veut pre- 
ciser les circonstances exactes de 
Faccident, essentielles au clinicien. 
Dans notre serie, trois sortes d’acci- 
dent furent retrouvees avec une re- 
marquable Constance.
Une histoire d’ejection (70% des 
cas).—Le passager sans ceinture de 
securite est necessairement projete au 
moment d’un arret brutal. II peut 
etre retenu dans Fautomobile mais 
projete dans toutes les directions a 
Finterieur de l’habitacle. Ou encore, 
il peut s’agir du blesse que l’on 
retrouve souvent a quelques distan­
ces du vehicule. L’example le plus 
manifeste est celui du motocycliste 
qui est transforme, au moment de la
collision, en objet volant non iden- 
tifie. Les lois de la physique nous 
apprennent qu’un sujet ejecte hors de 
son vehicule augmente de 10 fois sa 
force de deceleration lors de l’im- 
pact.2 II a ete observe, dans les exa- 
mens d’autopsie, une incidence dou- 
blee de rupture aortique chez les su- 
jets ejectes.2 La question du port de 
la ceinture de securite devient done 
un element diagnostique determinant 
dans ce type de lesion et notre expe­
rience clinique le confirme.
Un impact lateral (45% des cas).— 
II s’agit de Faccident classique des 
intersections, en ville et a basse vi­
tesse. Le maximum du choc est ab­
sorbs par les parties laterales du ve­
hicule. La deceleration absorbee par 
le thorax se fait egalement dans un 
plan lateral. II est probable que me- 
me une ceinture de securite bien ajus- 
tee protege moins bien Foccupant 
contre un tel mecanisme de decelera­
tion. De plus, la moitie de nos ma­
lades soumis a ce type d’accident ne 
la portaient pas. L’element d’ejection 
s'est done surajoute. Cette combinai- 
son ejection-impact lateral revet pour 
nous une importance capitale dans 
l’anamnese.
Une chute d’une grande hauteur 
(25% des cas).—11 est prouve en 
clinique que l’aorte thoracique sup- 
porte encore plus mal les decelera­
tions verticales que les decelerations 
horizontales. Ceci explique l’inciden- 
ce augmentee des ruptures aortiques 
dans les accidents d’avion. Dans notre 
serie, nous avons retrouve ce meca­
nisme lorsque le vehicule, apres avoir 
capote, fut precipite dans un ravin, 
en bas d’un pont ou d’une voie ele- 
vee.
Signes cliniques
Trois manifestations cliniques fu­
rent rencontrees avec une certaine 
Constance dans notre serie.
Une hypertension arterielle (60% 
des cas).—II s’agit d’une hypertension 
d’ordre systolique pouvant varier de 
150 a 200 mg Hg. Son explication 
reside probablement dans l’etirement 
aigu des plexus nerveux periaortiques 
situes au pourtour du segment aorti­
que traumatise et retracte. Elie n’est 
pas toujours apparente initialement 
lorsque le malade est hypovolemique, 
souvent a cause d’une lesion associee. 
Elle est notee cependant quelques 
heures ou quelques jours apres le 
traumatisme lorsque le volume san- 
guin est restaure.
Un souffle systolique (35% des 
cas).—Parfois tres subtil, parfois tres 
audible au niveau du thorax ante- 
rieur, il se situe avec predominance
cn parasternal gauche ou en sus-cla- 
viculaire gauche.
Un syndrome de pseudocoarcta­
tion (25% des cas).— Une obstruc­
tion mecanique au flot aortique par 
un clapet d’intima engendre un gra­
dient de pression entre les parties 
proximale et distale a la lesion. Com- 
me 90% des ruptures se retrouvent a 
quelques centimetres de la sous-cla- 
viere gauche, il s’ensuit une hyper­
tension dans les membres superieurs 
et une hypotension dans les mem­
bres inferieurs avec parfois absence 
de pouls femoral. Une difference de 
pression entre les deux membres su­
perieurs peut signifier une rupture 
plus proximale interessant l’origine 
de la sous-claviere gauche.3
Signes radiologiques
Parrni les nombreuses observations 
radiologiques mentionnees classique- 
ment dans la litterature, deux des 
plus constantes, rencontrees dans 95% 
de nos cas, ont ete retenues.
La presence d’un hematome me­
diastinal qui elargit parfois le rnedias- 
tin superieur mais surtout qui voile 
les structures anatomiques normale-
FIG. 2— Elargissement marque ilu 
mediastin superieur avec effacement du 
bouton aortique (fleches).
FIG. 3— Deformation du bouton aor­
tique (fleches) par un hematome qui de­
place egalement le tube de Levin a 
droite.
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ment bien delimitees sur line radio- 
graphie simple du poumon (Fig. 2).
L ’e'facement ou la deformation du 
bouton aortique. L’hematome peri- 
aortiq.ie peut imprimer sur le bouton 
aortique une image en forme de trois 
(Fig. 3).
Discussion
A la lumiere de ces 25 cas, nous 
avons realise que l’examen clinique 
peut varier d’un extreme a l’autre. 
En effet, la rupture aortique aigue 
a ete diagnostiquee autant chez des 
malades asymptomatiques et ambu- 
lants que chez d’autres avec atteinte 
multisystematique et en etat de choc. 
Dans notre experience, la plupart 
des maiades presentaient des trauma- 
tismes associes dont 60% etaient 
orthopediques, 30% faciaux ou cra- 
niens et 25% intra-abdominaux. Ces 
traumatismes concomitants facilement 
observables offrent le piege facile 
de les considerer comme prioritaires 
tout en ignorant la lesion intratho- 
racique potentiellement mortelle. Cet­
te erreur peut se glisser avec d’autant 
plus de facilite que l’on constate que 
50% de nos malades ne demon- 
traieiit aucun signe thoracique ex- 
terne ni aucune fracture de cotes 
capable d’attirer au moins l’attention
du clinicien sur le thorax. Le plus 
surprenant, compte tenu de la gravite 
de cette pathologie, c’est que 27% 
de nos malades se sont presentes a 
la salle d’urgence soit ambulants, soit 
semi-ambulants, n’etant limites que 
par des blessures orthopediques ou 
faciales mineures.
Conclusions
Ces 25 malades, malgre leurs ma­
nifestations cliniques variables, avaient 
tous un point en commun. Tous ont 
ete victimes d’un accident violent 
de la circulation avec deceleration 
rapide. Le meilleur indice diagnosti- 
que est done l’histoire que l’on peut 
obtenir de l’accident quelle que soit 
1’apparence externe du malade. Une 
histoire d’ejection, d’impact lateral, 
ou de chute libre d’une grande hau­
teur doit etre recherchee de faqon 
systematique. Parmi les trois signes 
cliniques mentionnes, l’hypertension 
et le souffle systolique se retrouvent 
frequemment mais seul le syndrome 
de pseudocoarctation signe le diagnos­
tic de faqon presque certaine. Les 
modifications du mediastin superieur 
sont constantes dans les ruptures aor- 
tiques mais non-specifiques puisqu’el- 
les sont causees, la plupart du temps 
lors de traumatisme thoracique, par
des ruptures de vaisseaux mediasti- 
naux secondaires. L’aortographie 
prouve la lesion et doit etre faite chez 
tout polytraumatise presentant au 
moins deux des criteres suivants. Le 
pourcentage mentionne traduit leur 
frequence telle qu’observee dans no­
tre serie: une histoire de deceleration 
rapide (100%), une histoire d'ejec- 
tion (70%), une hypertension arte- 
rielle (60%), un impact lateral (45%) 
et un effacement ou une modification 
du contour du bouton aortique (95%).
Nous n’insisterons jamais trop sur 
le fait que trois des cinq criteres ne 
peuvent etre precises que par l’obten- 
tion d’une description exacte de l’ac- 
cident. Dans le diagnostic des rup­
tures fermees de 1’aorte thoracique, 
le questionnaire garde done sa prio- 
rite sur l’examen clinique.
n  j. >-J^  C- S’j CXurvuD'lldkU ( QjuiC/
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Between July 1974 and August 1978, 
78 patients were entered into a study 
to assess the effect of immune 
stimulation with bacille Calmette 
Guerin (BCG) on gastric carcinoma. 
Patients were selected in random 
fashion for the two treatment 
regimens: 41 received BCG and 5- 
fluorouracil and 37 received 5-
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fluorouracil alone. Initial results, after 
a mean follow-up of 72 weeks, are 
presented.
Immunotherapy as used in this 
study did not affect survival. How­
ever, 5-fluorouracil given as an 
adjuvant to palliative resection did 
improve survival when compared 
with a matched control group in which 
patients received no additional 
treatment after palliative resection. 
Although this finding will have to be 
studied further by multicentre 
randomized prospective trials, our 
experience indicates that incurable 
gastric carcinoma should be managed 
more aggressively.
Entre juillet 1974 et aout 1978, 78 
patients ont ete inclus dans une etude 
visant a evaluer les effets d’une 
stimulation immunitaire par le bacille 
Calmette-Guerin (BCG) sur le cancer 
de I’estomac. Les patients se virent
attribuer selon un mode de distribution 
au hasard I’un ou I’autre de deux 
regimes therapeutiques; 41 recurent 
du BCG et du 5-fluorouracile, et 
37 requrent du 5-fluorouracile seul.
On presente les resultats initiaux 
apres une periode de surveillance 
moyenne de 72 semaines.
L’immunotherapie utilisee dans cette 
etude n’a pas modifie la survie. 
Toutefois, le 5-fluorouracile administre 
comme traitement d’appoint a la 
resection palliative a ameliore la 
survie, comparativement a un groupe 
temoin comparable dont les patients 
n’avaient recu aucun traitement 
additionnel apres une resection 
palliative. Cette observation devra 
etre etudiee davantage dans des essais 
prospectifs multicentriques randomises: 
toutefois, notre experience indique 
que les cancers gastriques incurables 
devraient etre traites de facon 
plus agressive.
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Surgical resection remains the only 
curative therapy available for gastric 
cancer. However, the problem of such 
resection today is similar to that in 
1S81 when Billroth performed the 
first subtotal gastrectomy for cure in 
an advanced adenocarcinoma— while 
the tumour was resectable the patient 
died of metastatic disease 4 months 
later. It is still rare for more than 5% 
to 15% of any given population of 
patients with gastric cancer to be re­
ported as cured,1'5 because in a large 
proportion the disease is in an ad­
vanced stage when it is first detected 
and because the biologic behaviour of 
this type of cancer is particularly ag­
gressive. Further improvement in sur­
vival will only be possible with im­
proved systemic or local adjuvant 
therapy after resection. While chemo­
therapy has been used, it has not im­
proved survival so far.6'8
This report will document the pre­
liminary clinical results of a ran­
domized prospective trial with 5-flu- 
orouracil (5-FU) and the systemic use 
of bacille Calmette Guerin (BCG) in 
patients with gastric cancer at various 
clinical stages.
The survival of a group of patients 
with gastric cancer from the same in­
stitution and time period of this trial, 
but who were not entered into the 
trial, will also be reported and com­
pared to the treatment group.
Patients and M ethods
From July 1, 1974 to Aug. 31, 
1978, 78 patients with pathologically 
proven carcinoma of the stomach were 
entered into the study. There were 54 
men and 24 women. Eighteen patients 
underwent resection for cure, 29 with 
microscopic or gross metastatic dis­
ease underwent resection for pallia­
tion and 31 had unresectable or me­
tastatic disease, or both. The aver­
age age for these patients was 60
years (range 34 to 76 years). The 
disease was staged as recommended 
by the American joint committee for 
cancer staging and end results re­
porting.9 Of the 18 patients who had 
resection for cure, 3 had stage I dis­
ease, 4 had stage If and 11 had stage 
III disease.
After they had given their informed 
consent, patients were randomized in 
two groups: in group 1 were 41 pa­
tients (33 men and 8 women) who re­
ceived BCG and 5-FU (Table I); of 
these 41 patients, 11 had a curative 
operation and 18 a palliative one; 12 
had no resection. In group 2 were 37 
patients (21 men and 16 women) who 
received 5-FU only (Table I); 7 had 
a curative operation, 11 a palliative 
resection and 19 had no resection. The 
majority of patients had severe febrile 
reactions to the initial intraperitoneal 
dose of BCG and after 1 year of the 
study the 2.0-mg dose was reduced 
to 0.5 mg. The duration of chemother­
apy and BCG administered orally 
ranged from 72 to 96 weeks. Aside 
from the initial febrile reaction with 
BCG all patients tolerated either form 
of therapy without serious symptoms.
The two groups of patients in the 
prospective study were compared to 
another group of 38 patients (group 3) 
who had undergone resection for gas­
tric carcinoma at the same institution 
during the same time period, but 
who had not been entered into the 
study. They were of comparable age 
(average 65 years, range 37 to 82 
years) and sex (25 men, 13 women); 
17 had undergone curative resection 
(4 with stage I disease, 10 with stage 
II and 3 with stage III) and 21 had 
had palliative resection.
Patient entry into this trial has ter­
minated but the follow-up continues. 
The average follow-up is 72 weeks 
(range 6 to 167 weeks). The trial has 
been evaluated primarily in terms of 
overall survival. Corrected life-table
survival curves compare the various 
groups.
Results
Fig. 1 shows the overall survival 
rate in the randomized prospective 
trial patients (groups 1 and 2). While 
there was an early difference in sur­
vival, this changed rapidly and at 167 
weeks no significant difference in 
survival was noted between the two 
groups. Thus BCG as a nonspecific 
adjuvant for gastric cancer combined 
with 5-FU does not appear to affect 
survival when administered by the 
two routes used in this study. The 
various patient groups were then an­
alysed separately according to the 
stage of their disease. Since the ad­
ministration of BCG did not improve 
survival, groups 1 and 2 were pooled 
and reclassified according to wheth­
er they had curative of palliative re­
section (Fig. 2) and were compared 
with group 3 patients who had re­
ceived no additional therapy and were
FIG. 1— Overall survival rate of 
groups 1 and 2 (chemoimmunotherapy, 
consisting of bacille Calmette Guerin 
and 5-fluorouracil and chemotherapy, 
consisting of 5-fluorouracil alone) as de­
termined by life-table survival curves. 
Solid line =  group 1, dotted line =  
group 2.
FIG. 2— Life-table survival curves 
comparing randomized treated group (T) 
with matched control group (C). Treated 
group was pooled according to type of 
resection (i.e., stage of disease).
Table 1— T re a tm e n t R egim en fo r th e  Tw o Groups of P atien ts  Who Received  
C hem oim m unotherapy (G roup 1 ) and Chem otherapy A lone (G roup 2)
T re a tm e n t
T im e
Group 1 Group 2
(BCG and 5 -F U ) (5 -F U )
A t operation  
P ostoperative ly , wk
2 mg BCG in tra p e rito n e a lly  (o r  
p ostop era tive ly  v ia  c a th e te r)
-
3 Loading course of 5 -FU : Loading course of 5 -F U :
15 m g /kg  d a ily  IV  X4 15 m g/kg  d a ily  IV  X4
4 BCG 120 mg o ra lly —
5 - 7 5-FU  15 m g /kg  IV 5 -F U  15 m g /kg  IV
8 BCG 120 mg o ra lly —
BCG =  bacille C a lm e tte  G uerin , 5 -FU  =  5 -fluorourac il.
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not entered into this study. It is ap 
parent from Fig. 2 that the survival 
at 167 weeks of those patients who 
had curative resection was excellent, 
regardless of whether they received 
adjuvant therapy. This result is better 
than that previously described in the 
literature.4,10'12 However, adjuvant 
therapy does appear to affect those 
patients who have had a palliative re­
section and, since there is no dif­
ference between the survival in groups 
1 and 2 (BCG and 5-FU, and 5-FU 
alone), this may be related to the 
prolonged (18 to 24 months) use of 
5-FU in our study.
Discussion
Nonspecific immune stimulatory 
therapy in patients with resectable or 
unresectable gastric cancer does not 
appear to affect survival in any way. 
This is comparable to' the findings 
of previous reports on the oral 
use of BCG in patients with lung 
cancer13 but is in contrast to the 
study of McNeally and associates14 
who used BCG intrapleurally in pa­
tients with lung cancer. Intraperitoneal 
use of BCG does not appear to have 
a positive effect on gastric cancer in 
contrast to BCG given intrapleurally, 
but there are several differences be­
tween our study protocol and that of 
McNeally and colleagues for lung 
cancer. McNeally’s group gave isonia- 
zide routinely after BCG treatment 
and used a lower dose and a different 
source of BCG. They did not add oral 
BCG or chemotherapy to the protocol. 
However, the general trend in clinical 
and experimental studies indicates that 
nonspecific adjuvant immune stimul­
atory therapy does not usually improve 
the general immune response to can­
cer.15 This is probably related to the 
fact that the immune response to neo­
plastic cells can be either positive or 
negative and that nonspecific adjuvant 
immunotherapy may stimulate either 
one. It appears therefore that the 
future of immunotherapy rests on 
more specific stimulation using altered 
autologous or allogeneic antigen plus 
adjuvant or specific stimulation of 
subpopulations of lymphoid cells in 
the immune system.
The adjuvant effect of 5-FU on pa­
tients in our series who had a palliative 
resection is noteworthy and certainly 
deserves further study. Our prelimi­
nary data suggest that a more aggres­
sive approach should be considered for 
the patient who at laparotomy is 
found to have incurable disease. Pal­
liative resection instead of bypass will 
not only improve the quality of
survival but may also prolong it sub­
stantially. Since this report is from 
one institution the possibility of a mul­
ticentre randomized prospective trial 
comparing various types of chemother­
apy (e.g., 5-FU alone, and the com­
bination of 5-FU, doxorubicin and 
mitomycin C, with which recent 
favourable results have been re­
ported16) should be considered for the 
palliative group.
It is too soon to offer an explana­
tion for the improved survival at our 
institution in the patients from whom 
all gross tumour could be removed at 
the time of the initial surgery. Fur­
ther follow-up is required. Possibly, 
the improved survival rate reflects 
earlier diagnosis (and consequently 
surgery for more favourable lesions). 
Perhaps it is a reflection of a change 
in the natural history of the disease 
itself.
Conclusion
The nonspecific immunotherapy 
used as an adjuvant in this study had 
no effect on survival. Other ap­
proaches to adjuvant therapy including 
more specific immunotherapy and a 
palliative resection with various com­
binations of chemotherapy must be 
explored. This can only be done by 
randomized prospective trials carried 
out in many cooperating centres.
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Twenty-nine cases of pancreatic 
pseudocyst requiring operative manage­
ment were reviewed to determine 
the method of diagnosis and to analyse 
the results of internal and external 
drainage. Pain and the presence of an 
intra-abdominal mass were the two 
most common clinical features in the 
29 patients. Serum amylase values 
were elevated in 50%. Diagnosis was 
confirmed by barium contrast ro­
entgenography and abdominal 
ultrasonography in 60% of cases. 
Endoscopic retrograde cholangio­
pancreatography was a valuable 
diagnostic technique in four problem 
cases.
The most common form of surgical 
treatment was internal drainage of the 
pseudocyst (18 patients). The mortality 
resulting from internal drainage was 
6% and there was an overall 
complication rate of 44%. External 
drainage was carried out in seven 
patients (six required emergency 
operation). The mortality associated 
with external drainage was 43% 
and the overall complication rate 86%.
Vingt-neuf cas de pseudokystes pan- 
creatiques necessitant une intervention 
chirurgicale ont ete etudies afin d'en 
determiner la methode de diagnostic 
et d’analyser les resultats d’un drainage 
interne ou externe. La douleur et 
la presence d'une masse intra- 
abdominale furent les signes cliniques 
les plus souvent retrouves chez ces 
29 patients. Une elevation de 
I’amylasemie fut notee dans 50% 
des cas. Le diagnostic fut confirme 
par radiographie en contraste au 
barium et par echographie ultra- 
sonique abdominale dans 60% des 
cas. La cholangiopancreatographie
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endoscopique retrograde represents 
une technique de diagnostic valable 
dans quatre cas difficiles.
La procedure chirurgicale la plus 
frequente fut le drainage interne 
du pseudokyste (18 patients). La 
mortalite rattachee au drainage interne 
fut de 6% alors que le taux de 
complication global fut de 44%.
Un drainage externe fut pratique chez 
sept patients (dont six necessitant 
une operation d'urgence). La mortalite 
associee au drainage externe fut de 
43% et le taux de complication 
global de 86%.
The prevalence of pancreatic pseudo­
cysts following acute pancreatitis is 
reported1,2 to range from 2% to 10%. 
Despite this low rate, high morbid 
ity and mortality have made pan­
creatic pseudocysts an important 
surgical entity. The operative mor­
tality for both emergency and elec­
tive drainage has been reported3-5 in 
the range of 3% to 11% and post­
operative complications are fre­
quent.6,7 The management of pan­
creatic pseudocysts continues to be 
problematic. The acute pseudocyst 
may regress spontaneously, it may 
give rise to potentially lethal com­
plications necessitating emergency 
external drainage or it may persist 
to become a chronic pseudocyst 
which is usually treated by internal 
drainage. We report our experience
Table 1—C linical Features
Feature No. of patients (% )
Symptom
Pain 28 (97)
Nausea and vom iting 16 (55)
Anorexia 10 (34)
Weight loss 10 (34)
Fever 6 (21)
Melena 5 (17)
Hematemesis 2 (7)
Sign
Tenderness 18 (62)
Abdominal mass 15 (25)
Hepatomegaly 7 (24)
Jaundice 6 (21)
Pleural effusion 5 (17)
Ascites 4 (14)
Splenomegaly 11 (38)
with 29 pancreatic pseudocysts 
treated surgically. We analyse the 
indications for, and the results of, 
external cutaneous drainage and in­
ternal cystoenterostomy.
Patients and Methods
We carried out a retrospective re­
view of 29 patients (15 women, 14 
men) who were operated upon for 
pancreatic pseudocyst at the Victoria 
General Hospital in Halifax and the 
Halifax Infirmary between 1973 and 
1978. The age range of the patients 
was 22 to 90 years (mean 53 years)). 
The pertinent data concerning clinical 
presentation, biochemical values, 
radiologic diagnostic procedures, sur­
gical therapy and postoperative com­
plications were abstracted and anal­
ysed.
Findings
The cause of pancreatitis was 
biliary tract disease in 11 patients, 
alcoholism in 9, hyperlipidemia and 
trauma in 1 each; 7 patients were 
classified as having idiopathic pan­
creatitis. Pseudocysts developed in 
14 patients during their first docu­
mented attack of pancreatitis. In the 
other 15 patients, the development 
of pseudocysts was preceded by sev­
eral attacks of pancreatitis.
Signs and Symptoms (Table I)
Pain was the most frequent symp­
tom (28 patients). The location of the 
pain was epigastric in 17, in the right 
upper quadrant, in 6 and left upper 
quadrant in 6; pain radiated to the 
back in 10 patients. Ten patients were 
anorectic and had weight losses rang­
ing from 4.5 to 27.2 kg. Bleeding 
occurred in seven patients; a history 
of melena was obtained in five and 
hematemesis was present in two.
On palpation, 18 patients had ab­
dominal tenderness and 15 of them 
had an abdominal mass. This mass 
was detected on admission in 5 pa­
tients and developed within 2 weeks 
of admission in the other 10 patients. 
Hepatomegaly was noted in seven pa­
tients. Jaundice was present on ad-
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mission in four and developed subse­
quently in two other patients. Five 
patients had pleural effusion and 
four had pancreatic ascites.
Diagnosis
The diagnosis was suspected on 
clinical grounds and was confirmed 
by serum biochemical measurement 
or radiologic examination, or both. 
Serum amylase values were elevated 
in only 14 of the 29 patients. Ten 
patients had abnormal findings on 
radiologic studies of the gastrointes­
tinal tract with barium. The upper 
gastrointestinal series showed dis­
placement of the stomach or duode­
num in eight patients and in two pa­
tients studies performed after a 
barium enema gave abnormal re­
sults. Abdominal ultrasonography be­
came available in the latter part of 
the study and was used to confirm 
the presence of a pancreatic pseudo­
cyst in nine patients. In four of five 
problem cases, endoscopic retrograde 
cholangiopancreatography (ERCP) was 
used successfully to demonstrate the 
pancreatic pseudocyst; arteriography 
was used in the fifth case.
The diagnosis was correctly made 
before operation in 21 of the 29 
patients (72%). Of the eight pa­
tients whose preoperative diagnosis 
was incorrect, three presented with in­
tra-abdominal masses which were not 
thought to be pseudocysts; the other 
five patients were thought to have 
peptic ulcer or biliary tract disease. 
These patients presented before the 
routine use of abdominal ultrasono­
graphy for the investigation of sus­
pected pancreatic pseudocysts.
Indications for Operation
The indication for operation in 15 
of the 21 patients in whom the diag­
nosis was correctly made preoperatlve- 
ly was a mature symptomatic pseu­
docyst; in the other 6 patients the 
indication was an acute complication 
of the pseudocyst. Of the patients 
who had elective drainage of the 
mature pseudocyst, five had a clini­
cally expanding abdominal mass, six 
presented with signs of biliary out­
flow tract obstruction, one had 
symptoms of duodenal obstruction 
and three had a chronic pseudocyst. 
In the six patients who underwent 
emergency operation for complica­
tions of the pseudocyst, the indica­
tions for operation were: sepsis in 
two, uncontrolled gastrointestinal 
hemorrhage in two and progressive 
ascites in two.
Operations Performed
Twenty-seven patients had a defi­
nitive operative procedure. In 18 pa­
tients the pseudocyst was drained 
into the gastrointestinal tract; in 12 
patients a cystogastrostomy was con­
structed, in 5 patients a cystoje- 
junostomy using a defunctionalized 
limb of jejunum was constructed by 
the means of a Roux-en-Y proce­
dure and in 1 patient a cystoduode- 
nostomy was established. In this series 
external drainage of the pseudocyst 
was restricted to the high-risk patient; 
this procedure was carried out in 
seven patients. All six patients who 
presented with acute complications 
of the pseudocyst necessitating emer­
gency operation underwent external 
drainage. Excision of the pseudocyst 
by partial distal pancreatectomy was 
performed in two patients. Two other 
patients had only a laparotomy.
Postoperative Course
Four (14%) of the 29 patients died. 
Complications occurred in 14 (48%) 
of the 29 patients. Of the 18 patients 
treated by internal drainage, 1 (6%) 
died, and 8 (44%) had complications. 
Of the seven patients treated by ex­
ternal drainage, three (43%) died 
and six (86%) had complications. 
Morbidity was related to septic com­
plications and their sequelae of mul­
tisystem organ failure. Intra-abdomi­
nal abscesses developed in five pa­
tients with associated septic shock in 
one; wound infection occurred in 
two patients. Adult respiratory dis­
tress syndrome with a progressive 
shunt requiring ventilatory support 
developed in three patients. Postoper­
ative gastrointestinal bleeding asso­
ciated with erosions of the stress type 
occurred in three patients. Two pa­
tients had renal failure and one pa­
tient had pancreatitis postoperatively. 
Two patients had pneumonia, one 
had gastric fistulas and one had a 
myocardial infarction.
Analysis of Mortality Data
Mortality and morbidity were re­
lated to acute complications of the 
pancreatic inflammatory process and 
the patient’s underlying medical con­
dition rather than to the type of 
surgical drainage procedure employed. 
There were no intraoperative deaths 
or intraoperative complications re­
lated to either internal or external 
drainage of the pseudocyst. The 
causes of death in the four patients 
with pancreatic pseudocysts treated
by operative drainage were as fol­
lows: hepatorenal syndrome in a pa­
tient with severe alcoholic liver dis­
ease; superinfection with Cryptococ­
cus sp. in the recipient of a recent kid­
ney transplant who was being given 
steroids and im m unosuppressive 
agents; adult respiratory distress syn­
drome in a patient with pancreatic 
ascites and chylous pleural effusion; 
and recurrent hemorrhagic pancrea­
titis secondary to hyperlipidemia with 
multiple intra-abdominal abscesses 
and gastrointestinal hemorrhage sec­
ondary to gastric erosions.
Long-Term Follow-Up
The long-term follow-up of pa­
tients treated by internal drainage 
has been satisfactory. Of the 17 
survivors only 1 had recurrent pan­
creatitis and this was associated with 
a recurrence of the pseudocyst.
Discussion
The natural history of pancreatic 
pseudocysts is uncertain.8 The fre­
quency of occurrence1’2 has been re­
ported to be 2% to 10% of patients 
with pancreatitis. However, it has 
been shown that pancreatic pseudo­
cysts may regress spontaneously, par­
ticularly if they are small; some may 
remain detectable but produce no 
symptoms while others may gradually 
enlarge to compress adjacent struc­
tures producing symptoms of biliary 
outflow tract or duodenal obstruction 
and a small number may cause acute 
complications. Complications may 
arise when the pseudocyst either be­
comes infected or erodes into a nearby 
blood vessel to produce bleeding into 
the gastrointestinal tract or ruptures 
into the peritoneal cavity. This rup­
ture may be slow and results in the 
development of pancreatic ascites or, 
more rarely, there may be a sudden 
release of cyst contents into the peri­
toneal cavity, presenting as a catas­
trophic collapse.
The complaint of abdominal pain 
with findings of tenderness and an 
abdominal mass, present in over 50% 
of patients, and the development of 
chronic or acute gastrointestinal 
bleeding in 25% of patients are com­
parable to the findings in most other 
reports.1,2,4 Pancreatic ascites was 
present in four (14%) of our patients 
and there are several reports5,9 of its 
association with pancreatic pseudo­
cysts. Serum amylase values were not 
diagnostic, being elevated in 14 pa­
tients (48%). Similar figures confirm­
ing the low sensitivity of amylase de-
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terminations were reported by Win- 
ship.8
Before the routine use of abdomi­
nal ultrasonography in the evaluation 
of patients suspected of having pan­
creatic pseudocysts, the diagnosis was 
not reliable. The eight patients in 
our study in whom an incorrect pre­
operative diagnosis was made pre­
sented before abdominal ultrasono­
graphy was used. This technique has 
been reported to have a diagnostic 
accuracy in pancreatic pseudocysts 
of approximately 85% to 90%.2,111 
Roentgenography of the upper gas­
trointestinal tract after a barium 
meal has become a routine and com­
plementary tool for evaluating pan­
creatic pseudocysts and aids in ac­
curate localization. In four patients 
in whom the diagnosis was suspected 
clinically but not confirmed by ab­
dominal ultrasonography, ERCP was 
used successfully. Because Bilbao 
and colleagues” reported a complica­
tion rate of 13%, associated mor­
tality of 2% and a nonvisualization 
rate of 40% with ERCP, we have not 
used this technique routinely, but 
have reserved it for investigation of 
suspected cases with negative findings 
on ultrasonography pr in cases of 
pancreatic ascites.12 Recently, Frey4 
has argued strongly for the routine 
use of angiography in the preopera­
tive evaluation of these patients be­
cause of the demonstration in his 
series of a 10% rate of pseudo­
aneurysms associated with pancrea­
tic pseudocysts. We used angio­
graphy only in evaluating patients 
with bleeding either pre- or post- 
operatively.
The management of pancreatic 
pseudocysts remains difficult and 
must be individualized. However, 
from a review of the literature2,4,8'13 
and the information from this study, 
we have adopted a number of guide­
lines. Asymptomatic patients with 
pancreatic pseudocysts demonstrated 
by ultrasonography to be 4 cm or 
less in diameter should have follow­
up ultrasonography at intervals of 
3 to 4 weeks. As many as 80% of 
these cystic masses may regress spon­
taneously.14 But the appearance of 
pain, biliary tract or duodenal ob­
struction, bleeding into the gastro­
intestinal tract or an increase in pseu­
docyst size requires reassessment and 
consideration of operative interven­
tion. The optimal time for operation 
is still debatable, since the success 
of an internal drainage procedure de­
pends upon the maturation of the 
pseudocyst wall to an adequate thick­
ness capable of retaining sutures.
An interval of 6 weeks from time of 
diagnosis to operation allowing for 
maturation of the pseudocyst is usu­
ally proposed4,6-13 and mortality fig­
ures of 60% and 9% for patients un­
dergoing internal drainage before and 
after 6 weeks from time of diagnosis,3 
strongly support this opinion. The 
indications for emergency operation 
are rapid enlargement of the pseudo­
cyst, increasing abdominal tenderness, 
signs of intra-abdominal or systemic 
sepsis, or both, occasionally massive 
gastrointestinal hemorrhage and, more 
rarely, rupture of the pseudocyst. 
Six of our patients presented with 
an acute complication of the pseudo­
cyst requiring emergency operation.
Although the best operation for 
the elective drainage of a mature 
pancreatic pseudocyst remains con­
troversial, most2,4,13 prefer an inter­
nal drainage procedure, whereas a 
minority1 support the use of external 
drainage. Eighteen of our patients 
underwent internal drainage and cys- 
togastrostomy was the most common 
procedure. The decision as to the type 
of internal drainage procedure de­
pends on the location of the pseu­
docyst and its adherence to an asso­
ciated viscus. When there is no ad­
herence between pseudocyst and 
stomach or duodenum, the pseudo­
cyst should be drained into a 
defunctionalized Roux-en-Y loop of 
jejunum. All authorities2,4,8,13 agree 
that external drainage should be per­
formed in pseudocysts when there is 
an acute complication such as rupture 
or sepsis, or when the wall of the 
pseudocyst is immature. Although 
the mortality and morbidity rate for 
patients treated by external drainage 
in this series was much greater than 
those managed by internal drainage, 
it must be appreciated that the two 
groups of patients are not comparable 
since the patients undergoing ex­
ternal drainage were far more ill 
and six of these seven patients pre­
sented with an acute complication of 
the pseudocyst requiring emergency 
operation. The mortality in this series 
was not related to the type of surgical 
procedure performed but correlated 
with the severity of the pancreatic 
disease process and concurrent medi­
cal problems. The postoperative 
morbidity associated with both types 
of surgical drainage procedure was 
related to sepsis and underlines the 
need for adequate bacteriologic cul­
tures at the time of operation and 
close clinical monitoring postopera- 
tively to detect and manage sepsis 
and its sequelae.
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CORRESPONDENCE 
continued from page 419
will choose something requiring a modicum of physical effort; if you are 
less able physically your efforts will turn to more intellectual and artistic 
interests. To retire with the idea of 
playing golf every day as so many 
Americans do is merely putting in time. Constant repetition is stultifying.
You have probably gathered that 
this communication is personally 
biased and you may be interested in 
how I arrived at the foregoing thoughts.
At the age of 60 I realized that I was not going to be a full pro­fessor or chief surgeon and visualized 
the surgical future stretching on with 
more arterial grafts, aneurysms and 
so on, extending to the day when I 
would not be able to cope. From that 
age on my wife and I took more and 
more time from practice until at the 
age of 70 it was 8 months away and 4 
on the job. Having been one of the 
fortunates who practised before med­
icare our financial future was assured. 
We built a house on the Island of 
Grenada, a gorgeous spot where the
horticulturist is in seventh heaven. The political climate there deteriorated progressively and, after 7 years of part- time occupancy, we moved to Mount Dora, Florida where the horticultural opportunities are almost as good and which has the advantage of being a stable, modern, well policed area. My wife is a flower show judge as well as 
a keen gardener and our activities mesh well on our extensive property where everything from pomegranates to 
avocados and every variety of citrus 
fruit are grown.
To keep the mind functioning, 1 
write a weekly newspaper column on 
subjects of national and international 
interest but there is always time for 
the odd game of golf. I hope you 
don’t think all this is a piece of brag­
gadocio from a smug old rascal, but 
one’s personal experiences are always the clearest and, as such, illustrate 
some of the thousands of ways a 
meaningful and happy retirement can 
be achieved.
« w « r C .  L u k e .^m d . frcs[c ], fr c s
Box 43-route 1,Mount Dora, Fla.
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SESAP III Question
424. Nonfamilial rectal and colonic polyps in children are
(A) not premalignant
(B) the commonest cause of rectal bleeding
(C) a frequent cause of intussusception
(D) often associated with Hirschsprung’s disease
(E) equally distributed throughout the colon
For the incomplete statement above select the answer that is best of the 
five given.
For the critique of Item 424 see page 494 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Educa­
tion and Self-assessment Program No. 3. For enrolment in the Surgical 
Education and Self-assessment Program No. 3, please apply to the 
American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
VOLUME 23, NO. 5, SEPTEMBER 1980 / THE CANADIAN JOURNAL OF SURGERY 435
A  Major Advance in Controlling 
Upper Gastrointestinal 
Bleeding (§
Tagamet r o
mm INJECTION “ W
(cunetidine)
>
1. Muhe, E., et al: Proceedings of Brussels Symposium on Cimetidine, 1977.
2. Dunn, D.H., et al: Gastroenterology, 1977.
3. MacDonald, A.S., etal: Canadian Journal of Surgery, 1978. TM:M 69CA
Rapidly Controls 
Bleeding
In hemorrhage due to 
stress lesions, bleeding stopped 
in most patients within 2-6 hours 
after treatment with 'Tagamet' 
began, and endoscopic reassess­
ment at 24 hours showed that 
57 out of 61 patients (93.4%) had 
stopped bleeding.1
In an additional study with 
'Tagamet' it was concluded "that 
cimetidine is an effective agent for 
controlling bleeding from hemor­
rhagic gastritis, even in situations 
where other medical and surgical 
measures failed".2
Permits Conservative 
Surgical Decisions
"The histamine Hrreceptor 
antagonist, cimetidine, was used 
in 27 patients with erosive gastritis, 
and bleeding ceased in 24. There 
is a prospect that such agents 
will obviate the necessity of total 
gastrectomy in the occasional 
resistant cases in favour of conser­
vative surgery."3
The H2 Receptor 
Antagonist ,
^Tagamet*
(cunetidine)
Tablets and Injection
(Product Monograph available to practitioners on 
request.)
PHARMACOLOGICAL CLASSIFICATION
Histamine H2-Receptor Antagonist
CHEMISTRY
Chemical Name:
Cimetidine is AT-cyano-TV-methyl-AT- [2 [[(5-methyl- 
l/f-imidazol-4-yl) methyl] thio] ethyl] guanidine. 
Structural Formula:
CHa ___^ ch2sch2ch2nhcnhch3
HN\ ^  N N-C=N
Molecular Formula: C,0H,6N6S 
ACTION
Cimetidine competitively inhibits the action of 
histamine at the histamine H2 receptor, and thus 
represents a new class of pharmacological agents, 
the histamine H2-receptor antagonists.
Cimetidine is not an anticholinergic agent. 
Studies have shown that cimetidine inhibits both 
daytime and nocturnal basal gastric acid secretion. 
Cimetidine also inhibits gastric acid secretion 
stimulated by food, histamine, pentagastrin, caf­
feine and insulin. Its ability to inhibit gastric acid 
secretion via this unique mechanism of action 
permits a new approach to the treatment of acid- 
related gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral adminis­
tration. The plasma half-life is approximately two 
hours. The principal route of excretion is the urine. 
The degree and duration of inhibition of basal 
and stimulated gastric acid secretion is dose- 
related; the data suggest that 80% or higher 
inhibition throughout a 24 hour period can be 
achieved by a dosage regimen of 300 mg four 
times daily given with meals and at bedtime. 
Cimetidine 300 mg reduced total pepsin output as 
a result of the decrease in volume of gastric juice. 
The drug had no effect on the rate of gastric 
emptying or lower esophageal sphincter (LES) 
pressure.
INDICATIONS AND CLINICAL USE
'Tagamet' (cimetidine) is primary therapy for 
conditions where the inhibition of gastric acid 
secretion is likely to be beneficial, such as: 
—Duodenal ulcer 
—Non-malignant gastric ulcer 
—Gastroesophageal reflux disease 
—Management of upper gastrointestinal 
hemorrhage
— Pathological hypersecretion  associated 
with Zollinger-Ellison Syndrome, systemic 
m astocytosis and m ultiple endocrine 
adenomas.
CONTRAINDICATIONS
There are no known contraindications to the use of 
'Tagamet' (cimetidine).
PRECAUTIONS
U se in Pregnancy; Nursing Mothers: There has 
been no experience, to date, with use of 'Tagamet' 
(cimetidine) in pregnant patients. Reproduction 
studies performed in rats, mice and rabbits have 
revealed no evidence of impaired fertility or harm 
to the fetus due to 'Tagamet'. Studies have 
demonstrated that 'Tagamet' crosses the placental 
barrier. It is also secreted in the milk of animals. 
'Tagamet' should be used in pregnant or lactating 
patients or women of childbearing potential only 
when, in the judgment of the physician, the antici­
pated benefits outweigh the potential risks.
Use in Children: Clinical experience in children 
is limited. Therefore, 'Tagamet' (cimetidine) ther­
apy cannot be recommended for children unless, 
in the judgment of the physician, anticipated 
benefits outweigh the potential | risks. In very 
limited experience, 20-40 mg/ kg per day has 
been administered in divided doses by mouth or 
intravenously.
U se in Im paired Renal F u n ctio n : Becau se 
'Tagamet' (cimetidine) is excreted by the kidney, a 
reduced dosage should normally be administered 
to patients with impaired renal function. (See 
DOSAGE AND ADMINISTRATION)
Drug Interaction: In patients on coumarin- 
type anticoagulants, further prolongation of 
the prothrombin time has been observed with 
concomitant 'Tagamet' administration. For this 
reason, close monitoring is recommended, and 
adjustment of the anticoagulant dose may be
necessary when these drugs are administered 
concomitantly.
Use in Gastric Ulcer: Symptomatic response to 
Tagamet does not preclude the presence of a 
gastric malignancy.
ADVERSE REACTIONS
Mild and transient diarrhea, muscular pain, 
dizziness and rash have been reported in a 
small number of patients during treatment with 
Tagamet (cimetidine). A few cases of reversible 
confusional states have been reported usually in 
elderly, severely ill patients such as those with 
renal insufficiency or organic brain syndrome. 
Overdosage may have played a role in some 
cases. These confusional states generally cleared 
within 24 hours of drug withdrawal. There have 
been reports that a few patients have developed 
mild non-progressive gynecomastia during pro­
longed treatment. No evidence of induced 
endocrine dysfunction was found, and the con­
dition remained unchanged with continuing 
Tagamet treatment. Rare cases of fever and 
intersitial nephritis which cleared on drug with­
drawal, have been reported. Som e increases in 
plasma creatinine and serum transaminase have 
been  reported.
OVERDOSAGE
In cases reported to date, involving oral ingestion 
of up to 10 r a m s  of 'Tagamet' (cimetidine), no 
untoward effects have been noted and recovery 
has been uneventful.
Treatment: The usual measures to remove un­
absorbed material from the gastrointestinal tract, 
clinical monitoring and supportive therapy should 
be employed. Studies in animals indicate that 
assisted respiration may be of value and that any 
tachycardia may be controlled by administration 
of a beta-blocker.
other compatible i.v. solution) to a total volume of 
20 ml and inject over 1-2 minutes.
Recommended dosage for intermittent intra­
venous infusion administration: 300 mg every 
6 hours. Dilute 'Tagamet' 300 mg in 100 ml of 
Dextrose Injection (5%) (or other compatible i.v. 
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase 
dosage. When this is necessary, the increases 
should be made by more frequent administration 
of a 300 mg dose, but total daily'dosage should 
not exceed 2400 mg.
DOSAGE ADJUSTMENT FO R PATIENTS 
WITH IMPAIRED REN AL FUNCTION
Usage in patients with severely impaired renal 
function has been very limited. Cimetidine half- 
life has been determined in patients with varying 
degrees of renal insufficiency to be:
Creatinine Clearance Cimetidine Half-life
50-80 ml/ min. 2.6 hr.
10-50 ml/ min. 2.9 hr.
< 1 0  ml/min. 3.7 hr.
On this basis, the recommended dosage in those 
patients who have creatinine clearance rates 
lower than 10 ml/min., including those who are 
anephnc, is 300 mg every 12 hours orally or by 
intravenous or intramuscular injection. Should the 
patient's condition require, the frequency of 
dosing may be increased to every 8 hours or even 
further with caution.
Hemodialysis: Greater than 80% of a 300 mg intra­
venous dose is cleared in a single 4 hour period of 
hemodialysis. It is completely cleared in an 8  hour 
period.
Peritoneal Dialysis: Peritoneal dialysis does not 
appear to remove cimetidine to any appreciable 
extent.
DOSAGE AND ADMINISTRATION-  
ADULTS
(Experience with 'Tagamet' in children is limited 
and it has not been evaluated in clinical studies — 
see PRECAUTIONS).
In clinical studies 'Tagamet' (cimetidine) has been 
used in divided doses of up to 2400 mg a day.
DUODENAL ULCER
The recommended adult oral dosage for duodenal 
ulcer is 300 mg four times a day, with meals and 
at bedtime.
While healing with 'Tagamet' often occurs during 
the first week or two, treatment should b e  con­
tinued for at least four weeks unless healing has 
been demonstrated by endoscopic examination. 
While sonie patients may require concomitant 
antacids initially, Tagamet' alone has been shown 
to promote rapid relief of symptoms.
Daily maintenance therapy may be used for those 
patients who would benefit from a reduction of 
gastric acid secretion, as well as those patients 
who are known to suffer frequent recurrence 
of duodenal ulcers. Following healing, mainten­
ance therapy for periods of 6 to 12 months may 
be initiated at a reduced frequency of dosage, 
with the last daily dose taken at bedtime. After 
this period of maintenance, patients should be 
reassessed periodically, preferably by endoscopy.
NON-MALIGNANT GASTRIC ULCER AND  
GASTROESOPHAGEAL R EFLU X D ISEA SE
The recommended adult oral dosage for non- 
malignant gastric ulcer and gastroesophageal 
reflux disease is 300 mg four times a day, with 
meals and at bedtime. While healing of non- 
malignant gastric ulcer may occur within the first 
two weeks, treatment should be continued fo r  at 
le a s t six  w eek s  unless healing has been demon­
strated by endoscopic examination.
While some patients may require concomitant 
antacids initially, Tagamet' alone has been shown 
to promote rapid relief of symptoms.
MANAGEMENT OF U PPER  
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding 
of sufficient magnitude as to require blood 
transfusions, Tagamet' should be administered 
parenterally, preferably by intravenous injection 
or intermittent infusion until 48 hours after active 
bleeding has stopped. At this time an oral dosage 
regimen may be instituted and should be con­
tinued for at least 7-10 days.
Recommended dosage for oral administration:
300 mg every 6 hours.
Recommended dosage for intramuscular injec­
tion administration: 300 mg every 6 hours. Inject 
the entire contents of a 2 ml ampul.
Recommended dosage for intravenous injec­
tion administration: 300 mg every 6 hours. Dilute 
'Tagamet' in Sodium Chloride Injection (0.9%) (or
PATHOLOGICAL H YPERSECRETO RY  
CONDITIONS (eg. Zollinger-Ellison Syndrome) 
Recommended adult oral dosage: 300 mg four 
times a day with meals and at bedtime. In some 
patients, it may be necessary to administer 300 mg 
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Despite major technical advances in 
coronary bypass surgery and myo­
cardial preservation, perioperative 
infarction remains a serious 
problem. The authors review the 
pathogenesis of the two different 
types of myocardial injury, occlusion 
necrosis and reperfusion necrosis. 
These two entities can be distinguished 
clinically by radioisotope scanning. 
Experimental studies have dem­
onstrated that reperfusion necrosis 
can be prevented pharmacologically. 
Since the majority of perioperative 
infarcts are probably due to reper­
fusion, the importance of distinguishing 
between these two entities is evident.
Malgre les recents progres accomplis 
dans le domaine de la chirurgie 
coronarienne et de la preservation du 
myocarde, I'infarctus perioperatoire 
demeure un probleme important. Notre 
expose se penche sur la pathogenese 
de cette lesion qui se presente sous 
deux formes bien distinctes: I’une est 
due a une occlusion coronarienne, 
I’autre a la reperfusion suivant une 
periode d’occlusion. Les deux types 
de lesions peuvent etre differenciees 
cliniquement a I'aide de la scintigraphie 
radio-isotopique. Des etudes de labo- 
ratoire ont demontre que Ton peut 
prevenir la myonecrose de reperfusion 
par des moyens pharmacologiques. 
Comme la majeure partie des infarctus 
perioperatoires sont dus a la reper­
fusion, il devient important de pouvoir 
les distinguer.
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Aortocoronary bypass grafting is an 
operation which definitely prolongs 
the life of some patients, possibly 
does so in others and dramatically 
diminishes the symptoms of coronary 
artery disease in the majority. In re­
cent years there have been a number 
of important advances in the man­
agement of patients who undergo the 
operation. These include improved 
preoperative visualization of the 
coronary arteries, and refinement of 
the techniques for anesthesia and 
for graft preservation and construc­
tion. Most important has been the 
notable improvement in myocardial 
protection during operation.1 Al­
though with these advances the opera­
tive mortality is now only 2%, the 
problem of perioperative infarction is 
serious and cannot be dismissed.
Perioperative infarction occurs as 
a result of the surgical procedure it­
self and may be fatal. The mortality 
of perioperative infarction is usually 
thought to be extremely low; clinical 
review shows that this is not so. The 
morbidity must not be lightly dis­
missed because left ventricular func­
tion, which is related to survival in 
coronary artery disease, independ­
ently of its extent, is affected by in­
farction2'3 and the functional capacity 
of the patient depends on the strength 
of the ventricle. Perioperative damage 
as a continuing feature of coronary 
artery grafting is unacceptable. Its 
prevalence varies between 10% and 
30% depending on the diagnostic 
technique used and the time the study 
was done.1,4'7
Perioperative infarction is now bet­
ter understood; because of this, more 
effective preventive measures can be 
undertaken. It is essential first to 
recognize the different types of peri­
operative infarction in order to appre­
ciate how diagnostic techniques can 
be used to allow testing of therapeu­
tic maneuvers directed at reducing 
the incidence and severity of the
problem. Our prime purpose is there­
fore to define the two types of peri­
operative infarction and then to illus­
trate how techniques such as myo­
cardial biopsy, electrocardiography 
and “infarct-avid” scanning can be 
used to distinguish between them.
Pathogenesis of
Perioperative Infarction
Two entirely different types of 
myocardial damage can occur during 
aortocoronary grafting. These types 
of damage differ in histologic appear­
ance and electrocardiographic evolu­
tion. The results of scanning with 
infarct-avid agents are also different. 
The first type—occlusion necrosis— 
results when the myocardium is dam­
aged because either a newly con­
structed graft or a nutrient portion 
of the native circulation is occluded 
and collateral flow is inadequate. The 
necrotic tissue within the infarct will 
have all the histologic features of 
coagulation necrosis (Fig. I).8 The 
electron micrograph illustrates strik­
ing ultrastructural changes in contrast 
to the normal heart (Fig. 2) in both 
the mitochondria and the sarcolemmal 
membrane. The former demonstrates 
enormous swelling and amorphous 
matrix densities and the latter is ex­
tensively fragmented. In particular, 
the appearance of the myofilaments 
is characteristic of this kind of cell 
death; their outlines are well main­
tained but are hyperrelaxed. The 
mechanism of cell death following 
prolonged occlusion probably repre­
sents a combination of intracellular 
protein denaturation, perhaps because 
of the profound intracellular acidosis, 
and cell destruction due to release 
of lysosomal enzymes. The appear­
ance of the relaxed myofilaments is 
not difficult to understand if one 
remembers that the severely ischemic 
region is stretched during systole by 
being included within the acute
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aneurysm.9 Ischemia therefore paraly­
ses the cell which then gradually 
deteriorates until death. In the dog 
heart this process takes more than 
1 hour.
The second type of myocardial 
damage— reperfusion necrosis—pro­
duces a very different picture of cell 
death. A  segment of myocardium is 
made ischemic for about 1 hour, 
then coronary flow is abruptly re­
started (a situation analogous to 
ischemic arrest during cardiopul­
monary bypass). The dead cells have 
a quite different appearance (Fig. 3). 
The most striking features are the 
prominent contraction bands between 
which are completely disrupted myo­
filaments and, in addition to the 
amorphous deposits within the mito­
chondria, glandular deposits of cal­
cium phosphate. This appearance is 
not due to the effect of reflow on 
already dead cells since several labora­
tories using different pharmacologic 
agents in various experimental mo­
dels10 13 have shown that this injury 
(reperfusion necrosis) can be entirely 
prevented or at least markedly re­
duced.
Just as their histology differs, so 
does the pathogenesis of these two 
forms of injury. In occlusion necrosis, 
there is a gradual progressive deterio­
ration in the intracellular, biochemical 
milieu until intracellular proteins can
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FIG. I— Electron micrograph of dog 
myocardium after 24 hours o f sustained 
coronary artery ligation showing occlu­
sion necrosis (centre of infarct). Car­
diac muscle cell is in hyperrelaxation 
as evidenced by wide I-bands (B). Mar­
kedly swollen mitochondria contain 
amorphous matrix densities (white ar­
row) and sarcolemmal membrane is dis­
continuous (black arrow) (uranyl acetate 
and lead citrate stain, reduced by 68% 
from X 33000).
no longer survive. In reperfusion 
necrosis, the cell remains alive but 
“ ill” , but within a few minutes of 
reperfusion it is destroyed. The exact 
pathogenesis of reperfusion necrosis 
is not known, but it has been hypo­
thesized that when reperfusion starts, 
the sarcolemmal membrane, damaged 
by ischemia, is unable to regulate the 
normal transmembrane fluxes of ions 
and suddenly excess calcium floods 
the cell resulting in its death. Using 
a dog model, we demonstrated that 
pretreatment with propranolol (chos­
en because of the histologic sim­
ilarity between hearts with reper­
fusion necrosis and hearts subjected 
to high doses of isoproterenol) pre­
vented almost completely the occur­
rence of reperfusion necrosis even 
when the heart rate—blood pressure 
product was kept constant by atrial 
pacing.11 Reimer, Rasmussen and Jen­
nings,12 in a similar study, also dem­
onstrated reduced myocardial necrosis 
with propranolol after temporary 
occlusion. Chemical sympathectomy 
with reserpine had a similar protec­
tive effect.11 Other workers13 have 
demonstrated that calcium blocking 
agents such as verapamil also reduce 
the rate of occurrence of experi­
mentally produced reperfusion necro­
sis. This is certainly crucial and de­
serves restatement. The myocardial 
cell can recover from the effects of 
ischemia and will do so if (and this 
is an important if) it can survive the 
initial recovery period. Thus we be­
lieve that agents such as propranolol 
or anticalcium drugs such as verapa­
mil modulate calcium entry into the 
cell during this critical period and
■ . y ■
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FIG. 2— Electron micrograph of nor­
mal dog myocardium. Cardiac muscle 
cell fixed in contracted state shows 
well preserved myofilaments, mitochon­
dria and sarcolemmal membrane (uranyl 
acetate and lead citrate stain, reduced 
by 68%  X 33000).
allow it to recover fully from the 
ischemic period.
Because coronary artery bypass 
grafting is generally elective, if reper­
fusion necrosis proved to be the pre­
dominant type o f myocardial injury, 
we could direct our efforts towards 
preventing it and be reasonably con­
fident o f success.
Diagnosis of
Reperfusion Injury
The critical question now becomes: 
How can occlusion and reperfusion 
necrosis be distinguished clinically as 
causes o f perioperative damage?
There are four general techniques 
by which myocardial cell death may 
be recognized: analysis o f serum en­
zyme changes, histologic examination, 
electrocardiography and infarct-avid 
scanning. But, instead of using these 
techniques simply to recognize cell 
death, we wish to use them to dis­
tinguish the two kinds of cell death.
Enzyme release does not help to 
make this distinction clinically. His­
tologic appearance obviously offers a 
rather absolute way of making the 
distinction. In their study, Bulkley and 
Hutchins,14 found that the majority of 
patients who died after aortocoronary 
bypass operation had infarcts in 
areas supplied by patent vessels. 
Furthermore the histologic appear­
ance was that o f contraction band 
(reperfusion) necrosis, not coagula­
tion (occlusion) necrosis. During a 
larger study of histologic abnormali­
ties in the ailing heart, we encoun­
tered a patient who had electrocardio­
graphic evidence of a perioperative 
infarction immediately after we re-
FIG. 3— Electron micrograph o f dog 
myocardium reperfused after I hour o f 
coronary artery ligation showing reper­
fusion necrosis. Cardiac muscle cell 
shows contraction bands with disruption 
of myofilaments between bands, and 
swollen mitochondria containing granular 
calcium phosphate deposits (arrow) in 
addition to amorphous matrix densities 
(uranyl acetate and lead citrate stain, 
reduced by 68%  from X 33000).
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started the heart (unpublished data). 
Figs. 4 and 5 show the histologic 
appearance of the biopsy specimen 
taken from this area; again, contrac­
tion band necrosis is seen. To our 
knowledge, this is the first example 
of such tissue obtained from the liv­
ing human heart.
Because there is considerable limi­
tation to the use of in vivo histologic 
diagnosis, we sought to use the elec­
trocardiogram to distinguish between 
these two forms of injury. In both, 
cell death, if extensive, produced a 
Q wave—the electrocardiographic sign 
of cell death. But in an experimental 
comparison of occlusion necrosis and 
reperfusion necrosis,10 we noted that 
epicardial Q waves did not appear 
until 4 to 6 hours after coronary oc­
clusion whereas they were present 
within 30 minutes of reperfusion fol­
lowing 1 hour of ischemia. Why such 
a difference exists is not completely 
clear. Perhaps because with occlusion 
cell death proceeds gradually from 
subendocardium to epicardium where­
as with reperfusion it is abrupt and 
virtually complete within a few min­
utes. Whatever the reason, this ob­
servation has been noted by others15 
and we attempted to use it clinically. 
Unfortunately this approach was 
thwarted by technical difficulties in 
accurately mapping multiple sites on 
the heart.
We therefore searched for a more 
practical approach to distinguish the 
two types of damage. Infarct-avid 
scanning has been used to diagnose 
transmural,16 subendocardial17 and
perioperative infarction.18’19 It de­
pends on localization of the isotope 
technetium-99m pyrophosphate with­
in the infarct. Reperfusion infarcts 
have at least two properties that oc­
clusion infarcts have not: the pres­
ence of flow to the damaged area and 
an increased calcium content within 
the cells of the damaged region.20 We 
reasoned, therefore, that a reperfu­
sion infarct would give a positive scan 
much earlier than an occlusion infarct. 
In dogs, we compared occlusion and 
reperfusion infarcts by the time at 
which scans became positive in each
FIG. 4— Light micrograph of left 
ventricular myocardium from patient 
following aortocoronary bypass opera­
tion. Specimen, obtained by transmural 
gun biopsy, shows marked contraction 
bands in cardiac muscle cells. Epon em­
bedded tissue (toluidine blue stain, re­
duce by 34% from X1000)-
form of injury.21 Scans were positive 
in only 1 of 6 animals, 4.5 hours 
after permanent coronary occlusion, 
but were positive in 12 of the 13 ani­
mals at the same time interval when 
occlusion for 1 hour was followed by 
reperfusion. Scans done at 48 hours 
were positive in both groups. Animals 
in the permanent occlusion group 
(late positive scan) demonstrated coa­
gulation necrosis histologically while 
those in the reperfusion group (early 
positive scan) had the typical findings 
of contraction band necrosis.
With these results and using a
FIG. 5—Electron micrograph from 
same biopsy specimen as in Fig. 4 shows 
contraction bands and granular mito­
chondrial densities in cardiac muscle cells 
indicating reperfusion necrosis (uranyl 
acetate and lead citrate stain, reduced by 
68% from X 33 000).
Fig. 6a Fig- 6b
FIG. 6—(a) Scan of focal area of hyperactivity (left anterior oblique view) indicates posterolateral reperfusion infarct 
(arrow), (b) Computer enhanced rib subtraded image of infarct (black arrow) shown in (a). White arrow indicates sternum.
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mobile Picker scintillation camera 
(Picker Corp., Cleveland, Ohio), we 
then began a study of our patients 
who underwent open-heart surgery, 
concentrating on serial infarct-avid 
scans obtained pre- and postopera- 
tively. This study differs from others 
in that the first postoperative scan is 
obtained on the patient’s arrival in 
the recovery room. Seventy-five pa­
tients have now been examined in 
this study and while it is not com­
plete, the major prediction of the 
study appears to have been satisfied. 
Of those patients who have a positive 
scan postoperatively (Fig. 6) the ma­
jority become positive immediately. 
This indicates that the infarcts are of 
the reperfusion type occurring pre­
sumably as a result of inadequate 
metabolic protection of the heart.
What have we learned? The im­
portant points are that the distinction 
can and should be made between the 
two forms of perioperative infarc­
tion—reperfusion necrosis and occlu­
sion necrosis. Reperfusion damage is 
now almost certainly the most fre­
quent cause of perioperative injury. 
Since experimental studies have in­
dicated that it may be preventable 
pharmacologically, efforts should be 
directed towards applying this finding 
in the clinical setting. The best tool 
to monitor the success of strategies 
to diminish the incidence of reperfu­
sion damage perioperatively appears 
to be infarct-avid scanning using 
99mTc pyrophosphate.
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Twenty-two patients with annuloaortic 
ectasia (an aneurysm of the ascending 
aorta and aortic valve incompetence) 
due to cystic medionecrosis underwent 
surgical repair between 1967 and 1979. 
Twelve patients had Marfan's syn­
drome and 4 had a forme fruste. The 
use of a valved conduit and improved 
techniques of myocardial protection 
have reduced the perioperative risks 
and may improve the survival of these 
patients. Between July 1, 1967 and 
June 30, 1978, 12 patients had supra- 
coronary repair of the aneurysm and 
replacement of the aortic valve 
(group 1); the mortality was 17%
(2 of 12). Between July 1, 1978 and 
Aug. 31, 1979, 10 patients underwent 
insertion of a valved conduit with 
implantation of the coronary arteries 
(modified Bentall procedure, group 2); 
the operative mortality was 10%.
In five group 1 patients (42%) and 
two group 2 patients (20%) technical 
problems resulted in bleeding in the 
early postoperative period. Evidence 
of a recurrent aneurysm in the diseased 
segment of the proximal aorta 
developed in 2 of the 10 group 1 
survivors, at 2 and 4 years after 
operation, respectively.
Use of the modified Bentall procedure 
and cold potassium cardioplegia 
reduced operative complications from 
58% (7 of 12 in group 1) to 20%
(2 of 10 in group 2). Because of the 
low risk of the current procedure 
and the high risk associated with its 
natural history, operative intervention 
should be considered for asymptomatic 
patients with annuloaortic ectasia.
Vingt-deux patients souffrant d'une 
ectasie annulo-aortique (un anevrysme 
de I'aorte ascendante avec insuffi- 
sance de la valvule aortique) due a
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une medionecrose kystique ont subi 
une reparation chirurgicale entre 1967 
et 1979. Douze malades presentaient 
les signes d’un syndrome de Marfan 
et 4 en avaient une forme fruste. 
L’utilisation d’un conduit muni d'une 
valve et I’amelioeation des techniques 
de protection du myocarde ont reduit 
les risques operatoires et peuvent 
ameliorer la survie de ces patients. 
Entre le 1er juillet 1967 et le 30 juin 
1978, 12 patients ont eu une reparation 
sus-coronarienne de I'anevrysme et 
le remplacement de la valvule aortique 
(groupe 1); la mortality a ete de 
17% (2 sur 12). Entre le 1er juillet 
1978 et le 31 aout 1979, 10 malades 
ont eu I'insertion d’un conduit muni 
d'une valvule avec I'implantation des 
arteres coronaires (technique de 
Bentall modifiee, groupe 2); la mor­
tality operatoire a ete de 10%.
Chez cinq patients du groupe 1 (42%) 
et deux patients du groupe 2 (20%), 
des problemes techniques ont 
entraine une hemorragie dans la 
periode post-operatoire immediate.
Des signes d'anevrysme recidivant 
dans le segment affecte de I'aorte 
proximate sont apparus chez 2 des 10 
survivants du groupe 1, respectivement 
2 et 4 ans apres I’operation.
1'emploi de la methode de Bentall 
modifiee et la cardioplegie avec une 
solution refroidie de potassium ont 
reduit les complications operatoires 
de 58%  (7 des 12 patients du groupe 
1) a 20%  (2 sur 10 dans le groupe 2). 
Vu le faible risque relie a ('intervention 
courante et le risque eleve associe 
a I'histoire naturelle de la maladie, 
une intervention chirurgicale devrait 
etre envisagee pour les patients 
asymptomatiques souffrant d’ectasie 
annulo-aortique.
Annuloaortic ectasia (Fig. 1) provides 
a challenge for the cardiovascular sur­
geon. Patients with this condition 
have diffuse cystic medionecrosis, 
originally described by Erdheim in 
1929,1 and many have sufficient ex­
ternal signs to be included in the 
clinical syndrome originally described 
by Marfan in 1986.2 Others have a 
family history and some but not 
all of the manifestations necessary 
for a diagnosis of Marfan’s syn­
drome; these patients have the forme
fruste of Marfan’s syndrome.3'4 How­
ever, many who have no family his­
tory or other external signs of 
Marfan’s syndrome present with an­
nuloaortic ectasia and mediocreno- 
sis. Because the prognosis for each 
of the groups of patients is prob­
ably similar and dependent on the 
progression of the cardiovascular 
disease,4*5 all patients with annuloaor­
tic ectasia are grouped together. This 
similarity was first recognized by Ellis, 
Cooley and DeBakey in 1961.6 
Cooley’s recent editorial7 again em­
phasizes the importance, from a sur­
geon’s viewpoint, of grouping these 
patients together.
Cardiovascular complications are 
responsible for most deaths in patients 
with medionecrosis and annuloaortic 
ectasia—95% in a study of patients 
with Marfan’s syndrome reported by 
Murdoch and colleagues.5 Three 
processes produced clinical deteriora­
tion: dissection or rupture of the 
ascending aortic aneurysm, or both, 
ventricular decompensation from pro­
gressive aortic insufficiency and mitral 
valve involvement producing cardiac 
decompensation, which was a less fre­
quent but well documented8 compli­
cation.
Because death may result from 
this condition, operation has been 
recommended since -the 1964 de­
scriptions of Wheat, Wilson and 
Bartley9 and Groves and coworkers10 
who documented the success as well 
as the difficulties encountered with
FIG . 1— Two m ajor com plications
were encountered am ong 22 patients with 
annuloaortic ectasia: aneurysm dissection 
and aortic insufficiency.
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surgical repair. Recent improvements 
in myocardial preservation and 
methods for excluding diseased tissue 
have led to better results of surgery.11 
In particular the technique originally 
described by Bentall and De Bono12 
has been a major advance in the sur­
gical approach to annuloaortic ectasia.
The results of operation encourage 
earlier intervention. In a recent review 
of the current approach at the Johns 
Hopkins Hospital, Pyeritz and 
McKusick4 recommend operation in 
asymptomatic adults if aortic dilata­
tion exceeds 6 cm.
In order to evaluate the morbidity 
and mortality of the surgical treat­
ment of annuloaortic ectasia at the 
University of Toronto hospitals, we 
reviewed our experience between 
1967 and 1979. Since luly 1978 a 
modified Bentall procedure has been 
employed at two hospitals for all pa­
tients with annuloaortic ectasia.
Patients
Between July 1, 1967 and Aug. 31, 
1979 operation was performed on 22 
consecutive patients with annuloaortic 
ectasia who were found on histologic 
examination to have cystic medione- 
crosis of the ascending aorta; patients 
with an atherosclerotic aorta were ex­
cludes. Twelve patients (54%) had a 
family history and lenticular subluxa­
tion, with or without skeletal mani­
festations, sufficient to permit a diag­
nosis of Marfan’s syndrome. Four of 
the remaining 10 patients had a family 
history and skeletal changes suffi­
cient to permit a diagnosis of forme 
fruste of Marfan’s syndrome; the 
other six patients had annuloaor­
tic ectasia and cystic medionecrosis 
with no evidence of a systemic dis­
order of connective tissue.
Between July 1, 1967 and June 30.
1978, 12 patients had aortic valve re­
placement and repair of an ascending 
aortic aneurysm using a tube graft 
in the supracoronary position (group 
1). Between July 1, 1978 and Aug. 31,
1979, 10 patients underwent the
modified Bentall procedure (group 2). 
The clinical information on the 22 
patients is outlined in Table I. The 
age of the patients was similar in the 
two groups. The majority (73%) were 
men. Ten patients presented with an 
acute dissection of the ascending 
aorta and required emergency oper­
ation (5 in group 1 and 5 in group 2). 
At the time of operation all patients 
were found to have dilatation of the 
ascending aorta and annulus of the 
aortic valve. Aortic regurgitation was 
found to result exclusively from
annular ectasia in 19 patients. In three 
patients a bicuspid aortic valve was 
discovered at the time of operation in 
addition to annular dilatation. Both 
processes may have contributed to the 
aortic regurgitation in these three pa­
tients.
Operative Procedures
Group 1
In each of these 12 patients the 
heart was exposed through a median 
sternotomy and cardiopulmonary by­
pass was instituted. The aorta was 
cross-clamped immediately proximal 
to the innominate artery. The aneur­
ysm was opened and the coronary 
arteries were cannulated. Ten of the 
12 patients had coronary perfusion 
throughout the repair; in the other 2 
patients, operated on towards the end 
of the study, cold potassium cardio­
plegia and topical hypothermia were 
used. Topical hypothermia was used 
in four other patients in addition to 
coronary perfusion to ensure ade­
quate preservation of the myocar­
dium. The aortic valve was replaced 
in all 12 patients (Fig. 2). Three 
patients, operated on early in the 
study, received a Starr -  Edwards 
valve but all others received a Bjork -  
Shiley aortic prosthesis. The ascending 
aortic aneurysm was replaced with a 
tube graft in the majority of patients.
Usually a cuff of diseased proximal 
aorta was used for the proximal an­
astomosis. In two patients the Wheat 
procedure12 was used. Only the por­
tion of proximal aorta containing the 
coronary ostia was left in place.
G roup 2
For the 10 patients who underwent 
a modified Bentall operation between 
July 1, 1978 and Aug. 31, 1979 a 
commercially available composite 
Dacron tube graft containing a Bjork -  
Shiley aortic prosthesis (Shiley Labo­
ratories, Santa Ana, Calif.) was used.
FIG. 2—Supracoronary resection and 
tube graft repair of ascending aortic 
aneurysm were combined with aortic 
valve replacement in 12 patients between 
July 1, 1967 and June 30, 1978.
Table I—Data on 22 Patients with Annuloaortic Ectasia
Information
Supracoronary Modified Bentall 
Total repair repair
22 12 10No. of patients 
Age, yr 
Mean 
Range
Sex, no. (% )
Men
Women
Valve type, no. (% )
Bjork Shiley 
Starr-Edwards
Duration of aortic cross-clamping, min 
Mean 
Range
Myocardial protection, no. (% )  
Coronary perfusion 
Cold potassium cardioplegia 
Topical hypothermia 
Hospital deaths, no. (% )
Reoperation for bleeding, no. (%  
of operative survivors) 
Complications of procedure (recurrent 
dissection or excessive anastomotic 
bleeding), no. (% )
Late mortality, no. {%  of 
operative survivors)
Actuarial survival, %  (no. of patients 
in interval) 
l y r
2 yr
3 yr
4 yr
35 36 32
18 - 59 18 -  59 22 -  54
16 (73) 8 (67) 8 (80)
6 (27) 4 (33) 2 (20)
19 (86) 9 (75) 10 (100)
3 (14) 3 (25) 0 (0)
78 80 74
50 - 94 52 -  94 50 -  86
10 (45) 10 (83) 0 (0)
12 (55) 2 (17) 10 (100)
12 (55) 6 (50) 6 (60)
3 (14) 2 (17) 1 (10)
4 (18) 3 (30) 1 (ID
7 (32) 5 (42) 2 (20)
2 (11) 2 (20) 0 (0)
83 (10) 88 (7)
73 (7) 88 (2)
73 (6) —
55 (3) —
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The operative technique was similar 
to that described originally by Bentall 
and De Bono12 and modified by 
Kouchoukos, Karp and Lell.13 The 
common femoral artery and right 
atrial appendage were cannulated for 
cardiopulmonary bypass. The left 
ventricle was vented from the right 
superior pulmonary vein. The sys­
temic temperature was lowered to 
22°C. The heart was allowed to beat 
in an empty perfused state until fib­
rillation occurred. The ascending aorta 
was then cross-clamped just proximal 
to the innominate artery. The aneu­
rysm Was opened and the incision was 
carried towards the noncoronary sinus. 
The coronary ostia were exposed and 
cold potassium solution was infused 
through coronary cannulas. The inter­
ventricular septal temperature was 
carefully monitored and the cardio- 
plegic solution was infused inter­
mittently to ensure a mean myocardial 
temperature of 18°C during the 
ischemic period. Six patients also 
received topical hypothermia in order 
to maintain adequate myocardial pro­
tection. After the aortic valve was re­
moved, a composite graft of appro­
priate size containing the Bjork-Shiley 
prosthesis was selected. The woven 
Dacron graft was preclotted using an 
asanguineous plasma solution of cryo- 
precipitates activated with topical 
thrombin (developed by Dr. M.F.X. 
Glynn, Toronto General Hospital). 
After the preclotted graft had been
rinsed with heparinized blood the 
aortic valve was inserted into the 
aortic annulus using interrupted pled- 
geted sutures (Fig. 3A). The site 
of the coronary implantation was 
carefully selected to avoid excessive 
stress on this delicate anastomosis; 
since the distance between the aortic 
annulus and the coronary ostia in­
creases with systole the implantation 
must be performed at the systolic ex­
tension rather than at the diastolic 
position. A button of graft 10 mm to 
15 mm in diameter was then excised. 
A pledgeted 3-0 Prolene suture was 
used to perform the coronary-to-graft 
anastomosis in a continuous fashion 
(Fig. 3B). The use of the pledgeted 
stitch permitted us to create a lip of 
aortic tissue to facilitate the coronary 
anastomosis. The distal anastomosis 
was performed with a continuous 
pledgeted 2-0 Prolene suture (Fig. 
3C). A controlled vent in the graft 
facilitated removal of air and per­
mitted control of intraluminal graft 
pressure as the cross-clamp was re­
moved. After hemostasis was secured, 
the aneurysm was closed over the 
graft (Fig. 3D).
Results
The perioperative mortality for the 
supracoronary repair was 17% and 
for the modified Bentall repair it was 
10%. Reoperation for bleeding was 
performed in 30% of group 1 sur­
vivors and in 11 % of group 2 survi­
vors. These differences were not statis­
tically significant.
The proximal anastomosis was the 
site of serious complications in 5 
(42%) of the 12 patients in group 1. 
In one patient a recurrent dissection 
developed and this segment of the 
aorta ruptured in the early postoper­
ative period. Another patient died of 
excessive bleeding from the proximal 
anastomosis. Three other patients re­
quired re-exploration for anastomotic 
leaks at both proximal and distal an­
astomoses.
One patient in group 2 who under­
went emergency operation for acute 
dissection had a recurrent dissection 
into the left main coronary artery 
soon after operation. Prolonged wash­
ing of the graft with heparinized 
blood resulted in excessive bleeding 
through the graft in one case which 
was treated by creating a fistula 
from the aorta to right atrium. The 
right atrial appendage was sutured to 
the aneurysm wall in order to allow 
blood escaping through the graft to 
flow into the right atrium. The left- 
to-right shunt appeared to close spon­
taneously when hemostasis was fi­
nally achieved.
The duration of aortic cross-clam­
ping was not statistically different for 
the two procedures, although it was 
slightly shorter for group 2 patients 
(mean 74 minutes) than for group 1 
(mean 80 minutes). Six (32%) of the 
19 survivors required inotropic agents 
or intra-aortic balloon pump assistance 
to maintain adequate perfusion post- 
operatively. The incidence of low 
output syndrome in the two groups 
was not statistically different (40% 
in group 1, 22% in group 2). The use 
of cold potassium cardioplegia since 
1977 has resulted in a decreased in­
cidence of postoperative low output 
syndrome.
L ate M ortality
There have been two late deaths 
among the 10 survivors in group 1. 
Both patients died suddenly, one 2 
and the other 4 years after operation. 
One patient had evidence of recur­
rence of his thoracic aneurysm before 
his death. No autopsy was performed 
on the other patient. The actuarial 
survival of patients undergoing supra­
coronary resection is given in Table I. 
The median follow-up time was 2.5 
years. Only three patients are alive 
and well more than 4 years after oper­
ation.
There have been no late deaths 
among the patients in group 2. The 
median follow-up period was 1.5
FIG . 3—Modified Bentall procedure was performed in 10 patients between 
July 1, 1978 and Aug. 31, 1979. (A) A ortic valve contained in valved conduit is 
attached to  aortic annulus using interrupted pledgeted sutures. (B) Coronary to 
graft anastomoses are performed with pledgeted continuous suture. (C) Proxim al 
anastomosis is also performed with pledgeted continuous suture. (D) Aneurysm is 
closed over valved conduit.
VOLUME 23, NO. 5, SEPTEMBER 1980 / THE CANADIAN JOURNAL OF SURGERY 447
years. Only two patients have been 
followed up for 2 years.
Complications of Operation
Nine (41%) of the 22 patients had 
complications attributable to the oper­
ative procedure, 7 (58%) of the 12 
in group 1 and 2 (20%) of the 10 in 
group 2. In group 1 three patients 
may have had recurrent aneurysms 
in the retained supracoronary seg­
ment of diseased aorta and four had 
excessive bleeding from the suture 
lines. In group 2 there was one 
coronary dissection and one patient 
had excessive bleeding from the suture 
lines. The difference between the rate 
of complications related to the oper­
ative procedure approaches statistical 
significance ( P =  0.06, / ;  analysis).
Discussion
Annuloaortic ectasia results from 
cystic medionecrosis of the aorta as 
first described by Erdheim1 in 1929. 
This process has been reported to 
occur in nearly 98% of patients with 
Marfan’s syndrome.4 The prognosis 
for patients with annuloaortic ectasia 
is poor. Murdoch and colleagues5 re­
ported that in 90% of patients with 
Marfan’s syndrome who die, death is 
related to complications of annuloaor­
tic ectasia.
Attempts have been made to treat 
this condition with negative inotropic 
medication (e.g., reserpine and pro­
pranolol) but without consistent suc­
cess.4 The treatment for annuloaortic 
ectasia is primarily surgical. The dif­
ficult decision is the timing of sur­
gical intervention in this unrelenting 
process. This decision must be made 
by comparing the surgical results to 
the natural history studies.5
The surgical treatment of annulo­
aortic ectasia resulting from cystic 
medionecrosis was first reported by 
Bahnson and Nelson in 1956.14 Wheat, 
Wilson and Bartley9 and Groves and 
associates10 in 1964 attempted to treat 
this process by replacing the aortic 
valve and ascending aorta. In 1970 
Symbas and associates15 reported a 
case and reviewed the literature on 19 
patients who had had this operation 
for M arfan’s syndrome. The hospital 
mortality among these 19 patients was 
32%. Other reports describing the ex­
perience of the 1960s confirms the 
high hospital mortality and morbidity 
associated with the supracoronary 
repairs advocated by Wheat and 
Groves. In 1978, Davis, Pluth and 
Giuliani8 reported a 42% mortality 
among 19 patients operated on be­
tween 1960 and 1969 at the Mayo
Clinic. In 1971, Wheat, Boruchow and 
Ramsey16 had a 15% mortality and 
an 18% rate of serious postoperative 
bleeding in 13 patients operated on 
using his technique. Edwards and 
Kerr17 reported serious bleeding from 
anastomoses, and one death, in two 
patients treated by supracoronary 
repair.
The classic repair for annuloaortic 
ectasia in the 1960s and early 1970s 
left in place a large segment of dis­
eased aortic tissue between the annulus 
of the aortic valve and the proximal 
anastomosis of the Dacron graft. 
This segment was the site of recurrent 
aneurysm in cases reported by Symbas 
and associates,18 Inberg and col­
leagues,19 Hashimoto and associates,20 
McCready and Pluth,11 Shulte and 
Bircks,21 Crosby, Ashcraft and Reed,22 
and Kouchoukos, Karp and Lell.18 In 
addition Nair23 reported recurrent 
aneurysm in a case of his own and in 
five others discovered in the literature. 
This difficult problem accounted for 
one operative death in our series; one 
other patient appeared to have died of 
recurrent aneurysm 2 years postoper- 
atively. Our third death occurred sud­
denly 4 years postoperatively and we 
cannot be certain that this patient did 
not also have a recurrent aneurysm.
The hospital morbidity and mor­
tality for the classic repair of annulo­
aortic ectasia was substantial. Until 
recently the indications for surgical 
repair included progressive aortic dila­
tation, dissection or rupture of the 
ascending aortic aneurysm, or the de­
velopment of left ventricular decom­
pensation from aortic or mitral insuf­
ficiency, or both.
In 1968 Bentall and De Bono12 de­
scribed a new technique for repairing 
annuloaortic ectasia. It avoided the 
difficult proximal anastomosis to a 
diseased aortic segment. Bentall and 
De Bono sutured the tube graft to a 
Starr -  Edwards valve and sutured the 
valve to the aortic annulus. They re­
implanted the coronary ostia through 
separate incisions in the graft. In 1970 
Edwards and Kerr17 reported excellent 
results in three patients using a slight 
modification of the original Bentall 
procedure. In 1972 Singh and Bentall24 
reported excellent results in 10 pa­
tients using Bentall’s technique. Coro­
nary perfusion was used for myocar­
dial preservation, but because coro­
nary perfusion was interrupted during 
performance of the distal anastomosis 
producing ischemic arrest, these 
methods of myocardial preservation 
may have limited the success of ear­
lier reports. Schulte and Bircks21 re­
viewed the literature and provided a
report of two of their patients oper­
ated on by the Bentall technique; they 
reported one operative death. In 1973 
Crosby, Ashcraft and Reed22 reported 
no operative mortality and no post­
operative bleeding in seven patients 
using a modified Bentall procedure. 
In 1976 Hashimoto and associates20 
reported an 18% mortality among 11 
patients using this technique. They 
introduced the concept of topical 
hypothermia to avoid the inevitable 
period of ischemic arrest associated 
with coronary perfusion. The follow­
ing year Kouchoukos, Karp and Lell13 
reported no perioperative mortality 
and one reoperation for bleeding 
among 15 patients who underwent a 
modified Bentall procedure for an­
nuloaortic ectasia. They used a com­
bination of epicardial and endocardial 
topical hypothermia for myocardial 
protection rather than coronary per­
fusion. This technique greatly sim­
plified the procedure and was tech­
nically similar to the procedure we 
used. In 1978 Mayer, Lindsay and 
Wang25 reported one perioperative 
death and no severe postoperative 
bleeding among 13 patients subjected 
to a modified Bentall procedure with 
coronary perfusion. Koizumi and 
associates26 reported one perioper­
ative death among seven patients who 
underwent the modified Bentall proce­
dure. Two of the patients had coro­
nary perfusion and five had topical 
hypothermia. In 1979 McCready and 
Pluth11 reported a 7% perioperative 
mortality and a 7% rate of excessive 
bleeding in 15 patients who had had 
a modified Bentall procedure between 
1972 and 1978. All patients had had 
coronary perfusion although the 
authors mentioned that they were cur­
rently using cold potassium cardio­
plegia for myocardial protection. They 
also reported two cases (14%) of peri- 
coronary false aneurysm.
The decreasing perioperative mor­
bidity and mortality for repair of an­
nuloaortic ectasia has resulted from 
two factors. First, elimination of the 
diseased segment of aorta between 
the annulus and the graft has reduced 
the rate of recurrent dissection and 
troublesome bleeding. Second, impro­
vements in myocardial preservation 
have enhanced left ventricular func­
tion postoperatively. Our results con­
cur with those reported in the litera­
ture.11,13
Unfortunately improvements in 
myocardial preservation and altera­
tions in the surgical technique have 
not eliminated all postoperative com­
plications. We encountered recurrent 
dissection of the coronary ostia, un-
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doubtedly related to progression of the 
disease process (cystic medionecrosis) 
into the coronary artery. Similar com­
plications have been reported by 
McCready and Pluth11 and Inberg and 
colleagues.9 Moreover, numerous re­
ports have documented recurrent 
dissecting aneurysms distal to the area 
of operation.6,8,11 This complication 
will not be eliminated using the newer 
surgical approaches.
The current operative results permit 
a reassessment of the timing of oper­
ation for annuloaortic ectasia. Asymp­
tomatic patients with dilatation of the 
aortic root should undergo surgical 
repair prophylactically, particularly if 
the dilatation is progressive or the 
aortic insufficiency is serious. We 
concur with Pyeritz and McKusick4 
that operation should be carried out 
when the aortic dilatation is more 
than 50% above the normal limits
f
(corrected for body surface area). We 
anticipate that the modified Bentall 
procedure will provide better long­
term results by reducing to a minimum 
the amount of diseased aorta at risk 
for recurrent aneurysm formation. 
However, recurrent dissection at the 
site of the coronary anastomosis must 
be anticipated (14% in the series of 
McCready and Pluth11).
The Bentall procedure requires 
careful attention to detail but has 
been mastered by a group of five sur­
geons at two University of Toronto 
hospitals. We therefore recommend 
this technique for the management of 
selected patients with annuloaortic 
ectasia.
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In the March 1980 issue, the name of 
T.R. Todd, md. frcs[c] was omitted 
from the byline of the paper “Lung 
abscess: surgical implications” (page
297). The byline should have read “N.C. 
Delarue, md, m s, facs, fc c p , frcs[c], 
F.G. Pearson, md, facs, frcs[c], J.M. 
Nelems, md, frcs[c], J.D. Cooper, md, 
frcs[c] and T.R.J. Todd, m d , frcs[c]”. 
We extend our sincere apologies to Dr. 
Todd for this oversight.&
In the paper “Tests for hemostasis and 
their relevance to venous thrombosis” 
(page 373, July issue), the reproduction 
of Fig. 3a was extremely poor. Fig. 3 
as it should have appeared, together 
with its legend, is reproduced below.
Fig. 3a
Fig. 3b
FIG. 3—(a) Impedance plethysmograph 
tracing: no obstruction to outflow, (b) 
Data point from tracing in (a) inscribed 
on graph.
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effective dry or moistened with thrombin solution, isotonic 
sodium chloride or antibiotic
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non-irritating, naturally-occurring, neutral pH; may be cut, 
molded, or sutured in place when necessary
stimulates natural clotting and healing of disrupted tissue
Gelfoam
used by a generation of physicians 
in hepatic surgery, haemorrhoidectomy, 
cholecystectomy and decubitus ulcer
still the only absorbable haemostat that meets all these criteria:
absorbed completely in four to six weeks
-------------------- - ---------— —  ------- -------------------------- i--------— *—  -----:---------— I— — — ~
safe as a permanent packing in any tissue; won’t interfere with bone 
regeneration, cause cyst formation or excessive scar tissue
76 9  REGISTERED TRADEM ARK: GELFOAM, GELFILM  CE 7 7 3 4 .3
Upjohn
THE UPJOHN COMPANY OF CANADA/DON MILLS, ONTARIO
available in a variety of sizes, shapes 
and forms for most areas of 
surgery where haemostasis is desired
for nasal packing packing for gynaecologic 
and rectal surgery
packing cavities -  obliterating 
dead space
Sterile Pack, size 2 cm
40 x 2 cm
jar of one sponge
Sterile Pack, size 6 cm 
40 x 6 cm
box of six sponges
Sterile Sponge, size 200 
80 x 250 x 10 mm 
box of six sponges
for general surgery for general surgery specially prepared for dry 
application and emergency 
haemostasis
Sterile Sponge, size 100 
80x125x100 mm 
box of six sponges
Sterile Sponge, size 50 
80 x 62.5 x 10 mm 
box of four sponges
Sterile Compressed Sponge
size 100
12.5 x 8 cm
box of six sponges
for general and neurological 
surgery
for general and neurological 
surgery
promote heating in chronic 
leg ulcer
Sterile Sponge, size 12-3 mm
20 x 60 x 3 mm
box of four sponges
Sterile Sponge, size 12-7 mm 
20 x 60 x 7 mm 
box of four sponges 
jar of four sponges
Sterile Powder 
jar containing 1 g
non-haemostatic 
for ocular surgery
Ophthalmic Sterile Gelfilm 
25 x 50 mm 
box of 6
Precautions
Gelfoam and Gelfilm are simple to use, and with conscientious observance of certain precau­
tions satisfactory results may generally be expected where their use is indicated.
1. Gelfoam should be used discriminately in arterial bleeding because of the intra-arterial pres­
sure. It is advisable to suture and reinforce where possible.
2. Although Gelfoam generally serves its purpose well in the presence of haemorrhagic blood 
dyscrasias, it should not be relied upon as the sole method of haemostasis in such conditions.
3. Gelfoam should not be used to stop menstrual bleeding. In postpartum and menorrhagic 
bleeding it serves only as a temporary vaginal tampon.
4. Gelfoam must be in snug contact with the bleeding surface in order to be effective.
5. Use Gelfoam as sparingly as possible in order to minimise the amount of implanted foreign 
material.
6. Do not overfill cavities with Gelfoam.
CE 7734.4
U p jo h n
7. Do not use Gelfoam in grossly contaminated wounds which are so deep that drainage is 
interfered with. However, it may be used for temporary haemostasis in more superficial 
contaminated wounds, provided it is removed after it has served its haemostatic purpose.
8. Avoid prolonged exposure to Gelfoam to contaminated air.
Detailed information available on request.
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Flow Studies in Glass Models of (Aortic Aneurysms
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A photodensitometer was used to make 
a quantitative analysis of flow into 
and out of glass models of three 
types of aortic aneurysm (small and 
large fusiform and small saccular).
The “aneurysms" were perfused with 
steady flow and injected with 
Evans’ blue dye. The aneurysms tended 
to fill linearly with time, but emptied 
exponentially. Flow out of both large 
and small fusiform aneurysms did 
not alter as a function of the Reynolds 
number (a nondimensional measure­
ment used to compare flows in tubes 
of the same shape but of different 
sizes), while flow from thfe saccular 
aneurysm did. The results suggest 
that the flow in fusiform aneurysms 
is very sluggish. This may increase 
the risk of thrombosis and could also 
lead to a false arteriographic analysis 
of size, particularly in large aneurysms. 
Emptying of saccular aneurysms is 
much more dependent on the 
Reynolds number and hence on 
location and blood viscosity.
Un photodensitometre a ete utilise 
pour analyser quantitativement la 
circulation dans et hors de modeles 
de verre de trois types d'anevrysmes 
aortiques (fusiformes petits ou grands, 
et grands sacciformes). Les 
anevrysmes etaient perfuses a debit 
constant et injectes de bleu d'Evans.
Les anevrysmes eurent tendance a se 
remplir lineairement avec le temps, 
mais a se vider exponentiellement.
Le debit hors des anevrysmes 
fusiformes petits et grands ne s’est 
pas modifie en fonction du nombre 
de Reynolds (une mesure non
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dimensionnelle servant a comparer 
les debits dans des tubes de meme 
forme mais de calibres differents), 
alors que le debit dans I’anevrysme 
sacciforme s’est altere. Ces resultats 
indiquent que le debit dans les 
anevrysmes fusiformes est tres lent. 
Ceci peut augmenter le risque de 
thrombose et peut aussi entrainer 
une analyse arteriographique erronnee 
de la dimension, particulierement 
dans les cas de gros anevrysmes.
Le vidange des anevrysmes sacciformes 
est beaucoup plus dependant du 
nombre de Reynolds et, par le fait 
meme, de sa localisation et de 
la viscosite du sang.
Aneurysms can develop in any large 
or medium-sized artery. They become 
apparent clinically as a mass, when 
thrombus within them gives rise to 
emboli or when they rupture. At 
present, we cannot predict which 
course an aneurysm will take. Most 
surgeons now use the size of the 
aneurysm or severity of symptoms as 
the criterion for treatment.
Intracranial aneurysms have been 
studied in more detail1 than aortic 
aneurysms. However, since most cere­
bral aneurysms arise at the apex of 
vessel bifurcations the flow in them 
is quite different from that in aneu­
rysms that develop as fusiform or sac­
cular dilatations along the axis of an 
artery.2 Moreover, many intracranial 
aneurysms contain only the original 
vessel wall tissue, stretched. In them, 
the elastin membrane is broken, and 
the wall of the aneurysm becomes 
very stiff so that much higher stresses 
are imposed on the wall.3 In these 
aneurysms the wall becomes thinner 
as the lumen enlarges, and we can 
now calculate, crudely, at what size 
rupture will occur.4
In the aorta and other extracranial 
vessels most aneurysms are fusiform 
enlargements which are more or less 
axisymmetric. Their frequency of oc­
currence increases with age and most 
are probably atherosclerotic in origin. 
The commonest site is the abdominal 
aorta, possibly because the decreased 
supply of oxygen from the lumen, due 
to a build up of plaques and the 
borderline number of vasa vasorum 
in the region, results in anoxia of the 
medial part of the wall.5 In this case, 
dissection may occur into the wall 
and rupture may be secondary to the 
dissection. Prokop, Palmer and 
Wheat6 suggested that this is related 
to the rate of change in pulse pres­
sure rather than to the absolute pres­
sure. Rupture, except by dissection, 
probably is less likely if the aneurysm
FIG. 1— Filling of small fusiform aneurysm. Dye from outside laminae tends to swirl around outside of aneurysm. Reynolds number (Re) =  390. (Reproduced bv permission from Roach MR: Thromb Diathesis Haemorrh suppl 59: 123, 1974.)
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is thrombosed. Thus it is of value to 
determine what factors led to propa­
gation of the thrombus. We believe 
that both are related mainly to the 
character of blood flow in the aneu­
rysm. This can be visualized by using 
glass models of different geometries 
to simulate the aneurysm and then 
injecting dye to study the flow pro­
files and the extent of stagnant flow 
within different types.
Methods
Three glass aneurysms were pro­
duced by an expert glass blower in 
long lengths of 1-cm diameter glass 
tubing: a small fusiform aneurysm 
(maximum external diameter 1.6 cm),
a large fusiform aneurysm (maxi­
mum external diameter 2.7 cm) and 
a small saccular aneurysm (external 
diameter 1.6 cm).
The aneurysms were mounted 
horizontally in a tray and connected 
to a constant pressure tank full of 
tap water as described for other model 
studies from our laboratory.7 The wa­
ter was allowed to sit for at least 
24 hours to allow it to reach room 
temperature and to permit gas bub­
bles to escape.
Dye (Evans’ blue) was injected 
from a second reservoir, kept at a 
lower pressure, by a 25-gauge needle 
which could be positioned in different 
streamlines as required. The tem pera­
ture of the water was checked at fre­
quent intervals and the temperature 
was used to obtain the viscosity of 
the water from the “Handbook of 
Chemistry and Physics” . Studies with 
an Ostwald viscometer (Fisher Scien­
tific Co., Toronto, Ont.) showed 
that even large quantities of dye 
did not alter the viscosity of the wa­
ter appreciably. Flow rates were 
measured with a calibrated cylinder 
and stop watch. The flow rates could 
be adjusted by a screw clamp on the 
the outflow.
Initially experiments were done to 
determine the flow patterns. Sub­
sequently filling and emptying times 
were arrived at by using a photoden­
sitometer to determine the amount 
of dye in the aneurysm. The test sec­
tion was illuminated from above with 
a desk lamp which did not heat the 
water notably (less than 2°C). A 35-mm 
Pentax camera was mounted over the 
model, and all pictures were taken 
with Kodak Panatomic-X film using 
constant aperture and exposure time. 
The interval between exposures was 
determined from preliminary experi­
ments on emptying and filling times. 
All sequences for each series were on 
one roll of film to avoid differences 
between films and between process­
ing at different times. The negatives 
were put in a photographic enlarger 
and projected onto the sensor of a 
photodensitometer.
The photodensitometer was cali­
brated by perfusing the system with 
serial dilutions of the dye; there was 
a linear correlation between the 
photodensitometer reading (PR) and 
dye concentration.
Results
Visualization of Flow
Fig. 1 shows a filling sequence for 
the small fusiform aneurysm. The 
frames are at 18-second intervals and
d e f
FIG. 2— Emptying sequence for small fusiform  
aneurysm. Re =  270. Exposures at 18-second intervals. 
Clearing took 4.4 minutes. (Reproduced by permission 
g from Roach MR: Thromb Diathesis Haemorrh suppl 59: 
123, 1974.)
FIG. 3—Filling of large fusiform aneurysm. Patterns are more complex than 
for small aneurysm. Re =  910. Exposures at 45-second intervals.
FIG. 4—Emptying of large fusiform aneurysm. Note complete vortices. Re =  
1120. Exposures at 45-second intervals. Clearing took 13 minutes. (Reproduced by 
permission from Roach MR: Thromb Diathesis Haemorrh suppl 59: 123, 1974.)
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show the slow filling of the aneu­
rysm. Dye entered in only one stream­
line here, but injection in other lam­
inae showed comparable although 
not identical patterns.
Fig. 2 shows an emptying sequence 
for the same aneurysm. Total clear­
ing even of this small amount of dye 
took 4.4 minutes.
The basic patterns for both clear­
ing and emptying were the same at 
any Reynolds number. The Reynolds 
number is a nondimensional measure­
ment used to compare flows in tubes 
of the same shape, but of different 
sizes. It is defined as: Re =  pv d/rj , 
where p =  density, v =  mean 
velocity, d =  diameter and rj —  
viscosity. As the flow rate, and hence 
the Re, decreased, the size of the 
core volume which contained the re-
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FIG. 5— Calibration curve obtained 
for large fusiform aneurysm. Absolute 
values vary with film processing so only 
relative values are used. Correlation 
coefficient (R) =  0.986. Slope of line 
(B) =  786 ±  17.6.
PHO TO DEN SITO M ETER REA D IN G
FIG. 6—Filling of small aneurysm. 
Relation is linear with high correla­
tion coefficient (R =  0.978). Re =  390. 
Time =  0.1365 ±  0.5150 X 10 2 (photo- 
densitometer reading |PR]) -f 0.1303 ±  
0.8370 X 10 2. Standard error of estimate 
(SEE) =  0.2974 X 10 A
circulated fluid increased. In general, 
the dye remained in the core until 
it reached the distal end of the aneu­
rysm and then was swept back to fill 
the periphery of the aneurysm. The 
central core appeared to fill at rough­
ly the same rate as the fluid in the 
tube and cleared in the same time. 
However, it subsequently received 
dye from the aneurysm to transport 
distally. Scherer8 pointed out, how­
ever, that the fluid velocity at the 
centre of the bulb was about three 
eighths of the parabolic velocity in 
the axis at the bulb inlet and outlet.
Flow in the large fusiform aneu­
rysm was similar, although filling (Fig. 
3) and emptying (Fig. 4) times were 
much longer. The exposures were 
made at 45-second intervals and the 
clearing time was 13 minutes. Tur­
bulence did not develop in either of 
these aneurysms at the Reynolds num­
bers noted biologically. Instead there 
was usually one vortex in the small 
aneurysm (Fig. 1) and often two in 
the large one (Fig. 3).
P H O T O D EN S IT O M ET ER  R EA D IN G
FIG. 7—Filling of saccular aneurysm. 
Relation is linear with high correlation 
coefficient (R =  0.961). Re =  920. 
Time =  0.1623 ±  0.1206 X 10 1 (PR) +  
-0 .5707 ±  5150 X 10 A SEE =  0.2273 
X 10-1.
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FIG. 8— Effect of Reynolds number 
on filling of small fusiform aneurysm. 
There is little correlation at low Reynolds 
number «  610), but at higher values 
filling is similar for all Reynolds num-
| » R  #
bers. —  =  photodensitometer reading, 
t time
Flow in the saccular aneurysm was 
less stagnant and the sac cleared more 
quickly. The patterns seen were com­
plex and very dependent on the Rey­
nolds number. We were unable to 
predict what caused each pattern, but 
there was no “core” of the sort seen 
in the axisymmetric aneurysms.
Photodensitometry
Fig. 5 shows the calibration curve 
obtained by putting known concentra­
tions of dye into the large aneurysm. 
The curve is linear with a correlation 
coefficient (R) of 0.986. Since the 
photodensitometer measures light 
transmission, the amount of disper­
sion of the dye is unimportant.
The time required to fill the small 
aneurysm is noted in Fig. 6. The 
curve is linear (R =  0.978), but the 
absolute values vary with the rate at 
which dye is injected into the tube 
and with the lamina(e) injected. Fig. 7
10-
REYNOLDS NUMBER
FIG. 9—Effect of Reynolds number 
on filling of asymmetric aneurysm. Low 
and high Re numbers seem to produce 
different rates of filling, but no consistent 
relation is observed.
T IM E  m inutes
FIG. 10—Dye clears from large fusi­
form aneurysm exponentially. R =  
—0.9378. Re =  810. Log PR =  -0.1317  
±  0.5005 x  10 2 (t) +  0.6932 ±  
0.1356 X 10A SEE =  0.6822 X 10A
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shows a comparable curve for filling 
of the saccular aneurysm. This was 
done at a higher Reynolds number 
and with more dye. While both these 
aneurysms appear to fill linearly, the 
effect of Reynolds number (Figs. 8 to 
10) is much less clear.
All of the aneurysms appear to clear 
exponentially (Figs. 10 and 11) al­
though the same variables caused 
scatter. Fig. 12 shows the effect of the 
Reynolds number on the clearing of 
the different aneurysms. Note that the 
curves for both sizes of fusiform aneu­
rysm do not drop as the Reynolds
T IM E  minutes
FIG. 11—Dye clears from saccular 
aneurysm exponentially. R =  —0.9475. 
Re =  280. Log PR =  —0.2193 ±  0.1047 
X 10 1 (t) +  0.6210 ±  0.2105 x  HU. 
SEE =  0.7122.
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FIG. 12—Effect of Reynolds number 
on log PR versus t for all aneurysms. 
Values for saccular aneurysm drop at 
high Reynolds number, while those from 
fusiform aneurysms remain approxi­
mately constant.
number increases, while that from the 
saccular aneurysm decreases.
Discussion
Any model study is only as good as 
the model. This one has a number of 
defects: it is rigid and smooth, and 
the flow is steady. Aortic aneurysms 
are rough and subjected to pulsatile 
flow. However, even with these flaws 
it seems safe to conclude that filling 
and emptying of aneurysms vary one 
from the other. This could well be im­
portant for trapping bacteria. The 
relatively stagnant flow will almost 
certainly increase the risk of thrombo­
sis, and this will be greater in large 
aneurysms regardless of the Reynolds 
number and in asymmetric ones at 
low Reynolds numbers. These results 
compare well with those of Scherer8 
for axisymmetric aneurysms but not 
for saccular ones.
We have been unable to find any 
detailed analysis of flow in human 
aortic aneurysms. Our work suggests 
that angiographic studies may not al­
ways give a true picture of the size 
of the aneurysm, since many are very 
slow to fill. They also suggest that 
both the size of the aneurysm and the 
character of the flow (i.e., the Rey­
nolds number) should be considered 
important factors in prognosis.
We thank Livio Rigutto for designing 
and building the photodensitometer, 
Dorothy Elston for technical help and 
Teresa Terpin for art work.
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dressings!
Op-Site once a week replaces 
7 days of painful, tedious 
dressing changes.
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decubitus ulcers 
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A soothing synthetic second skin
Op-Site is a thin, waterproof, adhesive mem­
brane that lets skin breathe and sweat normally. 
Just put it on a clean, crust-free ulcer and watch 
it go to work!
Op-Site relieves pain immediately, and provides 
controlled moisture that promotes faster healing,
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prevent
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Protects sensitive skin -*
Apply Op-Site to pressure areas at the first sign 
of redness, and make basic preventive measures 
more effective! Op-Site protects delicate skin <
against chafing, and it keeps out contaminants 
that contribute to tissue breakdown. <
Conforms to any body surface
Op-Site's hypoallergenic adhesive makes it fit
medicine for decubitus ulcers.
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surface moist and pliable.
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Op-Site is ideal for incontinent patients, because 
urine and feces cannot cross the waterproof 
Op-Site barrier. And because Op-Site shuts out 
Ipacteria, secondary infection is prevented.
It's easy to learn the Op-Site decubitus care 
technique. For a free colour brochure, just fill 
in and return this coupon to:
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2100 52 Avenue 
Lachine, Que. H8T 2Y5
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Erythema will disappear within a few days, as 
long as the patient is being turned frequently 
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for extra protection, as long as there is risk 
of skin irritation.
snugly and smoothly over any part of the body. 
Op-Site stays put, even though the patient is 
being turned frequently. The patient can be 
washed, too, without disturbing the dressing.
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for Subacromial Derangements
To allow adequate access to the 
subacromial region of the shoulder 
the authors designed a multipurpose 
approach. The exposure consists of an 
anterior and a posterior part. In the 
anterior part, the deltoid ‘fibres are 
separated between the anterior and 
middle thirds from the acromio­
clavicular joint for 5 cm distally; this 
provides the required access for the 
management of impingement syndrome, 
calcific tendinitis, bicipital tendon 
lesions and most tears of the rotator 
cuff. By extending the anterior part 
of the incision posteriorly over the 
supraspinatus muscle, this muscle 
may be advanced laterally for closure 
of a large tear. With this approach, 
osteotomy of the acromion or 
detachment of the deltoid muscle is 
avoided so that the integrity of the 
deltoid mechanism is maintained.
Afin de permettre un acces satis- 
faisant a la region sous-acromiale de 
I'epaule, les auteurs ont developpe 
un abord a fins multiples. L'exposition 
comprend une partie anterieure et 
une partie posterieure. Dans la partie 
anterieure, les fibres delto'ides sont 
separees entre le tiers anterieur et 
le tiers moyen a partir de I'articulation 
acromio-claviculaire, sur une longueur 
de 5 cm distalement; ceci assure 
I’acces requis pour le traitement du 
syndrome d'empietement, de la 
tendinite calcifiante des courts 
rotateurs de I'epaule, des lesions 
du tendon bicipital et de la plupart 
des ruptures de la coiffe des rotateurs. 
En etendant la partie anterieure de 
I’incision posterieurement au-dessus 
du muscle sus-epineux, ce muscle 
peut etre avance lateralement pour 
permettre la fermeture des dechirures 
larges. Grace a cette approche, 
I’osteotomie de I'acromion ou le 
detachement du muscle deltoi'de sont 
evites permettant de conserver le 
mecanisme deltoi'de.
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Subacromial derangements have been 
studied extensively in recent years. 
Codman1’2 was the first to describe 
these lesions in detail and he brought 
clarity to an area of obscurity. Others, 
such as McLaughlin,3 DePalma,4 
Moseley,5 Bateman,6 Macnab7 and 
Neer8 have also contributed to our un­
derstanding of this complex subject.
Despite all the efforts being made, 
management of the soft tissue lesions 
underlying the coracoacromial arch is 
still controversial. In patients for 
whom operation is planned, selection 
of a suitable approach is not always 
easy and is greatly influenced by an 
accurate diagnosis and localization of 
the lesion. This may sometimes be dif­
ficult because pathognomonic symp­
toms and signs may be lacking and 
ancillary tests inconclusive.
We therefore believed that a multi­
purpose approach to the subacromial 
region was needed. We combined an 
anterosuperior deltoid-splitting inci­
sion and a posterosuperior approach 
to the shoulder in an effort to achieve 
this goal (Fig. 1). In this approach, 
osteotomy of the acromion or detach­
ment of the deltoid muscle is avoided 
thus maintaining the integrity of the 
deltoid mechanism. Because of its 
flexibility this exposure offers the 
possibility of performing various pro­
cedures.
Surgical Technique
With the patient in a half-sitting
shoulder demonstrating surface anatomy in area of incision. Solid line represents initial incision (anterior portion) and in­terrupted line shows extension (posterior portion) of incision, a =  trapezius mus­cle fibres with their insertion to clavicle and scapular spine, b =  deltoid muscle fibres with their origin from clavicle and acromion.
position, the affected shoulder is 
propped up by a sandbag and the arm 
is draped free. An incision 5 cm long 
is made below and in front of the 
acromioclavicular joint. An interval 
is sought between the anterior parallel 
and middle multipennate fibres of the 
deltoid muscle. After incising the ex­
posed subdeltoid bursa the surgeon 
may obtain a limited view of the sub­
acromial region. Division of the cora­
coacromial ligament, while the ex­
tremity is distracted and moved by 
the assistant, will improve the ex­
posure. When indicated, the incision 
can be extended through the acromio­
clavicular joint which is excised with 
a 1-cm portion of the outer end of the 
clavicle and the anteromedial corner 
of the adjacent acromion (Fig. 2). The 
incision then crosses into the supra­
spinatus fossa just above the scapular 
spine. By dividing the trapezius mus­
cle close to the spine of the scapula, 
the operator encounters a dense fascia 
covering the underlying supraspinatus 
muscle. This fascia can be incised 
allowing the supraspinatus origin to 
be freed distally and advanced later­
ally if necessary.
Indications
The anterior part of the exposure 
(without extension of the original in­
cision) is usually adequate for the 
division of the coracoacromial liga­
ment, for anterior acromioplasty and 
for excision of the acromioclavicular 
joint, allowing the management of sub-
FIG. 2— Resection of coracoacromial ligament (arrow) and excision of acro­mioclavicular joint (shaded area), a =  acromion, b =  clavicle, c =  coracoid process, d =  humerus.
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acromial impingement. The calcium 
deposits in the rotator cuff may be 
removed and bicipital tendon lesions 
can be treated. Modest tears of the 
rotator cuff may be repaired (Fig. 3).
Unfortunately, the size and age of 
a rotator cuff tear may be difficult 
to predict preoperatively so that the 
surgeon may find a large defect having 
fibrotic edges (Fig. 4). Careful, time- 
consuming dissection may still enable 
the surgeon to advance such a lesion 
and permit suture of the tendon to its 
insertion. While separation of the 
supraspinatus muscle from the infra-
FIG. 3— Serious irregular rupture of 
supraspinatus tendon is exposed by 
separating anterior and middle deltoid 
muscle fibres and incising subdeltoid 
bursa, a =  anterior unipennate deltoid 
fibres originating from lateral end of 
clavicle, b =  middle multipennate deltoid 
fibres originating from lateral edge of 
acromion, c =  coracoacromial ligament.
FIG. 5— Better view of supraspinatus 
tendon rupture and its muscle belly can 
be obtained after excising acromiocla­
vicular joint. Cut end of clavicle is re­
tracted to assist exposure.
spinatus and subscapularis muscles, 
and dissection of the synovium and 
capsule from the undersurface of the 
tendon and the rim of glenoid may 
permit some lateral advancement, 
final positioning is often only possi­
ble under tension. In such circum­
stances the arm must be placed in 
abduction postoperatively. The need 
to resect a portion of the fibrotic 
edge of the tear adds to the dif­
ficulties of retraction. Advancement 
of the supraspinatus muscle de­
scribed by Debeyre, Patte and 
Elmelik9 helps in the suturing of such
FIG. 4— Large tear of supraspinatus 
tendon which is covered partly by acro­
mioclavicular joint. Arrow points to long 
head of biceps tendon seen through rup­
ture. a =  supraspinatus muscle, b =  in­
fraspinatus muscle, c =  subscapularis 
muscle.
FIG. 6— Case 1. Small transverse rup­
ture of supraspinatus tendon of right 
shoulder (arrow) seen through anterior 
part of incision.
difficult lesions and may be carried 
out through the extended incision 
(Fig. 5).
Case R eports
This exposure was used on 45 pa­
tients between Jan. 1, 1977 and Dec. 
31, 1979. On 21 occasions it was 
used to release subacromial impinge­
ment and on 24 occasions to repair 
a rotator cuff rupture. Eight pa­
tients with rupture of the rotator 
cuff required the extended incision 
for advancement of the supraspinatus 
muscle; seven had satisfactory results. 
These patients were relieved of pain 
and regained useful shoulder func­
tion. The following two case reports 
exemplify both the anterior and poste­
rior parts of our approach to rotator 
cuff ruptures.
Case 1
A 57-year old labourer had pain and 
stiffness in the right shoulder resulting 
from a fall onto his outstretched right 
(dominant) hand 2 months before 
admission. Conservative treatment had 
failed and he had been unable to work 
since the fall. Clinical examination dem­
onstrated a painful arc and active abduc­
tion of the arm was restricted but there 
was a full range of passive movement. 
Plain radiographs of the shoulder ap­
peared normal. An arthrogram of the 
glenohumeral joint suggested that the 
rotator cuff was ruptured.
At operation, the anterior part of the 
exposure was used. The subdeltoid bursa 
was incised and the coracoacromial liga­
ment was excised. The structures 
under the coracoacromial arch were in­
spected. There was a small transverse 
tear of the rotator cuff confined to the 
supraspinatus tendon at its insertion 
to the greater tuberosity of the humerus 
(Fig. 6). No bony excrescences were 
palpable on the undersurface of the 
acromioclavicular joint. After the prox­
imal stump of the supraspinatus ten­
don was trimmed, it was possible to 
suture the stump to the tuberosity with­
out appreciable tension with the arm at 
the patient’s side (Fig. 7). The shoulder 
was then put through the full range of 
movement. The anteromedial corner of 
the acromion was seen impinging on the 
repair site. Therefore, an acromioplasty 
was undertaken in the fashion described 
by Neer.8 Postoperatively, the shoulder 
was supported by a modified Velpeau 
bandage. Graduated shoulder exercises 
were begun the following day. The pa­
tient had satisfactory range of shoulder 
movement and was free from pain 3 
months after operation at which time he 
returned to a less physically demanding 
job.
Case 2
Five months before admission a 
64-year-old painter fell on his right 
shoulder and subsequently was unable
VOLUME 23, NO. 5, SEPTEMBER 1980 / THE CANADIAN JOURNAL OF SURGERY 459
to move the arm. A long course 
of physiotherapy failed to improve his 
disability. On physical examination at 
the time of admission, there was 20° of 
active abduction. He had a full range of 
passive shoulder movement. Plain films 
of the shoulder appeared normal. An 
arthrogram confirmed the presence of a 
rotator cuff rupture. Through the an­
terior part of the exposure an extensive 
tear of the supraspinatus tendon with a 
retracted proximal stump was found. 
Attempts to approximate the supra­
spinatus tendon stump to the humeral 
tuberosity failed even after the superior 
capsular attachment to the glenoid rim 
was divided. Therefore, the incision was 
extended through the acromioclavicular 
joint and the supraspinatus muscle was 
advanced laterally according to the 
method described previously (Figs. 8 to 
10). Postoperatively, the shoulder was 
supported by an abduction splint in 90° 
of abduction to obtain physiologic ten­
sion in the supraspinatus muscle and 
tendon unit. Following a 3-month super­
vised course of physiotherapy he gained 
a satisfactory range of shoulder move­
ment (Fig. 11) and returned to a mod­
ified version of his former job.
D iscussion
Careful history-taking and meticu­
lous physical examination with the aid 
of roentgenographic and arthroscopic 
investigations usually provide suf­
ficient information to recognize the 
type and the extent of lesions in the 
subacromial region. This helps in 
selecting a suitable surgical approach. 
The conventional anterosuperior ap­
proaches to the shoulder are usually 
satisfactory and offer adequate ex­
posure for the management of most 
subacromial lesions. However, at oper-
FIG. 7— Case 1. Rupture (arrow) re­
paired.
ation a supraspinatus rupture is some­
times found which is more extensive 
than suspected. This may require the 
muscle-slide operation described by 
Debeyre, Patte and Elmelik . 9 The in­
cisions traditionally used do not lend 
themselves to the extension required 
for this technique. Furthermore, del­
toid detachment, sagittal osteotomy of 
the acromion and acromionectomy 
2 ,3 ,1 0  are iosjng their appeal because of 
the resulting morbidity and the de­
layed rehabilitation. A transacromial 
approach in the line of the trapezius 
muscle and deltoid fibres may over­
come these problems , 11 but nonunion 
may result. This occurred in two 
cases among 41 osteotomies we re­
viewed. In the hope of eliminating
FIG. 8— Case 2. Massive old rupture 
of right rotator cuff seen through ex­
tended incision, a =  greater tuberosity of 
humerus, b =  long head of biceps, c =  
proximal stump of supraspinatus tendon, 
d =  articular surface of humeral head.
FIG. 10— Case 2. Repair completed.
these problems we developed a multi­
purpose approach that provides ade­
quate access for the management of 
subacromial derangements and may 
be used without inflicting significant 
trauma to the sensitive and important 
structures in the subacromial region. 
We used this approach in 45 cases 
with gratifying early results. More 
experience and a longer follow-up are 
necessary before we can make a final 
assessment.
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Colorectal Anastomosis by Transanal End-to-End
Stapling
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In 26 patients end-to-end colorectal 
anastomosis was attempted using 
a transanal stapling instrument. The 
anastomosis was successful in 
19 patients. Permanent colostomy 
would have been the only alternative 
treatment in 12 patients. In five 
patients, other sphincter-saving 
methods of anastomosis would have 
been technically feasible but more 
difficult and hazardous. In the 
remaining two patients standard sutures 
or side-to-side stapling could have 
been used equally easily. The 
technique of anastomosis, the 
complications and the functional 
results are reviewed. The authors 
conclude that transanal end-to-end 
stapled anastomosis is an important 
technical advance in colorectal 
surgery.
Une anastomose colorectale bout a bout 
a ete tentee chez 26 malades a I'aide 
d'un instrument servant a la pose 
transanale de broches. Cette 
anastomose a ete reussie chez 
19 patients. Une colostomie
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permanente aurait ete la seule 
alternative chez 12 patients.
Chez cinq patients, d'autres methodes 
d'anastomose permettant la 
conservation du sphincter auraient 
ete techniquement realisables, 
mais elles auraient ete plus difficiles 
et risquees. Chez les deux derniers, 
les sutures conventionnelles ou les 
broches cote a cote auraient pu etre 
utilisees avec la meme facilite.
La technique d'anastomose, ses 
complications et ses resultats 
fonctionnelles sont passes en revue.
Les auteurs concluent que I'anastomose 
bout a bout par broches transanales 
est une amelioration technique 
importante dans la chirurgie du colon 
et du rectum.
In this paper we review our early ex­
perience with an end-to-end stapling 
instrument for colorectal anastomosis 
(EEA Auto Stapler; Auto Suture Com­
pany, Division of United States Sur­
gical Corp., Stamford, Conn.).
After resection of lesions in the 
sigmoid colon or upper third of the 
rectum, continuity is usually re-estab­
lished easily and safely either by an 
end-to-end sutured anastomosis or by 
side-to-side stapling techniques. On 
the other hand, malignant tumours 
located up to 7.5 cm from the anal 
verge require abdominoperineal resec­
tion with a permanent colostomy. In 
lesions located in the middle third of 
the rectum (7.5 to 11.5 cm from the 
anal verge) a permanent colostomy 
may be avoided if the lesion is his­
tologically of low-grade malignancy 
and if a safe anastomosis is technically 
possible. End-to-end autosuture stap­
ling instruments have been designed 
to solve this problem.
Patients and M ethod
The daily operating lists from the 
Vancouver General Hospital and St. 
Paul’s Hospital, Vancouver, were re­
viewed over a 9-month period from 
May 1978 to January 1979 and the 
hospital records of these patients were 
examined. Use of the EEA stapler was 
planned for 26 patients. It was used 
successfully in 19 (10 women, 9 
men); in the other 7 it was tried but 
was found unsuitable. The average 
age of the 19 patients was 57 years 
(range 38 to 85 years).
Table I lists the diagnosis for each 
patient, the distance of the lesion 
from the anal verge measured at sig­
moidoscopy and the length of bowel 
left in the pelvis after resection.
Stapling Technique
The patient is prepared for large 
bowel resection according to the 
method preferred by the operating 
surgeon. Placement of an indwelling 
catheter is essential since the dissec­
tion will extend low in the pelvis. 
After anesthesia has been induced the 
patient is positioned as for abdomino­
perineal resection of the rectum, using 
Lloyd-Davis equipment. A laparotomy 
is performed and the growth is 
examined to make sure it can be re-
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sected. Two right-angled clamps are 
applied at the chosen distance below 
the lesion. The rectum is divided be­
tween them and removed. In mobil­
izing the rectum, the surgeon should 
not use metallic clips for hemostasis 
since these may block the action of the 
stapler or prevent staples from closing. 
With the lower clamp still in position, 
the remaining rectal stump should be 
thoroughly washed out through a 
transanal tube. Next, an over and 
over whipping stitch suture, using 
heavy suture material, is placed at the 
two ends of bowel to be anastomosed. 
In our series 1-0 silk was preferred 
but since these sutures are removed 
after anastomosis, any strong material 
will do. The stapler (Fig. 1) is loaded 
with the cartridge of choice (usually 
31.6 mm for rectum to colon). It is 
most important to keep the safety 
catch on the stapler in position to 
prevent accidental triggering. The anus 
is dilated with the fingers and the 
loaded stapler is introduced. Once in 
the lower rectum the anvil and staple- 
containing cartridge are separated by 
the end wing nut. This pushes the 
anvil out through the rectal stump 
into the upper pelvis. The whipping 
stitch suture on the rectal stump is 
tied firmly around the central column 
and the ends are cut short. The colon 
is now lifted over the anvil and its 
whipping suture is similarly tied and 
cut short. The wing nut is now used 
to bring the anvil and cartridge to­
gether again and at the same time 
the whole instrument is pulled as low 
in the pelvis as possible. If this is not 
done great tension will be applied to 
the suture on the rectal stump at the 
moment of stapling and the suture 
may break resulting in an incomplete 
anastomosis. With the instrument still 
low in the pelvis the safety catch is 
released and the trigger pulled. The 
wing nut is now turned three or four 
times to loosen the grip between the 
anvil and the cartridge. By alternate 
clockwise and anticlockwise quarter 
to half rotations, the stapler is slowly 
eased through the anastomosis and 
out of the anus. The anvil and car­
tridge should then be removed and the 
two doughnut shaped rings of tissue 
examined. If the anastomosis is suc­
cessful these circles of tissue will be 
unbroken. The two rings can be 
separately labelled and submitted for 
microscopic examination.
Results
Complications
In 3 of the 19 patients a leaking
anastomosis was recognized, but in 
only 1 could it be classed as clinically 
significant. This patient was one of 
two who had resection of the pelvic 
colon for diverticular disease. After 
stapling, the anastomosis was tested 
by air and water insufflation and was 
intact. But a major leak, and subse­
quently a fecal fistula, developed. The 
fistula closed after the patient had 
undergone a period of intravenous 
feeding and total rest of the 
alimentary tract. The two minor leaks 
were discovered after patients com­
plained of pain and bleeding on de­
fecation. Plain roentgenograms of the 
pelvis showed a defect in the bracelet­
like staggered rows of staples (Fig. 2). 
A water-soluble contrast enema con­
firmed the two very minor leaks. Both 
closed quickly, one without specific 
treatment and the other after the 
patient was fed intravenously. One 
other anastomosis was recognized as 
incomplete when the tissue rings were 
inspected after removal of the stapler. 
It was patched by sutures and there 
were no complications. Two patients 
had a minor wound infection with 
redness and induration. Both infec­
tions resolved spontaneously.
Rectal Function after Resection
Rectal function was assessed just
T a b le  1— P ath o lo g ic  F e a tu re s
L e n g th  o f
C ase D is ta n c e  from D is ta l re s id u a l bow el
no. D ia g n o s is a n a l v e rg e , cm c le a ra n c e , cm in  p e lv is , cm
i A d e n o c a rc in o m a 15 5 10
2 A d e n o c a rc in o m a 15 6 9
3 A d e n o c a rc in o m a 12 5 7
4 A d e n o c a rc in o m a 12 5 7
5 /.d e n o c a rc in o m a 12 4 8
6 A d e n o c a rc in o m a 12 5 7
7 A d e n o c a rc in o m a 11 5 6
8 A d e n o c a rc in o m a 10 5 5
9 A d e n o c a rc in o m a 10 5 5
10 A d e n o c a rc in o m a 10 5 5
11 A d e n o c a rc in o m a 10 5 5
12 A d e n o c a rc in o m a 9 5 4
13 A d e n o c a rc in o m a 9 5 4
14 A d e n o c a rc in o m a 5 0.5 4.5
15 S u tu r e - l in e
re c u rre n c e  o f
a d e n o c a rc in o m a 9 3.5 5.5
16 V il lo u s  adenom a 10 0.5 9.5
17 V il lo u s  adenom a 9 0.5 8.5
18 D iv e r t ic u l i t is 17.5 P e lv ic  colon 17.5
res e c te d
19 D iv e r t ic u l i t is 17.5 P e lv ic  colon 17.5
res e c te d
FIG. 1—Schematic view of EEA Auto Stapler and disposable loading unit. 
(Reproduced by permission from Auto Suture Company, Division of United States 
Surgical Corp., Stamford. Conn.)
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before the patient was discharged 
from hospital. The three patients who 
had a protective colostomy performed 
at the time of anastomosis were ex­
cluded. Results are shown in Table II. 
Ten patients had one normal bowel 
movement daily; 2 patients had four 
loose stools daily. Twelve patients had 
normal continence but 2 patients had 
pain and bleeding which heralded 
small leaks in the anastomoses.
Discussion
The EEA Auto Stapler is a develop­
ment of the original end-to-end 
stapler, Russian model 249, pioneered 
in the Soviet Union1 and now avail­
able in Western Europe. The specifica­
tions of the stapler are available in 
an excellent product booklet.2 The 
essential differences between the EEA 
Auto Stapler and the Russian model 
are in ease of loading and cost. In the 
249 model each metal staple and the 
circular knife must be loaded by hand 
whereas the EEA stapler has a pre- 
loaded cartridge with samples, anvil 
and knife all mounted and ready to 
use. The cost of each anastomosis is 
roughly $60 US for the EEA stapler 
but only a few cents for the Russian 
model. This economy of operation has 
to be balanced against the initial capi-
FIG. 2—Plain film of pelvis shows 
bracelet-like ring of staples, which is 
incomplete (arrow). Note that hemostatic 
clips have been used. This is inadvisable 
because clips may interfere with stapling 
procedure.
tal cost which is about three times 
greater for the Russian instrument 
than for the EEA stapler.
From the data we have presented 
end-to-end stapling in the rectum ap­
pears safe and allows anastomosis at 
a lower level in the pelvis than would 
be possible by conventional suturing 
techniques. In 12 patients, 7 cm or 
less of residual bowel was left in the 
pelvis and we believe that without 
stapling, abdominoperineal resection 
with permanent colostomy would have 
been necessary. The attending sur­
geons considered that it was tech­
nically impossible to achieve a secure 
anastomosis by suturing at these levels. 
In five patients who had between 8 
and 10 cm of residual bowel, the oper­
ating surgeons believed that a sutured 
anastomosis could have been done, 
although with difficulty. Thus, abdo­
minoperineal resection would probably 
not have been used by most surgeons. 
However, in reaching this conclusion 
one must allow for individual tech­
nical experience and varying anatom­
ical conditions. In two patients, stand­
ard suturing or side-to-side stapling 
methods were equally applicable and 
no advantage was gained by using 
the EEA stapler. It could be argued 
that the EEA stapler was not indicated 
in these two cases. In 12 of the 19 
patients a permanent colostomy was 
certainly avoided while another 5 
might have needed a permanent 
colostomy. Therefore the use of the 
EEA Auto Stapler must be con­
sidered an important new technical 
advance, especially since resection 
clearance margins were not seriously 
compromised, except in one case. 
This patient (case 14, Table I) was 
85 years old and in the surgeon’s 
opinion the avoidance of a colostomy 
was more important than any other 
consideration. Therefore, the surgeon 
elected to clear the tumour by only 
0.5 cm. Even though the smallest re­
sidual stump left in the pelvis was 
4.5 cm the fairly acceptable early
functional results are encouraging, 
and function is expected to improve 
with time.
We deduce from our one case of 
major leakage that it is not advisable 
to “test” the anastomosis with air or 
water. One cannot expect any bowel 
anastomosis to be air- or watertight 
within a few minutes of its construc­
tion. Previous reports3'7 indicated that 
stapling is much safer than hand 
suturing methods8 but as yet no com­
parative studies have been published. 
Our series is too small to draw any 
conclusions concerning anastomotic 
leakage, but the results show that the 
technique is at least as safe as hand 
suturing methods. Goligher1 has re­
commended that the anastomosis be 
inspected from below with a sterile 
sigmoidoscope because of the pos­
sibility of postanastomotic bleeding. 
We did not encounter any cases of 
anastomotic bleeding but gentle sig­
moidoscopy would probably be 
reasonable while the abdomen is still 
open and the sigmoidoscope can be 
doubly controlled.
Of the seven patients for whom 
EEA stapling was planned but not 
used, three had malignant tumours 
located 12, 10 and 7 cm, respectively, 
from the anal verge; these were 
treated by abdominoperineal resection. 
The surgeons concerned noted that 
technical difficulties did not allow 
adequate clearance below the lesion. 
This point is most important. We em­
phasize that the ability to perform 
safe, low colorectal anastomosis 
should not in any way dissuade sur­
geons from the well established need 
for clearance of at least 5 cm below a 
malignant tumour. If this rule is 
ignored suture-line recurrence of can­
cer can be expected. One other pa­
tient with cancer also had diverticular 
disease and was treated by total colec­
tomy. Ileoproctostomy was attempted 
using the stapler but the 31.6-mm 
diameter staple was too large for the 
ileum. The smaller 25- to 28-mm 
staple cartridges were not not in pro­
duction at that time. The anastomosis 
was eventually sutured. One patient 
underwent resection of the pelvic 
colon and anastomosis by side-to-side 
stapling and in two other patients a 
laparotomy was carried out but anas­
tomosis was not attempted.
The long-term cure rate associated 
with procedure we describe is un­
known, but there is no theoretical 
reason why it should differ from simi­
lar conventionally sutured resections.
In summary, we believe that trans- 
anal end-to-end stapling will allow
T a b le  I I —F u n c tio n a l R e s u lts  in  16 P a t ie n ts
F u n c tio n C o n s is te n c y  o f s tool N o . o f p a tie n ts
F re q u e n c y  o f s to o ls /d
1 N o rm a l 10
2 N o rm a l 1
3 Loose, fo rm e d 3
4 Loose , fo rm e d 2
C o n tin e n c e
N o rm a l 12
U rg e n c y /p o o r  d is c rim in a t io n 2
P a in /b le e d in g 2
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acceptably safe rectal anastomosis at 
a level in the pelvis that would either 
be impossible or at best difficult and 
hazardous by conventional suturing 
techniques. From this study, and other 
recent publications, the technique 
appears to be safer than low-level 
conventional suturing methods. How­
ever, a larger number of cases will 
have to be studied before this hypo­
thesis can be considered proved.
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November 1980 Issue
The November issue will include a 
review article entitled “Gallstones: 
current concepts of pathogenesis and 
medical dissolution”, the 1980 Gallie 
Memorial Lecture (“Lung cancer in 
historical perspective”) presented at 
the 49th annual meeting of the Royal 
College of Physicians and Surgeons 
of Canada and a number of papers 
presented at the 2nd annual meeting 
of the Canadian Society for Vascular 
Surgery.
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Zinacef is a new third generation injectable 
cephalosporin with advantages that 
make it an excellent first choice antibiotic.
Unlike most penicillins and cephalosporins which 
are inactivated by 0-lactamase producing pathogens, 
Zinacef has a novel structure (the addition of an 
a methoximino group)' which helps protectthe beta- 
lactam ring against destruction.
• Lower individual dosage (750 mg) and longer half-life 
(70 minutes)' than other third generation cephalosporins.
• Convenient eight-hour dosage interval for a low 
j usual daily dose of 2.25 g.’
• Therapeutically effective levels throughout body 
tissues.’
# # #  Range of M.I.C.'s
for most common pathogens.
C ---- CONH
NOCH
CH2OCONH
Time from dose (hours). Reference 2
Zinacef has a high intrinsic activity against the 
range of Gram-positive and Gram­
negative pathogens responsible for 
the vast majority of hospital 
infections.' Up to 92%  of isolated 
pathogens were effectively treated 
by Zinacef.3
Zinacef has a broad range of activity 
and excellent pharmacokinetics:
• Rapidly absorbed and not meta­
bolised, yielding high levels 
(91-96%) of active unchanged 
antibiotic in the urine.1
From Glaxo Laboratories We started cephalosporin research. And we’ve never stopped
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Persistent Sciatic Artery^*- Case Report
( G.G. Y oungson,)mb, ch b. F R rs f f p i n E *  B. T aylorI md,4r . Rankin,|mb, ch  b, FRCP[c]f and 
V““ _— ^R.O. Heimbecker^ ma, md, ms, frcs[c], FACS*
A persistent sciatic artery was an 
incidental finding in a 29-year-old man 
who was being investigated for 
severe varicose veins and venous 
ulceration.
The authors review the embryology 
and literature pertaining to persistent 
sciatic artery. Because it has a 
propensity for aneurysm formation and 
thrombosis they recommend that 
elective surgery be considered for 
this condition. In young asymptomatic 
patients the condition of the anomalous 
artery should be monitored by 
ultrasonography until operative 
intervention is indicated.
The operative procedure should 
consist of occlusion with a balloon 
catheter or ligation of the persistent 
artery followed by femoropopliteal 
bypass.
La persistance d’une artere sciatique 
a ete decouverte fortuitement chez un 
homme de 29 ans qui etait examine 
pour des veines variqeuses severes et 
une ulceration veineuse.
Les auteurs passent en revue 
I'embryologie et la litterature relative 
a la persistance de I’artere sciatique. 
Parce qu’il y a danger d’anevrisme et 
de thrombose, ils recommandent 
d'envisager une intervention 
chirurgicale non urgente. Chez les 
jeunes patients asymptomatiques,
I'etat de I'artere anormale doit etre 
surveille par echographie ultrasonique 
jusqu'a ce que I’intervention soit 
indiquee.
La technique operatoire consiste 
a ligaturer ou a obliterer I’artere 
persistante au moyen d'un catheter 
a ballonet puis de realiser une 
derivation femoro-poplitee.
Persistence of the primitive sciatic 
artery is a rare but clinically impor­
tant congenital anomaly of the ar­
terial supply to the lower limbs. The 
anomaly has been associated with 
hemihypertrophy of pelvis and leg,1 
short leg,2 atherosclerotic obstruction,3
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aneurysm formation,4 arteriovenous 
malformation, lymphatic malforma­
tion, neurofibromatosis5 and arterio- 
megaly.6 Although the condition was 
first described in 1831/ only 32 cases 
have been documented. The relative 
frequency of this anomaly in patients 
who undergo angiography has been 
estimated to be 0.01 %.8 Although 
the clinical importance of this vascu­
lar anomaly is apparent, its natural 
history is unclear. In this paper we 
describe a patient with a persistent 
arteriomegalic sciatic artery who 
had a concomitant venous disorder 
and we discuss the use of ultrasono­
graphy for continuing evaluation of 
this ectatic anomalous vessel.
Embryology
The sciatic artery, or axis artery, 
is the embryologic vessel supplying 
the lower extremity. It is first seen in 
the 6-mm embryo as a combination 
of the capillary plexus supplying the 
limb bud and arises as a branch from 
the dorsal root of the umbilical ar­
tery. The femoral artery appears as a 
branch of the external iliac artery 
at the 10-mm stage.
At first, the femoral artery termi­
nates by dividing into the descending 
genicular artery and ramus commu- 
nicans superior. The ramus communi- 
cans anastomoses with the popliteal 
artery (continuation of the sciatic ar­
tery) and gradually enlarges. As the 
perforating vessels develop from the 
deep femoral artery the sciatic artery 
atrophies and remains proximally as 
the first part of the inferior gluteal 
artery. Distally, the popliteal, peroneal 
and anterior tibial arteries are derived 
from the sciatic artery. The posterior 
tibial artery is a continuation of the 
primitive superficial femoral artery. 
The persistent sciatic artery can be 
complete with an intact vessel from 
the internal iliac to the popliteal 
artery, or incomplete with vestigial 
vessels along the sciatic nerve. This 
anomaly can be unilateral or bilateral 
and, when complete, is usually asso­
ciated with hypoplasia of the ipsi- 
lateral superficial femoral artery.6
Case Report
A 29-year-old man was admitted for 
possible operative treatment of severe 
varicose veins of the right lower limb 
with venous ulceration (Fig. 1). The
leg had been swollen since birth but the 
patient had experienced no intermittent 
claudication or pain. His previous med­
ical history included a closed fracture 
of the right ankle and a small-calibre 
bullet wound of the right thigh without 
major vascular injury. On physical ex­
amination the perforating and long 
saphenous vessels of the venous system 
in the right lower limb were found to 
be incompetent, there was a venous 
ulcer posterior to the right medial mal­
leolus and a palpable pulsatile mass 
extended from the buttock down the 
posterior aspect of the thigh. Ausculta­
tion over the mass disclosed no bruit 
and examination of the patient’s limb by 
Doppler ultrasonography failed to con­
firm the initial clinical diagnosis of 
arteriovenous fistula. The pedal pulses 
were present.
To exclude the presence of an arterio­
venous fistula, arteriography of the aorta 
and lower limb vessels was performed. 
Injection into the right common iliac 
and internal iliac arteries demonstrated 
a large (maximal diameter 2.5 cm) vessel 
continuing from the internal iliac artery, 
passing through the thigh, to form the 
popliteal artery—a complete persistent 
arteriomegalic sciatic artery. According­
ly, the superficial femoral artery was 
hypoplastic and ended in the region of 
the adductor canal by bifurcation into 
the descending genicular artery and 
ramus communicans (Figs. 2 and 3). 
There was extensive calcification in the 
wall of this anomalous vessel.
FIG. I—Lower limbs of patient show­
ing superficial varicosities and swelling 
of right leg.
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Ascending venography was performed 
to evaluate the perforator incompetence 
in the lower limb and the status of the 
deep venous system; the latter was ana­
tomically normal. B-scan ultrasonography 
of the right buttock and thigh visualized 
the persistent sciatic artery from approxi­
mately the level of the greater sciatic 
notch to the level of the popliteal fossa 
(Fig. 4). Ligation of the high saphenous 
and perforating vessels and stripping of 
the long saphenous system gave a good 
clinical result.
FIG. 2—Injection of right common 
iliac artery reveals arteriomegalic sciatic 
artery. Note apparently normal external 
iliac/common femoral artery.
FIG. 3—Sciatic artery forms popliteal 
artery. Arrows indicate distal extent of 
superficial femoral artery.
Discussion
Previously documented cases of 
persistent sciatic artery have received 
attention because of complications of 
the anomaly. The mean age at presen­
tation was 45 years. To our knowl­
edge this is the first report of the 
anomaly being detected incidentally.
Since a propensity for aneurysm 
formation and thrombotic atheroscle­
rotic occlusion has been documented, 
elective surgical intervention is in­
dicated. However, the timing of op­
eration remains to be established and 
because we were reluctant to have the 
viability of the limb dependent upon 
a bypass graft in a young asympto-
FIG. 4—Longitudinal B-scan ultra­
sonography of right posterior tliigli 
showing persistent sciatic artery (between 
arrows).
made patient, we chose to monitor 
the persistent sciatic artery by u ltra­
sonography. With the increasing per­
formance of angiography of the 
lower extremities this anomaly will 
likely be found more frequently. 
Evaluation of a pulsatile mass in the 
buttock should include angiography 
and ultrasonography. /
Should surgical intervention be 
necessary we advocate occlusion with 
a balloon catheter or ligation of the 
origin of the persistent sciatic artery 
and femoropopliteal bypass grafting 
using reversed autogenous long 
saphenous vein.
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Refresher Course for 
General Surgeons
The 21st annual refresher course 
for general surgeons, sponsored by 
the faculty of medicine, University of 
Toronto will be held from Feb. 2 
to 4, 1981 at the Women’s College 
Hospital in Toronto. There will be 
symposia on benign biliary tract 
problems, benign esophageal prob­
lems, breast carcinoma, rectal carci­
noma, pediatric surgery, what’s new, 
how I manage, and workshops on 
fractures, thoracoabdominal trauma, 
gastroduodenal surgery, intensive 
care, vascular surgery, sepsis and nu­
trition, head and neck surgery and 
proctology. For further information, 
contact: Office of Continuing Medi­
cal Education, Faculty of medicine,
Rm. 245, Fitzgerald Building, U ni­
versity of Toronto, Toronto, Ont. 
M5S 1A8 (telephone: [416] 978-2718.
Chemotherapy Congress
The 12th International Congress of 
Chemotherapy will take place July 
19-24, 1981 in Florence, Italy.
The topics will include antim icro­
bial, anticancer and antiviral chem ­
otherapy as well as immunology and 
immunotherapy.
The deadline for the submission of 
abstracts is Feb. 15, 981.
For further information write to 
the Secretariat, 12th International 
Congress of Chemotherapy, Via della 
Scala, 710, Florence, Italy, 50123 —  
Florence.
continued on page 470
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Of 11 patients who underwent elective 
aortocoronary bypass operation using 
nonpulsatile flow with moderate 
hypothermia (28°C), 8 had hypertension 
defined as blood pressure of 160/
100 mm Hg or greater. The plasma 
renin level was not elevated during 
bypass but postoperatively in the 
intensive care unit it became signifi­
cantly (P <  0.05) elevated. An in­
crease in the release of renin was 
associated with a rise in systemic 
vascular resistance and coincided 
with the onset of hypertension. 
Although the values of plasma catecho­
lamines were elevated during bypass 
and in the intensive care unit, they did 
not appear to contribute appreciably 
to increases in systemic resistance. 
The authors conclude that an increase 
in the release of renin is associated 
with increased vascular resistance 
and elevated blood pressure following 
myocardial revascularization.
Des 11 patients qui ont subi un 
pontage aorto-coronarien non urgent 
ou fut utilisee une circulation non 
pulsatile avec hypothermie moderee 
(28°C), 8 avaient une hypertension 
definie comme une tension arterielle 
de 160/100 mm de Hg ou plus. Le 
taux de renine plasmatique n'etait pas 
eleve durant I’operation de pontage 
mais il devint significativement elevee 
(P <  0.05) apres I’operation, dans 
I’unite de soins intensifs. Une aug­
mentation de la liberation de la renine 
fut associee a une augmentation de 
la resistance vasculaire generale 
et coincida avec I'apparition de 
I’hypertension. Bien que les concen­
trations plasmatiques de catecola- 
mines eurent ete elevees durant 
I’intervention et dans I'unite de 
soins intensifs, elles ne semblent pas
From The Maritime Heart Center, 
division of cardiovascular surgery, 
department of anesthesia and division of 
clinical chemistry, Dalhousie University, 
Halifax, NS
Supported by the Nova Scotia Heart 
Foundation
Accepted for publication Apr. 11, 1980
Reprint requests to: Dr. R.W. 
Landymore, 48 Turner Rd., Pearl 
River, N Y 10965, USA
avoir contribue de facon appreciable 
aux augmentations de la resistance 
generale. Les auteurs concluent 
qu’une augmentation de la liberation 
de renine est associee a une augmen­
tation de la resistance vasculaire et 
de la tension arterielle suite a une 
revascularisation du myocarde.
Hypertension is a frequent complica­
tion in the early postoperative period 
after myocardial revascularization.1'3 
The cause remains obscure although 
the transient rise in blood pressure 
appears to be associated with in­
creased systemic vascular resistance1 
and elevated plasma renin levels.4
The purpose of this study was to 
determine the frequency of hyper­
tension following myocardial revascu­
larization and its relation to circulat­
ing plasma renin and catecholamine 
concentrations.
Patients and Methods
Eleven men with coronary artery 
insufficiency underwent elective myo­
cardial revascularization. Their ages 
ranged from 36 to 64 years (mean 
49.9 years). They had no previous his­
tory of hypertension, or renal or 
endocrine disease. All were taking 
propranolol (40 to 120 mg c/6h, mean 
50 mg q6h). In addition the majority 
of patients were taking nitroglycerin 
and isosorbide dinitrate but no other 
medications.
Because earlier reports demon­
strated that propranolol suppresses 
renin release,5'7 propranolol intake 
was gradually reduced following the 
patient’s admission to hospital and 
was discontinued 24 hours before op­
eration. A screening biochemical 
profile was obtained; it included a 
complete blood count, measurement 
of plasma glucose, electrolyte, blood 
urea nitrogen and creatinine values 
and urinalysis. At 14:00 hours on the 
day before operation an arterial 
blood sample was drawn to determine 
the plasma renin and catecholamine 
levels.
All patients received identical pre­
preoperative medication consisting of 
sodium pentobarbital (100 mg hs) 
and morphine sulfate (10 to 15 mg 
intramuscularly at 06:45 h on the day
of operation). In the induction room 
a catheter was inserted in the radial 
artery and a Swan-Ganz thermodilu­
tion catheter (Edwards Laboratories, 
Santa Ana, Calif.) was positioned in 
the pulmonary artery. Anesthesia was 
induced with sodium thiopental and 
pancuronium bromide (0.1 mg/kg). 
Cardiac anesthesia was maintained 
with oxygen, nitrous oxide and halo- 
thane. Immediately following induc­
tion, cardiac output was measured by 
thermodilution with ice-cold (1°C) 
saline. Peripheral vascular resistance 
(dynes/srcnr5) was then calculated 
from the following formula:
Resistance =  SAM-RAM X 1333,
CO
where SAM is the mean systemic 
arterial pressure (mm Hg), RAM 
is the mean right atrial pressure 
(mm Hg) and CO is the cardiac out­
put (I/min). Arterial blood samples 
were drawn for a complete blood 
count and determination of the serum 
electrolyte and plasma renin and 
catecholamine levels.
Cardiopulmonary bypass was estab­
lished with a Bentley-Temptrol oxy­
genator (Bentley Laboratories, Irvine, 
Calif.) primed with 1500 ml of Plas- 
malyte (Travenol Co. Ltd., Deerfield, 
III.) and I unit of whole blood. 
Lincomycin was added to the priming 
solution in each case and was given 
in the recovery room every 6 hours. 
Bypass was maintained with standard 
nonpulsatile flow at moderate hypo­
thermia (28°C) and volume was re­
placed during bypass with Plasmalyte 
solution. Revascularization was com­
pleted with reverse saphenous vein 
grafts in each case.
Cardiac output was determined and 
samples of arterial blood were drawn 
for complete blood count and meas­
urement of serum electrolyte and 
plasma renin and catecholamine val­
ues 30 minutes and 1 hour after the 
start of bypass and 2Vz and 5 hours 
after bypass was terminated. In each 
case the blood samples for renin and 
catecholamine estimation were im­
mediately placed on ice and trans­
ported to the laboratory where they 
were centrifuged and frozen to -20°C. 
Catecholamine levels were analysed 
by the radioenzymatic method (Cat-A-
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Kit [3H]; Upjohn Diagnostics, Kala­
mazoo, Mich.) and plasma renin 
levels by the radioimmunoassay 
method (Radioimmunoassay Kit An­
giotensin I New England Nuclear, 
Bellerica, Mass.).
Results are reported as mean values 
with their associated standard errors, 
statistical analysis was carried out 
using the Student’s 7-test for paired 
samples.
Results
The 11 men received two to four 
(mean 2.9) grafts. Induction of 
anesthesia took between 90 and 160 
minutes (mean 120 minutes). The 
duration of bypass was from 90 to 
198 minutes (mean 133 minutes) and 
the duration of hypothermia 50 to 
170 minutes (mean 101 minutes). 
The time taken for closure ranged 
between 50 and 100 minutes (mean 
95 minutes).
FIG. 1—Plasma catecholamine levels 
(mean ±  standard error of mean) dur­
ing nonpulsatile cardiopulmonary by­
pass with moderate hypothermia. A =  
epinephrine, O =  norepinephrine and 
□  =  dopamine.
Plasma Renin
Preoperative renin sampling 24 
hours before operation demonstrated 
normal resting values of 0.71 ±  0.17 
ng/ml -h. During the induction phase 
plasma renin increased moderately 
over resting values to 1.5 ±  0.41 
ng/ml *h. The rise, however, was not 
statistically significant. During the 
period of cardiopulmonary bypass 
plasma renin returned to the range of 
preoperative levels. Following the ter­
mination of bypass plasma renin 
levels increased to reach the maximum 
value (2.2 ±  0.5 ng/ml «h) in the in­
tensive care unit. The increase was 
statistically significant (P <  0.05) and 
coincided with the onset of postoper­
ative hypertension. Normotensive pa­
tients did not demonstrate a signif­
icant increase in plasma renin values.
Plasma Catecholamines (Fig. 1)
Preoperatively, epinephrine and 
norepinephrine values were 116 =fc 
42 ng/ml and 200 ±  52 ng/ml, re­
spectively. During the induction phase 
both levels increased slightly but not
FIG. 2— Peripheral vascular resistance 
(mean ±  SEM) during cardiopulmonary 
bypass with moderate hypothermia.
Table I— Relation between Plasma Renin Values and 
Blood Pressure Postoperatively
Preoperative
Postoperative
Group
plasma renin, 
ng/ml *h
Plasma renin, 
ng/ml-h*
Hypertensive
patients 1.3 1.9
0.5 1.2
1.1 2.4
1.1 5.9
1.0 1.3
0.7 5.2
0.2 2.5
Normotensive
patients 0.6 1.1
0.6 1.0
0.2 1.1
0.5 1.5
Blood pressure, 
mm Hg
180/102
180/140
130/100
165/114
170/105
180/120
185/100
132/84
150/90
120/60
130/70
’Significantly elevated compared with preoperative data in the hypertensive group (P <  0.05, 
Student’s 7-test). Hypertension was associated with elevated plasma renin value (P <  0.05 
X 2 test).
significantly. The values gradually in­
creased with the onset of cardiopul­
monary bypass reaching their maxi­
mum postoperatively in the intensive 
care unit. All measurements follow­
ing the induction phase showed sta­
tistically significant increases com­
pared with preoperative values, with 
confidence limits of P <  0.05 or 
better. Dopamine levels were not 
elevated during the study.
Systematic Vascular Resistance
(Fig. 2)
Vascular resistance increased during 
induction of anesthesia and remained 
slightly but not significantly elevated 
throughout the period of cardiopul­
monary bypass. The value measured 
in the intensive care unit was signif­
icantly (P <  0.05) increased compared 
with preoperative values.
Hypertension
All patients were classified as nor­
motensive preoperatively; that is, they 
had a blood pressure of 140/90 mm 
Hg or less. Following the onset of 
extracorporeal circulation the arterial 
blood pressure decreased to a mean 
of 40 to 50 mm Hg in each case. The 
blood pressure was raised to a normal 
bypass range of 70 to 80 mm Hg by 
adding volume in the form of Plasma- 
lyte solution or by adding Neo-Syne- 
phrine to the bypass line. All 11 pa­
tients were normotensive when bypass 
was terminated and during closure. 
However, after transfer to the inten­
sive care unit, hypertension as de­
fined by a blood pressure of 160/100 
mm Hg or more was observed in eight 
(73%) patients. Elevated systemic 
pressure was treated in a similar 
manner in each case. As soon as hy­
pertension was noted Pantopon (2 to 
5 mg) was administered intravenously. 
If the hypertension persisted despite 
adequate sedation, chlorpromazine (2 
to 5 mg) was given intravenously. Fur­
ther persistent hypertension was 
treated with an infusion of sodium 
nitroprusside. Two of the eight hyper­
tensive patients responded to Panto­
pon alone and six were given chlor­
promazine; three of the six patients 
required nitroprusside.
Table I illustrates the relation be­
tween postoperative hypertension and 
plasma renin levels. Patients with an 
elevated systemic blood pressure also 
had significant (P <  0.05) elevation 
of plasma renin levels compared with 
preoperative values. However, there 
appeared to be no direct correlation 
between the degree of postoperative 
hypertension and the magnitude of
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plasma renin release. Comparative 
data between hypertensive and nor- 
motensive patients demonstrated a 
significant association (P <  0.05, -/2 
test) between hypertension and plasma 
renin levels.
Discussion
The rate of hypertension following 
myocardial revascularization has been 
reported to range from 33% to 
58% .2'4 The pathogenesis of the in­
crease in systemic blood pressure has 
not been fully explained although 
some contributing factors have been 
recognized.
Hypertension postoperatively is 
associated with increased vascular re­
sistance1 and elevated levels of angio­
tensin II, a naturally occurring endo­
genous vasoconstrictor.4 Taylor and 
colleagues4 demonstrated that plasma 
angiotensin concentration was in­
creased following cardiac surgery and 
implicated this hormone in the pro­
duction of hypertension postoper­
atively. Earlier reports showed that 
renin release is stimulated by sympa­
thetic discharge,8 hypotension8 and 
nonpulsatile flow.9 In our patients in­
creased sympathetic discharge oc­
curred during bypass and in the in­
tensive care unit as evidenced by high 
levels of circulating catecholamines. 
Hypotension results in a marked in­
crease in renin activity and the mean 
arterial pressure decreased temporari­
ly to 40 to 50 mm Hg in all our pa­
tients following the onset of bypass. 
In our study circulatory support was 
with roller pumps delivering non­
pulsatile perfusion. Renin production 
is stimulated by nonpulsatile flow as 
demonstrated by Many and asso­
ciates.9 Goodman and associates10 also 
noted that renin was released during 
nonpulsatile flow. They demonstrated 
that increased plasma renin levels 
were associated with a redistribution 
of blood flow within the kidney in 
favour of the juxtamedullary cortex. 
These factors should contribute to 
substantial renin production during 
bypass. However, our data fail to 
support the observations of Taylor 
and colleagues4 who demonstrated 
elevated plasma renin levels through­
out the period of cardiopulmonary 
bypass. The differing results are in 
part related to the fact that Taylor and 
colleagues did not use core hypother­
mia during circulatory support. Hypo­
thermia has a direct effect on the 
kinetics of the renin-angiotensin 
system. Schaffenburg, Haas and 
Goldblatt11 demonstrated that renin
activity may be decreased 700-fold by 
lowering the temperature from 37°C 
to 2°C.
A further explanation for the lack 
of renin activity observed during by­
pass relates to the period of ischemic 
arrest. Angiotensin I is converted to 
the vasoactive octapeptide angiotensin 
II by converting enzyme,12-13 which is 
found mainly in the lung, and 90% 
of the conversion takes place in one 
pulmonary circulation.13'16 After the 
heart is fibrillated or cross-clamped 
the lungs are no longer perfused, thus 
removing the main source of con­
verting enzyme from the circulation.
Plasma renin reached maximum 
values when the patient was in the 
intensive care unit. Renin release was 
associated with a substantial increase 
in systemic vascular resistance and 
coincided with the onset of hyperten­
sion. Although the levels of catecho­
lamines were elevated in all 11 pa­
tients, hypertension was observed in 
only 8. We must infer from this that 
high circulating levels of epinephrine 
and norepinephrine did not contribute 
significantly to the elevation of sys­
temic vascular resistance in the early 
postoperative period.
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NOTICES
continued from page 467
International Association 
for the Study of Pain
The Canadian chapter of the Interna­
tional Association for the Study of 
Pain will hold its annual scientific 
meeting at the Hotel Loews la Cite 
in Montreal, Quebec on Oct. 25 and 
26, 1980. The two themes of this 
meeting will be (a) pain assessment 
and (b) epidural space — diagnostic 
and therapeutic use. Further informa­
tion concerning this scientific meeting 
may be obtained by writing to: Secre­
tariat —  Chapter Meeting, c /o  Dr. 
R.A. Ramsay, 1025 Pine Ave. W, 
Montreal, PQ H3A 1A1.
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Surgical Management of Peyronie’s Disease
______________________ _ ____________________________ _ ! ~e^jJdL
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Various forms of treatment have been 
advocated for Peyronie's disease but 
none has been entirely satisfactory. 
Recent reports in the literature 
indicate that surgical management 
consisting of excision and dermal 
grafting may not be the perfect cure 
suggested in the original report of 
Devine and Horton. The authors 
therefore review their experience in 
the use of the Devine-Horton technique 
emphasizing factors thought to be 
important for success. These include 
careful selection of patients for 
operation (patients should be potent, 
have undergone at least 6 months of 
conservative treatment, have non­
inflammatory painless disease and a 
resectable localized fibrotic plaque), 
use of a circumferential incision to 
allow adequate operative exposure and 
use of a dermal graft 25% larger 
than the defect.
Plusieurs formes de traitement ont 
ete proposees pour la maladie de 
la Peyronie mais aucune ne s'est avere 
entierement satisfaisante. Des 
publications recentes indiquent que le 
traitement chirurgical par excision et 
greffe dermique n'est peut-etre pas 
la cure parfaite suggeree dans la 
communication originate de Devine 
et Horton. Les auteurs passent done 
en revue leur experience dans 
■ 'utilisation de la technique de 
Devine-Horton et soulignent les 
facteurs qui semblent influer sur le 
succes de (’intervention. Ceux-ci 
comprennent une selection judicieuse 
des malades pour I’operation (les 
patients doivent avoir conserver leur 
capacite sexuelle, avoir ete sous 
traitement conservateur pendant au 
moins 6 mois, avoir une maladie non 
inflammatoire et indolore, et avoir une 
plaque fibreuse localisee et resecable),
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I'emploi d'une incision circonferentielle 
adequat et I’emploi d'une greffe 
dermique permettant un champ opera- 
toire 25% plus etendu que le defaut 
a corriger.
Peyronie’s disease, first described in 
1743, is a condition in which varying 
degrees of fibrosis involve the areolar connective tissue between the tunica 
albuginea and the corpora cavernosa of the penis. Although many causes have been suggested, there is growing 
acceptance of the suggestion that a type of vasculitis is involved in the 
pothogenesis of the disease.1 The dis­
ease first causes a diffuse inflam­matory reaction that is followed by the healing phase in which fibrosis leads to formation of the classic 
Peyronie’s plaque. Patients have pain­ful erections in which the penis is 
curved and find intercourse difficult. This difficulty may be due to the pain, to excessive curvature which prevents satisfactory penetration or to partial impotence which may be or­ganic or psychogenic.
Although various forms of treat­ment, both medical and surgical, have been advocated none has been entire­ly satisfactory.
Recent conflicting reports on the results of surgical excision of the 
fibrous plaque with dermal grafting 
prompted us to review our experi­
ence with this technique in an attempt to determine some of the factors important for surgical success.
Patients and Method
Between Jan. 1, 1974 and Dec. 31, 1978, nine patients with Peyronie’s 
disease had the fibrous plaque ex­cised and the defect repaired with a dermal graft. The natural history of 
this condition suggests that sponta­neous improvement can occur in ap­
proximately 50% of patients.2 There­fore, the selection of candidates for the surgical procedure is critical. Pain itself was not an indication for surgery 
since this symptom will respond to conservative management. Candidates for operation had to be potent but with penile curvature of such a de­gree that intercourse was either un­satisfactory or impossible; they had
to have defined plaques considered to be resectable. Injection of the corpora cavernosa with saline and careful pal­pation of the plaque while the patient 
is under general anesthesia may help to determine resectability in difficult cases. All patients were initially 
treated for 6 months to 1 year with vitamin E; although the mechanism 
of its action is unclear, this agent has been used traditionally with some 
good results.
Because surgical excision of a Peyronie’s plaque may result in a 
scar that causes worse curvature than 
the original disease we used the Devine-Horton dermal graft tech­nique;3 theoretically the dermis will 
not contract thereby eliminating the possibility of further scarring and curvature of the penis.
Surgical Technique
A circumferential incision is made at the mucocutaneous junction behind the coronal sulcus of the penis. The incision is carried through the super­ficial areolar layer allowing the skin 
of the penile shaft to be retracted ex­posing the corpora cavernosa. Colies’ fascia is then divided and Buck’s fascia is clearly identified. As the 
plaque is adherent to the overlying Buck’s fascia, sharp dissection on the 
side opposite the plaque is used to separate the overlying neurovascular 
plexus. The plexus can then be mobil­ized to the contralateral side and the plaque completely isolated. The 
plaque is outlined with a sterile mark­
ing pen as well as by lateral stay 
sutures in the tunica albuginea. By lifting up these stay sutures the plaque can be sharply dissected and 
removed in its entirety (Figs. 1 and 2). The corpora cavernosa are then carefully palpated for residual fibrotic tissue since complete excision of plaque is essential. The excised plaque is used as a guide for determining the size of the dermal graft which is re­moved from the lower abdomen. The graft should be 25% larger than the defect and 0.03 cm thick. The de­fatted graft is sutured to the cor­
poral edge with the fat side face down (Fig. 3). In one case we acci­dentally sutured the graft fat side up
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but the patient had a satisfactory 
functional result. Therefore it may 
not matter how the graft faces when 
it is sutured. A running 4-0 and 
many interrupted 3-0 Dexon sutures 
provide excellent hemostatic closure. 
Buck’s and Colles’ fasciae are closed 
with 4-0 chromic catgut sutures and 
the circumferential skin incision with 
3-0 chromic sutures. A pressure dress­
ing is applied to the penis and is at­
tached to the anterior abdominal wall. 
A Foley catheter is left in place for 
24 hours.
Results
Eight patients were followed up 
for 2 years. Five patients (56%) had 
good results, that is, straight nonpain- 
ful erections and satisfactory inter­
course. In one patient, who had an 
incision over the plaque instead of a 
circumferential incision, distal penile 
swelling and impotence developed. 
One patient, although improved, has 
poor erections and another patient 
had a wound infection postoperative- 
ly with increased scarring. The ninth 
patient has been followed-up for only 
9 months and at present is not having 
satisfactory erections.
Discussion
We had a 56% success rate with 
the Devine-Horton technique of der­
mal grafting. Recent reports do not 
agree on the criteria for success."'7 
We believe that the criteria for a suc­
cessful end result should be a straight 
penis with painless erections and the 
ability to have intercourse. Wild, 
Devine and Horton7 stated that 
coitus was possible in only 53% of 
patients for whom it had been im­
possible preoperatively yet they re­
ported a success rate of 70%. Mel- 
man and Holland8 have recently re­
ported poor results with the proce­
dure. These conflicting reports sug­
gest that more stringent criteria are 
needed to assess results of this opera­
tion and have prompted us to search 
for factors that might be important 
in predicting surgical success.
Predictive Factors
Patient selection and operative tech­
nique seem to be the most important 
factors that can be controlled. If the 
disease does not resolve spontaneous­
ly after 6 months of conservative 
management the patient who is po­
tent may be considered for the 
Devine-Horton procedure. The dis­
ease should be in the noninflamma-
FIG. 1—Initial dissection of Peyronie’s plaque with aid of stay sutures.
FIG. 2— Dissection of Peyronie’s plaque completed.
FIG. 3—Dermal graft sutured in place.
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tory, pain-free stage with a localized 
fibrotic plaque that can be resected. 
Patients who are impotent should be 
treated conservatively or with a 
prosthesis as advocated by Raz, 
Dekernion and Kaufman.9
The surgical technique outlined ap­
pears simple and efficient. A circum­
ferential incision is best since an inci­
sion over the plaque may cause distal 
penile edema and impotence. Proper 
exposure of the plaque allows the 
surgeon to excise the plaque com­
pletely ensuring that no fibrotic tissue 
is left. The size of the dermal graft 
should be about 25%  larger than the 
defect to prevent contraction and fur­
ther scarring.
Conclusions
We believe that the Devine-Horton 
procedure is sound. If certain points 
of operative technique are observed 
and patients are carefully selected the 
success rate of this procedure will 
improve.
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Delayed Perforation of the Colon in Blunt „
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The authors describe three patients 
with similar clinical features and 
patterns of colonic injury following 
blunt abdominal trauma. Perforation 
was discovered 7 to 10 days after 
injury and was indicated by the clinical 
signs of systemic sepsis. A prominent 
sign of occult sepsis was post- 
traumatic pulmonary insufficiency.
Blunt trauma to the colon was 
initially present but was not very 
impressive, consequently diagnosis 
was delayed. The large number of 
concomitant injuries and the subse­
quent sepsis led to a higher morbidity 
and mortality than in cases of 
penetrating injuries to the colon. The 
key to successful management of 
blunt colonic injuries is early diagnosis. 
Awareness of the type of injury and 
the magnitude of the deceleration 
force combined with the presence of
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persistent ileus may lead to earlier 
laparotomy.
Les auteurs presentent le cas de trois 
malades avec un tableau clinique et 
des lesions coliques semblables a la 
suite d’un traumatisme abdominal 
ferme. Une perforation fut decouverte 
7 a 10 jours apres la blessure alors 
qu'apparurent des signes cliniques 
d’infection generalisee. Une insuffi- 
sance pulmonaire post-traumatique 
constitua un signe important d’infec­
tion occulte.
II y a deja une contusion du colon 
mais de peu d’importance, par con­
sequent, le diagnostic est retarde.
Le grand nombre de blessures 
coexistantes et I’infection subsequente 
entrainent une morbidite et une mor- 
talite plus grandes que dans les cas 
de perforation du colon. La cle du 
succes dans le traitement des contu­
sions du colon reside dans un diagnos­
tic precoce. La connaissance de ce 
type de blessure et de ('importance 
de la force de deceleration, associee 
a la presence d’une occlusion intesti- 
nale peuvent permettre une laparo- 
tomie plus hative.
Blunt injuries to the colon, although 
recognized more frequently in the 
last two decades,1 constitute only 3%  
to 7% of all traumatic injuries to the
colon.1"7 This small group of patients 
presents special problems in diagnosis 
and management. The morbidity and 
mortality are higher than in patients 
with penetrating injuries to the colon 
because of the increased number of 
associated injuries and because of con­
tamination resulting from the blunt 
colonic injury.
Nonpenetrating bowel injuries can 
be both immediate and delayed in 
nature. We report three patients with 
multisystem trauma and delayed pres­
entation of blunt colonic injuries to 
emphasize the salient features of this 
relatively infrequent but potentially 
lethal condition.
Case Reports
Case /
A 27-year-old truck driver was 
crushed between two trucks. He was 
admitted to another hospital with an 
“open book” pelvic fracture, severe 
diastasis of the pubic symphysis and 
separation of the sacroiliac joints. Radio- 
logically the genitourinary system ap­
peared intact. He required transfusions 
but did not improve; tachycardia, tachyp­
nea and paralytic ileus developed over 
the next 6 days. He was transferred to 
the Royal Victoria Hospital in Montreal 
because of respiratory failure. On ad­
mission he was confused and cyanosed
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with flushed skin. His pulse rate was 120 
beats/min, respiration rate 32/min and 
temperature 39°C. The abdomen was 
distended but not tender. The bowel 
sounds were decreased. Ecchymosis over 
the right lower quadrant, iliac crests and 
genitals was noted. The leukocyte count 
was 18.3 X 109/1, the serum bilirubin was 
4 mg/dl (68.4 jjimol/1), blood urea nitro­
gen was 100 mg/dl (35.7 urea mmol/1) 
and the serum creatinine was 3.1 mg/dl 
(274 ij.mol/1). Arterial blood gas meas­
urements on room air showed an oxygen 
tension of 37 mm Hg and carbon dioxide 
tension of 38.5 mg Hg. The pH was 7.49. 
No free intraperitoneal air was visible 
radiologically. The patient was intubated 
and ventilated continuously with posi­
tive end-expiratory pressure (PEEP). 
A hyperdynamic cardiac state was noted 
with a cardiac output of 15.0 1/min 
and an alveolar-arterial oxygen differ­
ence in tension (AaDo2) of 586 mm 
Hg. Because of progressive abdominal 
abnormalities, abdominal paracentesis 
was performed; it yielded bloody foul­
smelling fluid.
At laparotomy massive fecal spillage 
and established fecal peritonitis with 
fibrinopurulent exudate were found 
originating from an antimesenteric per­
foration in a totally avulsed devascular- 
ized sigmoid colon. There was also 
avulsion of the ascending colon and 
terminal ileum but without necrosis. The 
necrotic sigmoid was resected and an 
end-colostomy with a Hartmann pouch 
established. The postoperative course 
was prolonged. Complications included 
respiratory failure, urinary infection, 
organic brain syndrome and pulmonary 
embolism. The patient has a large inci­
sional hernia and has not yet returned 
to work.
Case 2
A 36-year-old male nurse was wear­
ing shoulder and lap belts, when his 
car went into a ditch at approximately 
96 km/h; a front seat passenger, also 
wearing a seat-belt, died. On admission 
the patient was conscious. He had a 
blood pressure of 70/50 mm Hg and a 
pulse rate of 120 beats/min. He had 
a large contusion of the left flank and 
abdominal wall; bowel sounds were dim­
inished. Concomitant injuries included 
a basal skull fracture, left hemothorax 
with first rib fracture, fractures of the 
left shoulder and hand, dislocation of 
the right ankle and internal derange­
ment of both knees. Peritoneal lavage 
gave a normal return. On the second 
day the patient had abdominal pain, a 
temperature of 39.7°C, tachypnea, 
dyspnea, metabolic acidosis with hy­
poxemia and hyperbilirubinemia (serum 
bilirubin 10.0 mg/dl [171 jxmol/1]). 
He became confused. An abdominal 
film showed loops of distended bowel. 
Intubation with controlled ventilation 
was necessary to manage his acute re­
spiratory insufficiency.
Laparotomy was performed 16 hours
later. There was a large hematoma of 
the left abdominal wall and the rectus 
muscle had ruptured. There was sero- 
purulent peritoneal fluid with necrosis 
of the distal 30 cm of the ileum (without 
perforation) and avulsion of its mesen­
tery at the root. Although there was 
avulsion of the cecum and mesentery 
of the sigmoid colon and the retroperi­
toneal space was denuded, both segments 
of bowel appeared viable. The distal 
ileum was resected and primary anasto­
mosis performed. Postoperatively there 
was improvement in the respiratory fail­
ure and the patient underwent open 
reduction with manipulation for his 
musculoskeletal injuries. Ventilatory sup­
port was discontinued. Eleven days after 
admission the patient’s condition deteri­
orated rapidly. He had tachypnea, tachy­
cardia, spiking fever, progressive hypoxe­
mia and mild abdominal tenderness with 
radiologic evidence of free intraperi­
toneal air.
A second laparotomy revealed a small 
perforation of the sigmoid colon with­
out gross fecal spillage, serosanguineous 
peritoneal fluid and fibrinopurulent 
exudate. The ileal anastomosis and 
cecum were intact. The perforated sig­
moid colon was exteriorized. Postopera­
tively the patient had a wound abscess 
continuous with an intra-abdomirial 
abscess. This was drained. A fundic 
stress ulcer with gastrointestinal hemor­
rhage necessitated multiple transfusions 
and subtotal gastrectomy. The infection 
was finally controlled by drainage of 
left abdominal wall and flank abscesses. 
Ultimately the patient recovered.
Case 3
A 45-year-old man was the driver 
in a single car accident. He was wear­
ing a lap seat-belt. On initial exami­
nation the abdomen was soft, the supra­
pubic and left flank areas were tender 
with ecchymoses. Bowel sounds were 
present. Concomitant injuries included 
cerebral contusion, renal contusion with 
hematuria, lung contusion with frac­
tures of right ribs, and fractures of the 
maxilla and left knee. Seven days after 
admission the patient became hypoten­
sive (blood pressure 70/40 mm Hg), 
he had tachycardia, abdominal pain, 
distension and rebound tenderness, 
and hyperbilirubinemia (serum bilirubin 
9.5 mg/dl [162.5 u.mol/1]. Radiologic 
examination showed free air intraperi- 
toneally. Abdominal paracentesis yielded 
air and blood.
At laparotomy there was necrosis and 
perforation at the junction of the de­
scending and sigmoid colon without 
gross fecal spillage, avulsion of sigmoid 
mesocolon, laceration of the ileal mesen­
tery with necrosis of the terminal ileum, 
subserosal hematomas of the cecum and 
ileum, a retroperitoneal paraduodenal 
hematoma and a hematoma in the right 
paracolic space. The involved colon was 
resected with end-colostomy and mucous 
fistula. The ileum was resected and pri­
mary anastomosis performed. The para­
duodenal hematoma was explored and 
drained. Postoperatively the patient re­
quired ventilatory support with PEEP. 
His course was complicated by progres­
sive hypoxemia, hemorrhage from a 
stress ulcer and increasing jaundice. A 
small intestinal fistula developed 4 days 
after operation. It closed only after 
prolonged administration of total par­
enteral nutrition. He has since had his 
colostomy closed and an incisional 
hernia repaired. He is now back at 
work.
Discussion
The solid organs (spleen, kidneys, 
liver and pancreas) are more likely to 
be damaged by blunt trauma, while 
the colon, small intestine and stomach 
are less likely to be involved. Injury 
to the colon occurs in only 3% to 
5%  of cases of blunt abdominal 
trauma and has been the subject of 
only a few reports.4'8'9 The blunt force 
required to injure the colon directly 
is considerable so the number of pa­
tients with associated injuries (90% 
to 100%) is considerably higher than 
in those with penetrating trauma of 
the colon (67% to 87% j,1'2'4-8'1013 thus 
contributing to a poor outcome.
Several mechanisms have been pro­
posed to explain how blunt intestinal 
trauma occurs. The theories of rup­
ture of a hollow viscus (fluid-filled 
closed loop) because of increased pres­
sure and torsional tear at a point of 
bowel fixation do not have as much 
experimental support as that of direct 
compression between a force in front 
and a vertebral column or bony pelvis 
behind, with a shearing effect. Sud­
den deceleration is a more likely ex­
planation for bowel—mesenteric dis­
ruption and subsequent devasculariza­
tion. The mobile colon segments (i.e., 
the transverse and sigmoid colon) are 
more vulnerable.4'8 However, injuries 
are also frequently located near the 
junction of mobile and fixed segments 
of colon, such as the junction of the 
descending and sigmoid colon or the 
junction of cecum and ascending 
colon. The sigmoid mesentery, the 
terminal ileum and cecum were dis­
rupted in our three patients.
Blunt trauma of the sigmoid colon 
found in our patients at exploration 
or re-exploration 7 to 10 days after 
injury resulted in fecal spillage with 
massive intraperitoneal contamination. 
Unless associated injury to other ab­
dominal organs leads to early laparo­
tomy, these silent bowel injuries are 
not recognized until late. Even care­
ful inspection at early laparotomy to 
detect bowel and mesenteric hema-
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tomas and devascularized bowel wall 
may not show lesions that indicate 
delayed perforation (case 2). Peri­
toneal lavage may be normal at the 
time of admission unless there is as­
sociated hemoperitoneum. Colonic 
perforations are not often disclosed 
by the presence of free air radiologic- 
ally or by localized tenderness: none 
the less, serious injury may be present 
even in their absence.
Similar patterns of bowel injury 
with delayed diagnosis have been de­
scribed in seat-belt trauma.5'14 Two of 
our patients (cases 2 and 3) were 
wearing seat-belts at the time of in­
jury. The lap belt tends to direct 
the decelerating forces to the lower 
abdomen. Two patterns of clinical 
presentation have been described: one 
of obvious intra-abdominal injury 
with or without intraperitoneal hem­
orrhage that leads to early explora­
tion, diagnosis and treatment, the 
other of direct or indirect bowel in­
jury with few abdominal signs, early 
but persistent ileus and a normal re­
turn from peritoneal lavage is asso­
ciated with a consequent delay in 
diagnosis and treatment. The im­
portance of persistent paralytic ileus 
in early diagnosis and treatment is 
emphasized. It has been suggested14 
that exploratory laparotomy be per­
formed in those in whom persistent 
and even minimal abdominal signs 
do not clear within 12 hours of in­
jury.
The acute respiratory insufficiency 
that developed or progressed in our 
patients, as the first sign of delayed 
bowel perforation, was an accurate 
indicator of occult sepsis. Post-trau­
matic pulmonary insufficiency (PTPI) 
occurs in a relatively small but im­
portant percentage of patients with 
multisystem trauma. Infection is by 
far its most common cause.15 The 
development of PTPI is generally in­
dicative of incipient or established 
systemic infection, from an extrapul- 
monary source in over half the cases. 
The presence of PTPI suggests the 
need to search for a septic focus. In 
case 1, transferred to our hospital 
because of respiratory failure, the 
falling arterial oxygen pressure and 
the need for ventilation obscured the 
evolving peritonitis, which was the 
primary cause of the respiratory 
failure. Other occult manifestations 
of systemic sepsis, hyperbilirubinemia 
and renal failure, were also present. 
Successful management was there­
fore the treatment not only of the 
secondary manifestations of the sys­
temic sepsis, but also the identifica­
tion and elimination of its source.
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W. Jay Eldredge, Harry Goldberg and 
Gerald M. Lemole. 209 pp. Illust. 
Spectrum Publications, Inc., Jamaica, 
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As an inveterate buyer of medical books, 
especially those devoted to pediatric car­
diology and associated disciplines, I 
looked forward to reading this mono­
graph. However, it is hard to know for 
whom this multiauthored book was writ­
ten. Although it tries to offer a little 
something for everyone, it rarely suc­
ceeds.
There are 18 chapters beginning with 
Van Praagh’s “segmental approach” and 
including reviews of cardiac defects 
causing symptoms in infancy, medical 
management of the symptomatic infant, 
right and left ventricular function studies 
in various forms of congenital heart 
disease, the role of exercise testing in 
children and some data on echocardio­
graphy in congenital heart disease. There 
is something for the surgeons as well, 
with a brief commentary on hypother- 
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Colonoscopic Polypectomy: ffe First 200
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Colonoscopic polypectomy is a safe, 
reliable method of excising most 
colonic polyps. This paper reports 
200 colonoscopic polypectomies 
performed by one surgeon in a Toronto 
teaching hospital and reviews results 
and complications of polyp removal 
and the treatment of malignant polyps. 
The relative value of colonoscopic 
and radiologic detection of polyps is 
assessed and a plan for follow-up 
after polypectomy discussed.
La polypectomie au colonoscope est 
une methode sure et fiable d’excision 
pour la plupart des polypes du colon. 
Cette publication fait le bilan de 
200 polypectomies au colonoscope 
effectuees par un chirurgien d’un 
hopital universitaire de Toronto et 
passe en revue les resultats et les 
complications de I’excision des 
polypes ainsi que le traitement des 
polypes malins. L’utilite relative du 
colonoscope et de la detection 
radiologique des polypes est evaluee 
et un programme de surveillance 
apres la polypectomie est discute.
Colonoscopic polypectomy is now the 
treatment of choice for almost all 
pedunculated or sessile colonic polyps. 
The procedure has a high rate of suc­
cess1-6 and is accompanied by few 
complications7,8 and negligible mortal­
ity. Many large sessile lesions can be 
excised safely9,10 and malignant polyps 
can often be handled adequately by 
endoscopic polypectomy alone.11-14
Since 1975,1 have performed colon­
oscopic polypectomy in my general 
surgical practice. I undertook the 
present review to assess the results and 
complications of my first 200 colon­
oscopic polypectomies including those 
for malignant polyps carried out at 
the Toronto Western Hospital. I 
wanted to ascertain whether the pro­
cedure was justifiable and safe when
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performed less frequently than in 
large clinics. Also, I wanted to assess 
the value of the colonoscope in diag­
nosing and treating tumours not de­
tectable by air-contrast barium enema.
Patients and Methods
Two hundred polypectomies were 
performed on 128 patients in 133 
procedures. There were 72 men and 
56 women; the average age for both 
sexes was 67 years. The presenting 
complaints were bright red rectal 
bleeding, abdominal pain, constipation 
or diarrhea; some patients presented 
for follow-up of other polyps or bowel 
cancer. Approximately 50% of the 
polyps found were thought to be un­
related to the presenting symptom. 
Nearly all procedures were performed 
on an outpatient basis. The bowel 
preparation consisted of 2 days of 
clear fluids by mouth, mild laxatives 
and magnesium citrate (Citro-Mag) 
on the evening before the procedure. 
Fleet and soap-suds enemas were ad­
ministered on the morning of en­
doscopy.
The Olympus CF.LB2, 2.2 m colon­
oscope (Olympus Corporation of 
America, New Hyde Park, NY) was 
used as described in other reports.4-15 
The colonoscope was passed as far 
along the bowel as patient comfort 
would allow, even when the air-con­
trast barium enema had demonstrated 
only a left-sided lesion. The more 
proximal polyps were removed first. 
After each polypectomy the specimen 
was retrieved and placed in a separate 
specimen container. This frequently 
necessitated reinsertion of the instru­
ment several times during one proce­
dure. An Olympus snare, with the aid 
of a Cameron—Miller cautery machine 
(Cameron-Miller, Inc., Chicago, 111.) 
was used to excise the polyps. A single 
pass was usually sufficient with the 
pedunculated or small sessile tumours, 
but piecemeal excision with many 
coagulations was required on several 
occasions when larger lesions were 
encountered. Carbon dioxide was in­
stilled into the colon only when the 
bowel was not extremely clean. Since 
the colon has been shown to contain 
no explosive gases if well cleansed 
mechanically, carbon dioxide was not 
needed in most instances.
Material for microscopic examin­
ation consisted of sections stained with 
hematoxylin and eosin of represent­
ative cuts from the submitted polyps. 
Obvious polypoid carcinomas were ex­
cluded. If there was invasion by 
malignant cells beyond the muscularis 
mucosae, location of the invasion with 
respect to the incision line was con­
sidered crucial. When the invasion of 
the mucosa was at the tip of the polyp 
and the line of excision was situated 
clearly across the stalk at some dis­
tance from the invasion, no additional 
treatment was given. However, if the 
site of invasion was within a few mil­
limetres of the excision line, or if 
piecemeal removal of a large sessile 
polyp demonstrated invasion by 
malignant cells in any part, laparo­
tomy was recommended. Indications 
for segmental colonic resection such 
as lymphatic involvement of the polyp 
or poorly differentiated cell types as 
described by Shatney and associates,13 
or both, were not seen in this series. 
In several patients requiring laparo­
tomy, intraoperative colonoscopy was 
used to locate the previous site of en­
doscopic excision, since the site could 
not be located by palpation.
The location of polyps is shown in 
Table I. The predominance of left­
sided lesions is similar to what has 
been reported previously. A greater 
proportion of the larger lesions, how­
ever, was in the transverse and right 
portions of the colon.
Most polyps were approximately 1 
cm in diameter (Table II). The largest 
was 6 cm in diameter and was suc­
cessfully removed. Slightly more than 
half (53%) were pedunculated and 
the remainder were sessile.
Results
Of the 200 polyps, 191 were re-
T a b le  1— S it e  o f 200 C o lo n ic  P o ly p s
S ite
No.
o f  p o ly p s
R ig h t  co lo n 4
H e p a t ic  f le x u re 3
T r a n s v e r s e  co lo n 17
S p le n ic  f le x u re 4
L e ft  c o lo n 31
S ig m o id  co lo n 94
R e c to s ig m o id  a n d  u p p e r  rec tum 47
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moved completely; the 9 that could 
not be removed entirely by endoscopic 
means, were sessile tumours, all 
larger than 2 cm in diameter. After 
initial attempts at endoscopic removal, 
I decided that these nine polyps would 
be better excised at laparotomy for 
two reasons: (a) the polyps were so 
large that multiple coagulations in­
creased the possibility of perforation 
to a prohibitive degree, especially on 
the right side where four of the nine 
were located and (b) the large size 
in even an apparently benign sessile 
lesion increased the possibility that 
there was malignant invasion at the 
base. In fact, seven of the nine in­
completely removed sessile lesions had 
malignant cells at the base; the other 
two were benign villous adenomas.
Multiple procedures were used in 
five instances to remove either more 
of a large lesion in a patient unfit for 
laparotomy or remaining tumours in 
a patient with many lesions. The 
greatest number of tumours removed 
at any one time was seven. In most 
cases of multiple excision, the colon- 
oscope was removed each time a new 
polyp was snared so that separately 
indexed specimens could be retrieved 
for microscopic examination.
The long-term results were excel­
lent. There were no cases of recur­
rence, whether the polyps were re­
moved at colonoscopy or, when that 
failed, at laparotomy. Moreover, none 
of the malignant polyps has recurred.
Tumour Type
Most tumours were adenomatous
Table I I— Size of Polyps
No.
Diam eter, cm of polyps
<1 101
1-2 67
2-3 19
> 3 13
Table I I I — Tumour Type
No.
Type* of polyps
Tubular adenoma 115
Tubulovillous adenoma 29
Hyperplastic pseudopolyp,
metaplastic polyp 23
Villous papilloma 13
Submucous lipoma 1
Invasive carcinoma 14
Carcinoma in situ 3
*2 polyps w ere lost.
polyps (tubular adenomas) as reported 
in other publications. Tubulovillous 
adenomas, villous adenomas and me­
taplastic polyps were also excised 
(Table III). Three polyps demon­
strated foci of carcinoma in situ and 
14 showed invasion of the muscularis 
mucosae. Management of the patients 
with malignant polyps is summarized 
in Table IV.
Roentgenography versus
Endoscopy
Of 200 polyps found endoscopically 
all but 9 were removed. Only 113 of 
these polyps had been demonstrated on 
barium enema and air-contrast roent­
genography. Of the remaining 87 le­
sions not detected by air-contrast ro­
entgenography, 35 were located in the 
rectosigmoid and upper rectal area, 
26 in the sigmoid colon and the rest 
were evenly distributed throughout the 
descending, transverse and ascending 
portions of the colon. Sixteen of the 
lesions not in the rectosigmoid region, 
were 1 cm or larger in diameter, but 
none was malignant.
Polyps Occurring Simultaneously
with Carcinoma
In this series, seven polyps were 
found in the presence of a known 
carcinoma, and on two occasions un­
suspected carcinomas were discovered 
in the presence of polyps to be re­
sected. On one occasion, an extremely 
small (3 mm) plaque-like carcinoma 
was found at a site remote from a 
sigmoid polyp, which was discovered 
on air-contrast roentgenography. Sub­
sequent segmental resection with the 
aid of intraoperative colonoscopy 
showed that the lesion was minute, 
both grossly and microscopically (Fig. 
1).
Complications
Three patients had serious com­
plications. One had brisk rectal bleed­
ing after removal of a large pedun­
culated adenomatous polyp from the 
left colon. No attempt was made to 
coagulate the site of bleeding because 
of the fear of perforation. Two units 
of blood were given and the bleeding 
stopped after 12 hours. Another pa-
Table IV— Carcinoma in Polyps
Type No. of polyps Treatm ent
Carcinoma in situ 3 Polypectomy alone
Invasive carcinoma
A t tip  of polyp 6 Polypectomy alone
A t base of polyp 8 6 laparotom ies-residual tumour
1 laparotom y-no residual tumour 
1 fu lgarization a t rectosigmoid
FIG. 1—Low-power photomicrograph showing entire adenocarcinoma, which is 
presumably de novo ulcerative lesion (hematoxylin and eosin, reduced by 15% from 
X 1 0 ) .
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tient had a transient hemorrhage and 
lost approximately 300 ml of blood, 
but did not require transfusion.
Early in the series attempts to 
visualize a pedunculated polyp in a 
patient with diverticulosis resulted in 
perforation of a sigmoid diverticulum, 
probably from air insufflation. Initial 
conservative management failed, and 
laparotomy, polypectomy and closure 
of the perforation were carried out 
with good results.
Discussion
There is no doubt that colonoscopic 
polypectomy is the best treatment for 
removing the majority of colonic 
polyps. In this series, 95% of polyps 
were successfully removed, and serious 
complications of either bleeding or 
perforation occurred in 2% of pa­
tients. There were no deaths. Pedun­
culated polyps with invasive malig­
nant tumour at the tip were treated 
by polypectomy and eight patients 
with invasion at the line of excision 
required further operation. Air-con­
trast barium enema demonstrated the 
presence of 56% of all polyps re­
moved endoscopically. These results 
were comparable to those of large 
series1-3-15 with respect to efficacy 
and safety.
Two questions concerning colonic 
polyps are pertinent: Which polyps 
are better removed by laparotomy? 
How should a malignant polyp be 
managed?
With experience, a particular sur­
geon will become more capable of 
dealing with lesions that are difficult 
to treat, so that absolute guidelines 
regarding size and morphology are 
impossible to recommend. The most 
challenging polyps technically are the 
larger tumours, the sessile ones and 
those situated in areas difficult to 
reach (e.g., just beyond hairpin con­
volutions in redundant sigmoid, 
splenic or hepatic flexures, or the 
right side of the transverse colon). 
Most of my difficulty has been with 
the large sessile lesion; on nine occa­
sions, laparotomy was necessary to 
effect complete removal of two villous 
adenomas and seven tumours with 
malignant invasion at the base.
The elderly, high-risk patient with 
cardiopulmonary disease is the one 
in whom we would like to persist with 
a difficult colonoscopic polypectomy 
and spare an operation; however, this 
same patient is less able to tolerate a 
long, arduous endoscopic procedure 
and certainly is at very high risk 
should bleeding or perforation ensue. 
Therefore, the factors have to be
weighed individually. During colon­
oscopic examination in the high-risk 
patient it must be remembered that: 
(a) perforation is the most lethal com­
plication threatening the patient, prob­
ably more dangerous than routine 
colotomy and polypectomy, even 
though colonoscopic perforations may 
be treated conservatively; (b) another 
colonoscopic examination can be per­
formed later; and (c) the polyp may 
not be malignant, and may be quite 
safe to ignore, at least temporarily, 
particularly in a high-risk patient. 
Some polyps remain asymptomatic for 
long periods.
Controversy still exists regarding 
the management of the polyp with 
malignant invasion. Rules regarding 
anatomy of excision lines with respect 
to the invasion as described earlier13 
have been generally adopted, but a 
basic question still is frequently posed. 
Is carcinoma in situ or a malignant 
tumour at the tip of a pedunculated 
polyp capable of metastasizing? Most 
believe that this very rarely hap­
pens,12'17 and so endoscopic polypec­
tomy through the stalk for either car­
cinoma in situ or invasive carcinoma 
at the tip of a polyp is used as a cura­
tive procedure. To date, only one 
possible case of metastatic disease has 
been reported after colonoscopic ex­
cision of a polyp containing carcinoma 
in situ.18 As for invasion of the tip, 
statistics on metastases will be avail­
able only when large numbers of 
patients have been followed up for 
many years. In the malignant tumours 
in my series, the number and the short 
follow-up preclude any conclusions; so 
far there has been no recurrence after 
simple polypectomy, the longest fol­
low-up being 4 years.
There is no consensus regarding the 
method of follow-up for patients who 
have had malignant polyps removed. 
Clearly the cancer-prone colon should 
be observed closely, but if barium 
enema examination misses so many 
lesions, how should the colon be 
scrutinized? At the Toronto General 
Hospital we have adopted the plan 
of repeating colonoscopic examination,
1 to 2 years after polypectomy. If 
symptoms such as bleeding ensue, 
further investigation is urgently re­
quired. If the polyp removed is benign, 
then we carry out barium enema or 
colonoscopic examination every 3 
years, assuming that development of 
a polyp and malignant transformation 
in that polyp require at least several 
years.19-20 If the roentgenogram seems 
adequate and displays the mucosa 
clearly, we feel safe in watching the
patient for a further 3 years. If there 
is any doubt, we carry out colo­
noscopic examination which is usually 
tolerated by patients at least as well 
as barium enema studies.
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Primary biliary peritonitis was 
diagnosed in a 14-year-old girl by 
means of gallbladder scintigraphy.
The girl was treated conservatively 
and subsequent investigations revealed 
a normal hepatobiliary system.
The initial scan showed free entry 
of the isotope into the general 
peritoneal cavity and its absence 
from the bowel. After 7 days, the 
scan and oral and intravenous 
cholangiography showed no 
abnormality.
line peritonite biliaire primaire 
a ete diagnostiquee chez une fillette 
de 14 ans grace a une scintigraphie 
de la vesicule biliaire. La fillette a recu 
un traitement conservateur et les 
examens subsequents ont revele un 
systeme hepatobilaire normal. La 
scintigraphie initiale avait montre 
le passage libre de I’isotope dans la 
cavite peritoneale et son absence 
de I'intestin. Apres 7 jours, la 
scintigraphie et les cholangiographies 
orale et intraveineuse ne montraient 
aucune anomalie.
The general peritonitis that follows 
perforation of an acutely inflamed 
gallbladder is associated with a high 
mortality. On the other hand, escape 
of sterile bile into the peritoneal cavity, 
such as that which follows injury to 
the extrahepatic biliary system, results 
in a chemical peritonitis and a rela­
tively mild clinical course.1 On the 
basis of experiments performed in 
dogs it was thought for some time 
that the irritant action of sterile 
bile resulted in a lethal peritonitis. 
Mentzer2 concluded that the results 
of animal experiments could not be 
applied to man and suggested that the 
animals died because the concentra­
tion of sodium taurocholate was 
higher than in man and the bile con­
tained pathogenic organisms.
Spontaneous rupture of the extra-
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hepatic biliary system is a rare condi­
tion that may occur at any age but is 
more common in infants.3 The patient 
presents with sudden abdominal pain, 
diffuse tenderness and rigidity. Within 
hours, the effusion of peritoneal fluid 
results in distension and a decrease 
in pain and physical signs. Mild jaun­
dice may be present. The sudden de­
velopment of peritonitis, the absence 
of toxemia and the presence of jaun­
dice should suggest the diagnosis. 
Peritoneal lavage should be performed 
to establish the diagnosis. Treatment 
should be conservative and operation 
performed only if there is deteriora­
tion in the patient’s general condition 
or doubt about the diagnosis. In 
most cases reported in the literature 
the diagnosis was made at laparotomy. 
The extrahepatic biliary system and 
liver are normal and the site of escape 
of the bile can seldom be found. The 
bile is evacuated from the peritoneal 
cavity, a drain inserted and the gall­
bladder is retained.
We report a case of primary biliary 
peritonitis in a young girl. The diag­
nosis was made by scintigraphy. Treat­
ment was conservative. Subsequent 
investigations revealed that the hepato­
biliary system was normal.
Case Report
A 14-year-old girl was admitted 6V2 
hours after the sudden onset of severe 
abdominal pain associated with nausea 
but without vomiting. She had no his­
tory of abdominal pain, trauma or bil­
iary tract disease. On examination she 
was not jaundiced, she did not look ill 
and her temperature and pulse rate were 
normal but she had generalized ab­
dominal tenderness and guarding. An up­
right film of the abdomen showed 
marked gastric distension. The leukocyte 
count was 10.5 X 109/1, the serum amy­
lase value was 1250 IU/1 (normal 70 to 
300 IU/1) and the total serum bilirubin 
value was 0.6 mg/dl (10.3 amol/1) 
(normal 0.2 to 1.0 mg/dl [3.4 to 17.1 
amol/1]). The initial diagnosis was acute 
pancreatitis. She was therefore treated 
by nasogastric suction and intravenous 
administration of fluids.
During the first 48 hours, the pain and 
physical signs decreased and the 
hyperamylasemia subsided. Gallbladder 
imaging with 3 mCi of technetium-99m-
HIDA (N-[2,6-dimethyl-phenyl carbo- 
amoxylinethyl] iminodiacetic acid), 48 
hours after admission, showed that the 
gallbladder and bile ducts were normal, 
that there was free escape of the radio- 
tracer into the abdominal cavity and that 
none was present in the bowel (Fig. 1). 
A peritoneal tap performed 72 hours 
after admission yielded normal peri­
toneal fluid. Gallbladder scintigraphy 
repeated at 7 days showed that entry 
of the radiotracer into the duodenum 
and stomach was normal and that none 
escaped into the abdominal cavity. Oral 
and intravenous cholecystograms showed 
no abnormality.
Discussion
This is the first report of primary 
biliary peritonitis that was diagnosed 
by nuclear imaging and treated with­
out operation. Subsequent investiga­
tions have revealed no abnormality in 
the hepatobiliary system. The etiology 
of this condition is not known. Aird4 
suggested that bile may escape from a 
small perforation in the liver or extra­
hepatic biliary system and that the 
defect may heal spontaneously. Bile 
may escape from the surface of the 
liver from a ruptured subcapsular bile 
channel. Extrahepatic causes possibly 
include rupture of a mucous gland 
due to an increase in biliary pressure, 
the presence of a cholangitic ulcer or 
erosion of a bile duct following regur­
gitation of pancreatic juice.
Gallbladder scintigraphy can be 
performed promptly upon admission 
to hospital in the patient who is vomit­
ing or jaundiced and in whom there is 
no danger of a hypersensitivity reac­
tion. Information is obtained about 
hepatic function, the state of the ex­
trahepatic biliary ducts, the presence 
or absence of a functioning gallbladder 
and the entrance of the radiotracer 
into the stomach and duodenum. In 
our patient the scan was diagnostic. 
Radioactivity was present throughout 
the peritoneal cavity and none was 
present in the bowel. The serum amy­
lase level was increased due to ab­
sorption of pancreatic secretions from 
the peritoneal cavity. The amount of 
bile that was absorbed was insufficient 
to cause jaundice or an elevation in 
the serum bilirubin level. The diag-
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nosis was not confirmed by peritoneal 
lavage possibly because the procedure 
was performed too late (at 72 hours 
after admission).
The tracer was uniformly deposited 
throughout the abdomen. The only 
possible explanation was that the 
isotope was free in the peritoneal 
cavity. If the tracer was present within 
the gut, the bowel would be clearly 
seen. The sequence of activity, appear­
ing in the liver, gallbladder and com­
mon bile duct before outlining the 
peritoneal cavity, was consistent with 
an extrahepatic biliary leak and not 
with any other route of tracer deposi­
tion, as, for example, secretion by 
the parietal or visceral peritoneum. 
There was therefore no possibility of 
making a false-positive interpretation 
of the scan.
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BOOK REVIEWS 
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mia by Zubermanian, and experience 
with the Rastelli operation for repair 
of complex cardiac defects. The Mayo 
Clinic is well represented with a sec­
tion on monitoring of the postoperative 
cardiac patient. There is emphasis on 
treatment of the patient with transpo­
sition of the great arteries with chapters 
describing the Mustard and palliative 
Mustard operations.
I really doubt that this book was in­
tended for the pediatric cardiologist be­
cause it is very superficial and outdated. 
Indeed, although the book has a 1979 
publication date, I could find no 1978 
references and only a scattering of 1976 
and 1977 references. Several chapters 
had only one or two references and some 
none at all. I was somewhat offended to 
find a chapter on the medical manage­
ment of the symptomatic infant relegated 
to about 1V4 pages, and there is no 
mention at all of the use of the E-type 
prostaglandin in maintaining patency of 
the ductus arteriosus in those conditions 
in which the pulmonary or the systemic 
blood supply is mainly duct-dependent. 
These are just a few of many drawbacks 
to this book.
On the other hand, there are some 
quite good sections. I found the chapter 
on exercise testing in children helpful 
and comprehensive. Marron and Ebstein, 
from the National Institutes of Health, 
have provided a comprehensive chapter 
on hypertrophic cardiomyopathy in in­
fants and children and the chapter de­
voted to clues to the etiology of pul­
monary hypertension was most informa­
tive.
Generally, I was disappointed by this 
monograph, and I think it will have a 
very limited readership.
Robert M. Freedom, md, frcp[c], facc,
Professor of pediatrics (cardiology),
The Hospital for Sick Children, 
Toronto, Ont.
ESSENTIAL NEUROLOGY. William
Pryse-Phillips and T.J. Murray. 644
pp. Illust. Medical Examination Pub­
lishing Co., Inc., Garden City, NY,
1978. $25. ISBN 0-87488-740-2.
The authors have designed this book for 
medical students up to and beyond gradu­
ation. The format is new and pragmatic 
and is best described by Hugh Mac­
Donald in the foreword: “the problem 
oriented record represents a notable ad­
vance in neurology. Patients present with 
symptoms . . . symptom analysis there­
fore becomes an exceedingly important 
aspect of neurological teaching and 
diagnosis.”
To achieve this, the first part of the 
book describes the examination of the 
nervous system and the short second 
part, the principles of neurologic local­
ization. The third section, approximately 
one third of the book, examines symp- 
continued on page 491
FIG. 1—Gallbladder scintigraphy performed at 30 minutes (A, B), 1 hour (C, 
D) and 2 Vi hours (E, F) after injection of technetium-99m-HIDA. A, C and E were 
right lateral views while B, D and F were anterior projections. Initially there was 
normal visualization of liver, gallbladder and bile ducts. Radiotracer did not enter 
gut but was progressively dispersed throughout peritoneal cavity.
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In a prospective study of cephalothin 
prophylaxis for patients who under­
went aortocoronary bypass an unac­
ceptably high rate (44%) of 
Staphylococcus aureus sternotomy 
infections occurred in a placebo-treated 
group. In two other groups of 
patients, one group given cephalothin 
intraoperatively and the other given 
the antibiotic both intra- and 
postoperatively, such infections 
occurred with similar frequency (2.6% 
and 2.1% respectively).
This study demonstrates the need 
for antistaphylococcal agents during 
aortocoronary bypass operation. No 
advantage is derived by extending 
this therapy beyond the operative 
period.
Dans une etude prospective de 
■ 'utilisation prophylactique de la 
cefalotine chez les patients qui 
subissent un pontage aortocoronarien, 
un taux inacceptablement eleve (44%) 
d'infections de sternotomie a 
Staphylococcus aureus a ete observe 
dans un groupe recevant un placebo. 
Chez deux autres groupes de patients, 
un groupe recevant de la cefalotine 
durant I’operation et I'autre recevant 
I'antibiotique pendant et apres 
I’intervention, de telles infections 
sont survenues, a la meme frequence 
(2.6% et 2.1% respectivement).
Cette etude demontre la necessity 
d'un agent antistaphylococcique durant 
('operation de pontage aortocoronarien. 
Aucun avantage n'est obtenu en 
prolongeant le traitement au-dela 
de la periode operatoire. ‘
The prophylactic use of antibiotics at 
operation to reduce the occurrence o f 
wound infection has a valid scientific 
basis.1 While many clinical studies
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have been carried out and support 
such an approach for “ dirty” operative 
procedures, studies of “clean” but 
high-risk operations are less numer­
ous. The prophylactic administration 
o f antibiotics during cardiac bypass 
operation is almost universal. How­
ever, its efficacy has not been 
proved. This paper outlines a study 
that supports the use o f antistaphylo­
coccal chemotherapy. It examines the 
effect o f such therapy on oropharyn­
geal colonization by enteric organisms 
and yeasts and the need for chemopro­
phylaxis beyond the immediate oper­
ative period.
Patients and Methods
All patients who underwent aorto­
coronary bypass operation at Victoria 
Hospital, London, Ontario, between 
Sept. 1, 1977 and June 30, 1978, were 
eligible for the study. Patients were 
excluded (a) if they had a history o f 
an accelerated allergic reaction to 
penicillin or allergy to cephalosporins, 
or (b) if they refused to give their 
informed consent.
Initially patients were randomly 
assigned in a double-blind fashion to 
two groups: antibiotic or placebo 
only. Unfortunately, o f the first 15 
patients entered into the study 4 had 
Staphylococcus aureus sternotomy in­
fections. Because o f this the study 
was terminated. When the drug code 
was broken, it was found that all in­
fections had occurred in the nine pa­
tients treated with placebo. Thereafter 
the protocol was altered so that all 
patients received cephalothin (2 g) in­
travenously immediately before car­
diac bypass was begun and 2 g at the 
end o f the operation.
Eighty-five patients were studied. 
They were assigned randomly to two 
groups; group 1 included 47 patients 
who received cephalothin postoper­
atively (1 g intravenously q6h for 3 
days) and group 2 comprised 38 pa­
tients who did not receive cephalothin 
postoperatively. In all patients during 
operation, the surgical field was 
sprayed with a combination o f poly­
myxin and bacitracin.
Data examined were: age, sex, num­
ber o f vessels bypassed, duration o f 
cardiac bypass, number and types o f 
infectious complications, number and 
types o f noninfectious complications 
and duration o f hospitalization. The 
effect of the shorter and longer 
courses of antibiotic therapy on 
oropharyngeal flora was also studied.
Infections were diagnosed clinically 
and supported by total and differential 
leukocyte counts, by local cultures and 
by blood cultures and roentgenograms 
where indicated. Specimens o f urine 
were cultured preoperatively and 3 
days following operation. For the 
diagnosis of asymptomatic bacteriuria 
two positive cultures o f the same 
pathogen in substantial numbers were 
required while symptomatic urinary 
tract infections were diagnosed from 
a single culture.
The diagnoses o f noninfectious 
complications were based on a typical 
clinical picture and supported where 
possible by appropriate laboratory 
tests. The duration of hospitalization 
was defined as the number o f days 
from  operation until discharge. Statis­
tical analysis was by the unpaired 
Student’s f-test or the y2 test. A  P 
value o f less than 0.05 was considered 
significant.
Results
The data on the two groups with 
respect to sex, age, number o f vessels 
bypassed, duration o f cardiac bypass 
and of hospitalization is presented in 
Table I. The duration of hospital­
ization was longer for group 1 
(P <  0.05), but for all other features 
the findings in the two groups were 
similar.
Noninfectious complications occur­
red in 17 (35% ) group 1 patients and 
in 10 (26% ) group 2 patients. They 
consisted of postcardiac injury syn­
drome,2 myocardial infarction, pul­
monary embolism, gout, acute psy­
chosis and wound dehiscence (Table 
II). One group 1 patient and two 
group 2 patients had enteric organ­
isms in the oropharynx preoperatively. 
Postoperatively the numbers increased 
to eight and five, respectively. N o 
group 2 and two group 1 patients had
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t:
yeast present preoperatively. Post- 
operatively these figures increased to 
3 and 11. This difference is not sig­
nificant (P <  0.2).
Of primary interest was the de­
velopment of wound and other infec­
tions (Table III). Seven (15%) group 
1 and 11 (29%) group 2 patients had 
infectious complications (P <  0.2). 
The greater number of urinary tract 
infections seen in group 2 is not sig­
nificant.
Discussion
In the past antibiotic prophylaxis 
was criticized for failing to prevent 
infection, enhancing the risk of super­
infection and for being a crutch for 
the technically poor surgeon. Some 
criticism is justified. Agents were 
often chosen on an empirical basis, 
started too early and continued too 
long. More recently such practices 
have been examined in the light of 
current knowledge of wound sepsis,3 
and there appears to be a very real 
role for such therapy.
No previous study has justified pro­
phylaxis during cardiac surgery. An 
early prospective study of patients 
who underwent valve replacement was 
terminated prematurely when pneu­
mococcal endocarditis developed in 
two patients receiving a placebo.4 A 
more recent study found no difference 
in the number of infections in patients 
subjected to cardiac bypass operation 
who received prophylaxis intraoper- 
atively or intra- and postoperatively.5 
Goldmann and associates6 had a 
similar experience in comparing 2- 
and 6-day courses of cephalothin pro­
phylaxis. These studies did not include 
a placebo-treated group. We chose to 
study patients who underwent aorto­
coronary bypass because this proce­
dure carries a lower risk of infective 
endocarditis than does valve replace­
ment.7 Cephalothin is effective against 
most staphylococci, the majority of 
streptococci and some enteric organ­
isms. Dosage and timing were based 
on the results of an earlier study by 
our group.8
With the initial study protocol there 
were four sternotomy infections due 
to S. aureus in 15 patients studied. All 
infected patients had received a place­
bo only. By phage typing it was ascer­
tained that all organisms were of dif­
ferent strains. Nasal cultures of the 
operative team demonstrated no or­
ganisms of similar strain. Thus no 
common source was demonstrated 
and this suggests that the patients were 
endogenously infected from their own
skin flora. We believe that this reflects 
a high rate of contamination of the 
surgical field, as has been shown by 
others,9 and supports a previous ob­
servation that sternotomy infections 
due to Staphylococcus sp. occur fre­
quently in patients who receive in­
adequate prophylaxis.6 The operative 
fields in all our patients were sprayed 
with a polymyxin-bacitracin mixture. 
This form of therapy appears to be 
totally inadequate.
The number of sternotomy infec­
tions in placebo-treated patients com­
pared with those receiving antibiotics 
(4 of 9 versus 2 of 91, respectively) 
differed significantly (P <  0.01). This 
finding supports the use of prophy­
laxis to reduce the risk of such in­
fection. There was, however, no dif­
ference between groups 1 and 2 pa­
tients using the revised study protocol. 
This suggests that intraoperative pro­
phylaxis alone, consistent with an ear­
lier study,5 is important and that no
advantage is derived by prolonging 
such treatment. The higher frequency 
of urinary tract infection in group 2 
patients, although not significant is 
nevertheless interesting. We believe 
the timing of the postoperative urine 
culture, usually within 1 day of re­
moving the Foley catheter and within 
3 days of beginning cephalothin ther­
apy accounted for this. Cox and 
Hinman10 demonstrated that catheter- 
acquired bacteriuria generally resolves 
spontaneously within 48 hours of ca­
theter removal in otherwise healthy 
persons. At least two studies have 
found a decreased incidence of urinary 
tract infection for the first 72 hours 
of systemic antibiotic therapy in pa­
tients with closed urinary tract drain­
age.1112 Thus the timing of the post­
operative culture was most likely to 
show group 1 patients to better ad­
vantage. Possibly a larger study would 
demonstrate a significant difference. 
One should bear in mind, however,
Table I—Data on Patients in the Two Groups
No. of Duration of Duration of
Group Men Women Age, yr* vessels bypassed* bypass, min* hospitalization, d*f
1 30 17 51.1 ±  9.5 2.78 ±  0.69 142.5 ±  45.8 14.6 ±  7 5
2 28 10 47.9 ±  18.6 2.76 ±  0.67 137 ±  45.0 12.03 ±  4.2
‘ Mean ±  standard deviation
(Duration of hospitalization was significantly (P <  0.05) longer for group 1 than for group 2.
Table II— Noninfectious Complications*
Group
Postcardiac
injury
syndrome
Myocardial Pulmonary Wound 
infarction embolism dehisence Psychosis Gout
Total no. 
of patients
1 4 5 3 3 2 0 17
2 2 1 3  2 1 1 10
*The differences between the two groups were not significant.
Table I I I— Infectious Complications: Location and Type of Infecting Organism*
Location Group 1 Group 2
Wound site Sternotomy (1) ( Staphylococcus 
aureus)
Cellulitis, arterotomy site (1)
(S. aureus)
Femoral incision (1) (organism 
unknown)
Tracheobronchitis (2) (normal 
flora)
Pneumonia (1) (Escherichia coli)
Asymptomatic bacteriuria (1)
(£ .  coli)
Sternotomy (1) (S . aureus)
Respiratory tract 
Urinary tract
Tracheobronchitis (2) (normal 
flora)
Pneumonia (3) ( Streptococcus 
pneumoniae)
Asymptomatic bacteriuria (4), 
(£ . coli 3, Pseudomonas 
aeruginosa 1)
Prostatitis (1) (enterococcus)
‘ The differences were not significant.
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Cox and Hinman’s observation10 and 
the danger of prolonged treatment, 
that of superinfection with multire- 
sistant species.11
Some may think that rates of in­
fection of 15% and 29%, respect­
ively, for groups 1 and 2, are ex­
cessively high for a “clean” surgical 
procedure. Our results however, com­
pare favourably with at least two 
well designed studies done elsewhere5’6 
on patients undergoing similar oper­
ations.
In view of the important role played 
by the oropharyngeal flora in the cau­
sation of hospital acquired pneu­
monia13 we wanted to study the effect 
of a short versus long course of ce- 
phalothin therapy on this population. 
No difference was found in the coloni­
zation rates for enteric bacteria but 
yeasts were found in a greater num­
ber of group 1 than group 2 patients, 
although the difference was not sig­
nificant.
Noninfectious complications were 
more common in group 1 than group 2 
patients. The patients in group 1 were 
hospitalized longer than those in 
group 2, who received intraoperative 
prophylaxis only. We do not suggest 
that the longer course of antibiotic 
therapy was responsible; the reason
for this difference is not apparent 
from our study. However, this obser­
vation does not support the prolonged 
prophylactic use of antibiotics for pa­
tients who undergo aortocoronary by­
pass operations.
This study demonstrates that in­
traoperative prophylaxis with an anti- 
staphylococcal drug is indicated for 
all patients undergoing cardiac bypass 
operation to reduce the risk of 
staphylococcal wound infection. There 
is no apparent advantage to extending 
prophylaxis beyond the immediate 
operative period.
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The Retrocaval Ureter: en Intrinsic Abnormality
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An 11-year-old boy underwent 
resection of an abnormally draining 
ureteral segment of a retrocaval right 
ureter. Compression by the inferior 
vena cava may have caused the faulty 
drainage. End-to-end ureteroureteral 
anastomosis was carried out. intra­
operative study of perfusion was 
helpful in the management of this 
child’s condition.
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Un garcon de 11 ans a du subir la 
resection d’un segment d’une uretere 
droite retrocave donnant un drainage 
anormal. Une compression par la 
veine cave inferieure peut avoir ete 
la cause de ce drainage defectueux. 
Une anastomose uretero-ureterale 
bout a bout a ete pratiquee. Une 
etude de perfusion faite durant 
I’intervention fut utile au traitement 
de la maladie de cet enfant.
Embryologic persistence of the right 
subcardinal vein as the vena cava 
results in the ureter being situated 
behind the vena cava. Compression of 
the ureter by the vena cava against 
the anterior spinal tissues causes 
ureteral obstruction and hydrone­
phrosis. The preferred treatm ent of 
this condition according to Campbell1 
consists of division of the upper ureter 
well up in the pelvis so that after 
anastomosis a large ostium remains. 
The mobilized upper ureter is re­
moved from behind the vena cava, 
placed in its normal position and re­
paired by ureteropelvic anastomosis. 
Others2’3 have suggested that the vena 
cava be divided because the ureter is 
normal and is more likely to form  a 
stricture than the anastomosed vena 
cava.
The patient described in this report 
had a retrocaval ureter. He was re­
ferred to us by his urologist who 
thought that section of the vena cava 
was indicated and did not wish to do
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this in a community hospital. As it 
turned out either of the two suggested 
approaches would have been wrong. 
Use of perfusion testing intraopera- 
tively allowed us to identify a poorly 
draining retrocaval segment of ureter 
which required resection.
Case Report
An 11-year-old boy was admitted to 
hospital because of recurrent episodes 
of pain in the right flank. Findings on 
physical examination, on the hemogram 
and on the voiding cystourethrogram 
were all normal as were the serum elec­
trolyte values and the results of urinaly­
sis and of renal function studies. Intra­
venous and retrograde pyelography was 
performed by the referring urologist 
(Fig. 1). A diagnosis of a right retro­
caval ureter was made. Subsequently an 
iodine-131 hippurate renogram showed 
obstruction on the right side (Fig. 2).
Through a right paramedian incision, 
the cecum and ascending colon and their 
mesentery were reflected and the retro­
peritoneal space was exposed. The diag­
nosis was confirmed. The ureter was 
mobilized medial to the inferior vena 
cava. Gross examination of the ureter 
distal to the dilated part indicated no 
abnormality. A 20-gauge needle was 
inserted in the dilated ureter and normal 
saline was infused. Drainage was poor. 
The ureter was therefore divided distal 
to the segment that was compressed by 
the vena cava and the perfusion study 
was continued. The dilated ureter be­
came intensely full, but drainage was 
poor even through the divided ureter 
and it was clear that the apparently nor­
mal retrocaval segment had poor empty­
ing ability.
A 3-cm segment of ureter was resected
FIG. 1— Retrograde pyelogram show­
ing s-shaped, dilated right ureter.
and ureteral continuity was restored 
by continuous 4-0 catgut sutures. A 
watertight anastomosis was achieved 
and perfusion of the ureter was repeated. 
There was good drainage. A no. 8 
French infant feeding tube was inserted 
as a splint, through a short cystotomy 
and the retroperitoneal space was 
drained.
Ten weeks after operation, an intra­
venous pyelogram and renogram (Fig. 
3) indicated marked improvement in the 
caliectasis and urinary drainage. The
child is now symptom-free and has 
sterile urine.
The resected ureter, examined under 
the light microscope, showed an exces­
sive amount of fibrous tissue replacing 
the normal musculature.
Comments
The anatomy and management of 
retrocaval ureter have been thorough­
ly reviewed.1'4 The consensus is that
FIG. 2— Preoperative renogram shows normal left, obstructed right kidney. 
R =  right kidney, L =  left kidney, H =  heart curve.
FIG. 3—Postoperative renogram: drainage from right kidney is almost as 
prompt as from left. R =  right kidney, L =  left kidney, H =  heart curve.
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the anomaly is due primarily to ab­
normal development of the vena cava; 
the extent of ureteral involvement is 
not clear. The management of this 
condition is often surgical; only 25% 
of patients require no treatment.1
When function of the opposite kid­
ney is compromised or absent Cathro2 
recommends division of the inferior 
vena cava. Goodwin, Burke and Mul­
ler3 reviewed the literature and inter­
viewed 37 urologists, some of whom 
suggested division of the ureter. 
Others preferred to divide the vena 
cava because the ureter is uninvolved, 
but is more likely to form a stricture 
than the anastomosed vena cava. 
Campbell1 advocated sectioning the
dilated upper ureter to allow wide 
anastomosis. In our patient any of 
of these approaches would have left 
the abnormal ureteral segment in 
place and the result might have been 
disappointing.
The abnormality of the ureteral 
musculature may be due to compres­
sion by a major vessel in utero and 
interference with the ureteral bud. 
Bitker probably suspected these 
changes in the ureter since he divided 
it on both sides of the vena cava 
then reunited the ureteral ends thus 
leaving the retrocaval ureteral seg­
ment undisturbed.1
If ureteral revision is contemplated 
it may be wise to resect the retrocaval
ureteral segment and demonstrate 
inadequate ureteral emptying by an 
intraoperative study of perfusion.
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Effect of Actinomyces israelii on Human Peripheral
Lymphocytes
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Actinomycosis is rare and responds 
well to antibiotic therapy. The causative 
organism, Actinomyces israelii which 
is now considered to be a bacterium, 
has long been suspected of exerting 
an immunosuppressive effect. The 
authors provide further evidence of 
this in their study of three patients 
with actinomycosis and four healthy 
control subjects. Skin reactivity 
to various standard antigens was 
depressed in all seven patients. 
Peripheral lymphocytes from the 
patients and the control subjects 
were isolated. A. israelii was added 
to the cell cultures following challenge 
with several standard mitogens.
Blast transformation in response to 
phytohemagglutinin was inhibited by 
A. israelii in all seven subjects, 
but was preserved in response to 
concanavallin A and pokeweed 
mitogen.
A. israelii appears capable of
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inhibiting the subset of human peri­
pheral lymphocytes responsive to 
phytohemagglutinin stimulation in vitro.
L'actinomycose est une maladie rare 
qui reagit bien a I'antibiotherapie. 
L’agent pathogene, Actinomyces 
israelii, qui est maintenant considere 
comme une bacterie, a longtemps ete 
soupconne d’exercer une effet 
immunosuppresseur. Les auteurs en 
apportent de nouvelles preuves dans 
une etude portant sur trois patients 
souffrant d'actinomycose et sur quatre 
sujets sains. La reaction cutanee a 
divers antigenes standards etait a la 
baisse chez les sept patients. Les 
lymphocytes peripheriques des 
malades et des sujets furent isoles.
A. israelii fut ajoute a la culture 
cellulaire apres une provocation avec 
plusieurs mitogenes standards. La 
transformation blastique provoquee 
par la phytohemagglutinine fut inhibee 
par A. israelii chez les sept sujets, 
mais elle s’est maintenue en reponse 
a la concavalline A et au mitogene 
pokeweed.
A. israelii semble capable d'inhiber 
un sous-groupe de lymphocytes 
peripheriques humains reagissant a la 
stimulation in vitro par la phyto­
hemagglutinine.
Actinomycosis, an uncommon but 
potentially lethal infection, can be 
managed by chemotherapy with ex­
cellent results. The organism, although 
first classified as a fungus, is consi­
dered to fulfil all the criteria of a 
bacterium.1 Israel2 postulated that the 
causative organism was delicate, prob­
ably anaerobic, growing only at body 
temperature. Actinomyces sp. are 
common saprophytic inhabitants of 
the oral cavity and the respiratory and 
gastrointestinal tracts.
The ability of these organisms to 
cause infection has been well docu­
mented. We studied the effect of 
Actinomyces israelii on lymphocyte 
reactivity in vitro in three patients 
with actinomycosis. One patient with 
actinomycosis of the greater omen­
tum has previously been reported.3 A 
second patient had actinomycosis of 
the anterior abdominal wall and the 
third had a submandibular cervical 
abscess. We also studied lymphocyte 
reactivity to this organism in four 
healthy control subjects.
Methods
We determined the skin reactivity 
of the patients to a group of antigens
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including tuberculin, mumps, Candida 
albicans and Varidase. Peripheral 
blood lymphocytes were isolated 
on a Ficoll-Hypaque gradient.4 These 
cells were washed three times 
with RPMI culture medium (Roswell 
Park Memorial Institute, Buffalo, 
NY). 1 X 106 cells were cultured in 
triplicate in RPMI-1640 medium sup­
plemented with gentamicin (20 ^g / 
ml), tetracycline (3 /xg/ml) and heat- 
inactivated fetal calf serum (20%). 
Cultures were stimulated with phyto­
hemagglutinin (PHA) (Difco Labo­
ratories, Detroit, Mich.) (0.01 ml/ml), 
concanavallin A (Difco Laboratories) 
(6.25 jLig/ml) and 0.01 ml of rehy­
drated pokeweed mitogen (PWM) 
(Gibco Laboratories, Grand Island, 
NY), with or without A. israelii (stock 
strain, American type culture collec­
tion), in a saline suspension. The 
cultures were incubated in a humid­
ified atmosphere of 5% carbon 
dioxide at 37°C for 72 hours. For 
the last 6V2 hours 0.625 jCiCi of 
tritiated thymidine was added (5 mCi/ 
mmol). Cells were collected in Milli- 
pore filters (Millipore Corp., Bedford, 
Mass.) and washed with 5% trichloro­
acetic acid. The filters were dried 
and placed in 5 ml of scintillation 
fluid and the radioactivity was meas­
ured in a liquid scintillation counter. 
The stimulatory index was obtained by 
dividing the mean of triplicate sam­
ples with the unstimulated counts and 
then converting to a percentile. Auto­
logous serum from the patients was 
also tested for inhibition of PHA 
stimulation.
Results
Skin reactivity was present in each
of the three infected patients, when 
tuberculin was used as the antigen. 
There was no skin reactivity to mumps 
or C. albicans antigen. The reactivity 
to Varidase was tested in only one 
patient and was weakly positive.
Table I shows the results of the 
effect of A. israelii on lymphocyte 
reactivity in vitro to PHA stimulation 
in three patients and in four healthy 
control subjects. The stimulatory index 
was inhibited in each of the three 
patients. The first patient who was 
very ill had a low initial PHA stimul­
ation which was further depressed (by 
25%), by the addition of 50 yu,g of 
A. israelii in saline. The other two 
patients showed a 70% and 75% in­
hibition of PHA stimulation, respect­
ively, when a similar concentration of 
A. israelii was added. In each of the 
four control subjects PHA stimula­
tion was inhibited; in one varying 
concentrations of A. israelii were 
added producing dose-dependent in­
hibition. We could not demonstrate 
any inhibition of lymphocyte reactivity 
to concanavallin A or PWM. Auto­
logous serum from patients did not 
inhibit PHA stimulation.
Discussion
Actinomycosis is an interesting type 
of chronic inflammation. Patients’ skin 
reactivity showed a normal response 
to tuberculin. The absence of re­
activity to C. albicans and mumps 
antigens suggested possible impair­
ment in delayed hypersensitivity re­
sponse to them.
Studies carried out on three patients 
showed that when A. israelii was 
added to the culture media, blast 
transformation by PHA was inhibited.
Lymphocytes from four healthy 
donors also consistently showed 
inhibition of stimulation with PHA 
when A. israelii was added. It ap­
peared that there was a dose-related 
inhibition of PHA stimulation as 
shown in the study of one of the 
control subjects. Maximal inhibition 
was achieved by adding A. israelii in 
a concentration of 50 yng/ml. Any 
further increase in concentration did 
not increase the inhibition.
A. israelii did not inhibit lympho­
cyte reactivity to concanavallin A or 
PWM. We conclude, therefore, that 
the organism probably acts at a spe­
cific locus on the lymphocyte. Recent 
studies with peripheral blood lympho­
cytes indicate the presence of various 
lymphocyte subsets.5 One of these 
responds to PHA stimulation whereas 
the other responds specifically to con­
canavallin A stimulation. It is con­
ceivable that A. israelii in vitro inhibits 
the particular subset of human peri­
pheral lymphocytes responsive to 
PHA stimulation.
In a previous review of actinomy­
cosis, we suggested that immunosup­
pression may play a part in the propa­
gation of this disease.2 The disease is 
rare but our studies to date on three 
patients and four healthy control sub­
jects have shown that the organism is 
capable of inhibiting peripheral lym­
phocyte transformation to phyto­
hemagglutinin in vitro.
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Table I—Reduction (%) from Phytohemagglutinin Stimulatory Index upon 
Addition of Actinomyces israelii
Concentration of A. israelii in saline, irg/ml
Subject yr Sex 5 10 25 50
Patient
1 66 M — — — 25
2 81 F — — 60 71
3 31 M — __ __ 75
Control
1 60 F — — __ 70
2 40 M — _ — 60
3 31 M — _ 69 83
4 23 M 41 70 80 87
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Congenital Esophagobronchial Fistula in tile Adult
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Communications between the 
esophagus and the tracheobronchial 
tree in adults are usually acquired and 
are generally caused by tumour, 
trauma or infection. Congenital fistulas 
persisting to adult life are uncommon. 
The authors present the case of 
a 72-year-old woman with a congenital 
fistula between the esophagus and 
the posterior segmental bronchus of 
the lower lobe of the left lung.
The relative lack of symptoms in this 
patient for so many years is a well 
recognized feature of such fistulas. 
The fistula and lower lobe of the 
left lung were excised. Some of the 
reported cases of congenital 
esophagobronchial fistulas in adults 
are reviewed and the clinical, radiologic 
and histologic features of this entity 
are described.
Les communications entre I'oesophage 
et I'arbre tracheo-bronchique chez 
I'adulte sont habituellement acquises, et 
generalement causees par une tumeur, 
un traumatisme ou une infection.
Les fistules congenitales persistant 
jusqu'a I'age adulte sont rares. Les 
auteurs decrivent le cas d'une femme 
de 72 ans porteuse d’une fistule 
congenitale entre I'oesophage et le 
segment bronchique posterieur du 
lobe inferieur du poumon gauche. 
L'absence relative de symptomes chez 
cette patiente pendant tellement 
d’annees est un aspect bien connu 
de ce type de fistules. La fistule 
et le lobe inferieur du poumon gauche 
furent excises. Quelques-uns des cas 
de fistules oesophago-bronchiques 
congenitales chez I'adulte sont passes 
en revue, et les caracteristiques 
cliniques, radiologiques et histologiques 
de cette entite sont decrites.
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Fistulas between the esophagus and 
tracheobronchial tree are usually clas­
sified as either congenital or acquired. 
Most esophagobronchial or esophago- 
tracheal fistulas that occur in adults 
are acquired and are generally due to 
neoplasms, trauma or infections, par­
ticularly tuberculosis. Less common 
causes of acquired fistulas in the adult 
are infected esophageal diverticula 
and caustic burns of the esophagus. 
Congenital fistulas persisting undiag­
nosed into adult life are rare. Our 
recent experience with a woman who 
had a congenital fistula between the 
distal esophagus and a lower lobe seg­
mental bronchus of the left lung 
prompted us to review the reported 
experience of congenital esophago­
bronchial fistulas in the adult.
Case Report
A 72-year-old woman was admitted to 
the Jewish General Hospital, Montreal, 
in June 1978, because of the onset of
FIG . 1—Roentgenography after ba­
rium swallow demonstrates com m unica­
tion (arrows) between distal segment of 
esophagus and posterior segmental bron­
chus of left lower lung lobe. Broncho- 
gram obtained by passage of barium  into 
bronchial tree demonstrates cylindrical 
bronchiectasis of lower lobe.
paroxyms of coughing after drinking 
liquids, together with flatulence and 
belching which had been present for 6 
months.
She had been in excellent health until 
June 1970 when she was admitted to 
the medical service for treatment of 
pneumonia of the left lower lobe. She 
was given antibiotics and responded 
promptly. She was discharged 10 days 
after admission. One year later she had 
a second episode in the lower lobe of 
the left lung. Again she responded 
promptly to antibiotic therapy. In Janu­
ary 1978 she started to complain of bel­
ching, flatulence, occasional episodes of 
nocturnal heartburn and occasional re­
gurgitation of “brownish mucus”. She 
had no history of dysphagia or weight 
loss. Findings on physical examination 
at that time were unremarkable.
She was thought to have a hiatus 
hernia. Roentgenography after barium 
swallow demonstrated a communication 
between the distal esophagus and a 
bronchus in the lower lobe of the left 
lung (Fig. 1) with filling of the bronchial 
tree. A bronchogram showed cylin­
drical bronchiectasis of the left lower 
lobe.
She was admitted to hospital in April 
1978 for 10 days of observation. She ate 
well, had no episodes of coughing after 
drinking or eating and, except for ex­
cessive belching, she was asymptomatic, 
so surgical intervention was not in­
dicated. On readmission in June 1978 
she had no recurrence of her pneumonia 
but because of the development of 
paroxysmal coughing, operation was 
advised.
Operative Findings
On July 4, the left pleural cavity was 
explored via a posterolateral thoracotomy 
through the bed of the resected sixth 
rib. Approximately 6 cm above the gas­
troesophageal junction, the fistula was 
seen arising from the esophagus. There 
was no inflammation around the fistula, 
which was easily dissected. The fistula 
ran slightly upwards from the esophagus 
to the left lower lobe bronchus. It ap­
peared to be covered by a flimsy layer 
of muscle fibres. We divided the fistula 
at its esophageal end using a stapling 
instrument and the row of staples was 
reinforced with a layer of fine silk 
sutures. The fistula was left attached to 
the left lower lobe bronchus and a left 
lower lobectomy was carried out. The 
postoperative course was smooth and 
the patient was asymptomatic 1 year 
later.
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Pathological Findings
The specimen, weighing 200 g, con­
sisted of a fistulous tract connected to 
the lower lobe of the left lung. The fis­
tula was 3 cm long and funnel shaped. 
Its diameter varied from 2 cm at the 
esophageal end to 1.2 cm at the bronchial 
end. The fistula opened into the post­
erior segment of the left lower lung lobe. 
The lining of the fistula was smooth. 
There were no surrounding lymph nodes. 
The lung itself showed multiple areas of 
bronchiectasis and patchy areas of con­
solidation.
The fistulous tract was lined by 
squamous epithelium at its esophageal 
end and abruptly changed to ciliated 
respiratory epithelium towards the bron­
chial end. The submucosa contained 
loose connective tissue at the esophageal 
end, but near the bronchial end several 
islands of cartilage and well developed 
bronchial mucosal glands were seen. 
This segment of the fistula had the ap­
pearance of a bronchus (Fig. 2). The 
muscularis consisted of smooth muscle. 
The parenchyma of the lung contained 
many areas of chronic inflammation.
Discussion
Communications between the eso­
phagus and the tracheobronchial tree 
occur most commonly in infancy and 
are usually associated with esophageal 
atresia. Much less commonly do such 
congenital fistulas present in adults 
and indeed most are acquired due to 
neoplastic disease, infection or trauma. 
In 1966, Blackburn and Amoury1 re­
viewed 260 patients with congenital 
esophagopulmonary fistulas without 
atresia. Of the entire group only 68 
patients had esophagobronchial fis­
tulas. Of these, the diagnosis in 51 
was made after the age of 15 years 
and the patients were considered to 
be adult.
It has been suggested that the em- 
bryogenesis of the esophagobronchial 
and esophagotracheal fistulas may 
differ. Fistulas high in the tracheo­
bronchial tree may arise from in­
complete fusion of the lateral foregut 
plates which are responsible for 
separating the trachea from the eso­
phagus proximal to the stem bronchi. 
Frater and Dowdle2 and Gerle and 
colleagues3 postulated that fistulas 
distal to this point arise from super­
numerary lung beds in a manner sim­
ilar to a bronchopulmonary seques­
tration. Although this theory has been 
supported by report of congenital eso­
phagobronchial fistula in the adult 
associated with an abnormal artery 
arising from the aorta,4 in almost all 
other reported cases no such anomal­
ous artery has been found. Smith5
speculated that the eventual site of the 
fistula between the esophagus and the 
tracheobronchial tree depends on the 
degree of esophagotracheal separation 
taking place before the caudal elong­
ation of the trachea. Apparently the 
embryologic explanation for esophago­
bronchial communications remains 
unclear.
Braimbridge and Keith0 classified 
congenital bronchoesophageal fistulas 
into four types. Type 1 is associated 
with a wide-necked congenital diver­
ticulum of the esophagus. Perforation 
of this diverticulum can result in an 
acquired esophagobronchial communi­
cation. Type 2 fistula, the simplest 
and by far the commonest type, is a 
simple tract joining the esophagus to 
a lobar or segmental bronchus. A type 
3 fistula extends from the esophagus 
to a lung cyst which in turn commu­
nicates with a bronchus. Type 4 fis­
tula extends from the esophagus to the 
bronchus of a sequestrated pulmonary 
segment. As pointed out by Lyons and 
Seremetis,7 the truly indisputable type 
of congenital fistula is the type 2. The 
remaining three types are associated 
with another congenital abnormality 
which could lead to an acquired fis­
tula. In these instances it may be dif­
ficult to determine if the fistula is 
congenital or acquired. Indeed, the 
type 1 fistula does represent an ac­
quired fistula secondary to infection 
and perforation of a congenital diver­
ticulum.
Histologically, the fistula, in most 
reported cases, has contained a lining
of squamous epithelium with a sub­
mucosa and muscularis.8'11 However, 
fistulas lined with columnar epithelium 
both ciliated and nonciliated have 
been reported6'13 as well as combina­
tions of columnar and squamous epi­
thelium.13 In our case the fistulous 
tract was lined by squamous epithe­
lium at its esophageal end, with an 
abrupt change at its bronchial en­
trance to a ciliated respiratory epi­
thelium with well developed bronchial 
mucous glands and islands of cartilage 
in the submucosa, as well as a mus­
cularis of smooth muscle. In most re­
ported instances the parenchyma of 
the lung at the site of fistulous com­
munication has shown evidence of 
varying degrees of bronchiectasis and 
chronic inflammation. The congenital 
nature of the fistula is assumed be­
cause of the absence of any evidence 
of old or new inflammation around 
the fistulous tract or the esophagus, 
by the absence of adherent lymph 
nodes and by the histologic appear­
ance of an epithelial lining with a 
submucosa and a muscularis mucosae.
The symptoms of congenital esopha­
gobronchial fistulas are variable and 
usually begin after the teens. The 
mean age of patients at diagnosis in 
the review by Blackburn and Amoury1 
was 33 years. In the review by 
Braimbridge and Keith6 the duration 
of symptoms varied from 6 months to 
50 years (mean 17 years). Typically, 
symptoms consist of paroxysmal 
coughing and choking after drinking 
and occasionally after eating. The pre-
FIG. 2— Mid-portion of fistula demonstrates mucosal lining consisting of 
squamous (A) and respiratory (B) epithelium. Well developed bronchial mucous 
glands (C) are seen towards bronchial end of fistula. Segment of cartilage (D) is seen 
on bronchial side (hematoxylin and eosin, original magnification X40; reduced 
by 29%).
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sence of food particles in the sputum 
is extremely suggestive. However, 
symptoms can be exceedingly mild 
and may be elicited only by careful 
questioning. Recurrent episodes of 
pneumonia are common and bronchi­
ectasis may be the end result of the 
recurrent episodes of pulmonary in­
fection. Hemoptysis is sometimes 
present and may be massive.4’14 Eso­
phageal symptoms are uncommon. 
The excessive flatulence and belching 
in our patient was probably due to air 
passing from the bronchial tree to the 
gastrointestinal tract.
The lack of symptoms in these pa­
tients until adult life is difficult to un­
derstand. Several explanations have 
been offered. Jackson and Coates15 
proposed that the lack of symptoms 
is due to the presence of a membrane 
which occludes the fistula during the 
early years and which subsequently 
ruptures. Negus16 postulated that the 
fistula is protected by an esophageal 
fold that acts as a flap valve which 
becomes incompetent with age. An­
other explanation proposed by 
Demong, Grow and Heitzman17 is that 
the upward course of the tract from 
the esophagus prevents the reflux of 
esophageal contents into the bronchial 
tree. However, none of these pos­
tulates satisfactorily explains the late 
onset of symptoms and the relatively 
mild course in some patients.
The symptoms of esophagobron- 
chial fistulas are not always typical so 
this condition should be borne in mind 
when assessing any patient with a 
chronic cough for which the cause is 
not readily apparent. The same ap­
plies in patients with recurrent pneu­
monia or a pulmonary abscess in­
volving the lower lobe of a lung, or 
with bronchiectasis. Cine-esophago- 
graphy, after a barium swallow, per­
formed with the patient in various po­
sitions, is the most useful method for 
diagnosing esophagobronchial fistula. 
Occasionally, a satisfactory broncho- 
gram can be obtained if barium passes 
via the fistula into the bronchial tree. 
If this does not happen bronchography 
should be done to assess the extent of 
pulmonary damage. Esophagoscopy 
and bronchoscopy usually do not de­
monstrate the fistula.
Congenital esophagobronchial fis­
tula is treated by excision with resec­
tion of any diseased portions of the 
lung. Simple excision of the fistula 
with closure of both the bronchial and 
esophageal ends may be all that is 
required if the lung damage is not 
severe.10,18 The extent of concomitant 
pulmonary resection can vary from
segmental resection to pneumonec­
tomy.1,6 The results of the reported 
cases have been excellent; all patients 
have had relief of symptoms.
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toms and syndromes in detail. It is in 
this section that the special value of 
the text lies. Students and even residents 
should find this section valuable for 
orienting their investigation of patients 
who present with the symptoms and syn­
dromes it describes. The last 250 pages 
cover, relatively briefly, the neurologic 
diseases that are the sole subject of 
most conventional neurologic texts. This 
fourth section therefore complements the 
third by describing the diseases previous­
ly suggested as possible causes of pa­
tients’ complaints.
The book is written in a “breezy” 
style since the authors seek to avoid the 
pedantry of most neurologic texts and 
the fears that, they suggest, this engenders 
in students who come to regard the spe­
cialty as recondite and hard to under­
stand. It also contains much common 
sense, such as, “the history is all im­
portant and if you do not know what is 
going on and more or less where, when 
you stop asking questions and pick up 
the ophthalmoscope, then the examina­
tion won’t help you very much”. How­
ever, the. authors may upset some read­
ers with similes such as the Argyll 
Robertson pupil which is likened to a 
prostitute who accommodates but does 
not react, or the finger following a per­
functory rectal examination which 
comes out cleaner than it went in.
The book is printed by the photo­
graphic process which has the advantage 
of reducing publication time, as illus­
trated by the fact that the manuscript 
was apparently completed in mid-1977. 
Therefore a major deficiency of this 
book is that only perfunctory notice is 
taken of computerized tomography which 
has revolutionized the investigation of 
intracranial disease. Moreover, the few 
computerized tomograms that are used 
as illustrations are of poor quality.
Since the field of neurology is now so 
extensive that no individual, or pair of 
individuals, can be an expert in all its 
aspects, it is easy for a reviewer to disa­
gree with some of the authors’ opinions 
and emphases. However, such objections 
would be picayune and generally this is 
a book that can be recommended to all 
medical students and even junior house- 
staff. In this regard the authors appear 
to have succeeded in their stated aim to 
write a book that is easy for the student 
to read during the course of under­
graduate training and they state that they 
would be content, as indeed I would, if 
students were familiar with the contents 
of this book on graduation. The book 
could also be used with advantage by 
junior housestaff, supplemented, as the 
authors suggest, by additional reading as 
training progresses.
D.N. White, md, frcp
Professor of medicine (neurology), 
Queen’s University,
Kingston, Ont.
continued on page 495
VOLUME 23, NO. 5, SEPTEMBER 1980 / THE CANADIAN JOURNAL OF SURGERY 491
(X
/  ULerpQ&sz
Laparotomy for Staging of Hodgkin’s Disease
R i c h a r d  J. Warren^ m dJ j . T ftg y w t M. Sandy Amp. FRCsrcLfyiAtflBwE. BascoI mb, ch b, frcp[c] 
" —' V"  A N D \ J. Ballantyne.^md
Laparotomy was used for staging 
Hodgkin’s disease in a selected group 
of 71 patients over a 9-year period 
at the Cancer Control Agency of 
British Columbia. Operative results 
altered the staging in 30 patients 
and the treatment in 28 patients. 
Negative lymphangiograms were found 
to predict accurately the absence of 
abdominal lymph-node involvement.
No investigation was as accurate as 
laparotomy in identifying subdiaphrag- 
matic Hodgkin's disease. There were 
no operative deaths and the overall 
morbidity was 18%. The value of 
staging laparotomy depends on the 
adjustment of therapy to match the 
changes in staging made as a result 
of this procedure. Of specific advantage 
is the avoidance of unnecessary 
chemotherapy. Improved long-term 
survival as a result of staging 
laparotomy has yet to be proven.
A I'Agence de controle du cancer 
de la Colombie-Britannique, la 
laparotomie pour le classement du 
stade clinique de la maladie de 
Hodgkin a ete utilisee chez un groupe 
choisi de 71 patients sur une periode 
de 9 ans. Les resuitats operatoires 
ont modifie le classement chez 30 
patients et le traitement chez 28 
patients. On a observe qu'un 
lymphangiogramme negatif predisait 
avec exactitude I'absence d’atteinte 
des ganglions lymphatiques abdomi- 
naux. Aucun examen ne s’est avere 
aussi precis que la laparotomie pour 
identifier une maladie de Hodgkin sous- 
diaphragmatique. On n’a enregistre 
aucun deces operatoire et la morbidite 
globale fut de 18%. L'interet du 
classement par laparotomie reside 
dans I’ajustement du traitement en
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fonction des changements de classe­
ment resultant de cette intervention. 
Un avantage specifique consiste a 
eviter une chimiotherapie inutile.
II n'a pas encore ete demontre que 
la laparotomie pour le classement de 
la maladie de Hodgkin permettait 
de prolonger la survie a long terme.
Since the introduction1 of the “staging 
laparotomy”, surgeons have become 
increasingly interested in Hodgkin’s 
disease. Despite many papers analys­
ing the effectiveness of staging lapa­
rotomy, there remain basic disagree­
ments concerning its use.
Our objective was to review the 
results of staging laparotomy at the 
Cancer Control Agency of British 
Columbia (CCABC) and to compare 
our findings with those reported in 
the world literature.
Methods
The records of 506 patients pre­
senting with Hodgkin’s disease be­
tween 1969 and 1977 were reviewed 
retrospectively. The study involved 
patients who were usually referred to 
the CCABC for care after diagnosis 
of the disease by lymph-node biopsy.
The initial staging of the disease on 
a clinical basis was decided at a mul­
tidisciplinary lymphoma clinic and 
was based on the history, physical 
findings, chest roentgenograms, re-
Table I—Indications for Laparotomy at the 
Cancer Control Agencyof British Columbia*
Laparotomy often recommended
For clinical stage lb  or lib  regardless of 
histologic findings
For clinical stage la or ila  w ith lympho­
cyte depletion
For clinical stage Ila w ith mixed cel- 
lularity
For clinical stage Ila with positive nodes 
in all areas above diaphragm
When lymphangiography is contrain­
dicated or a technical fa ilure 
Laparotomy sometimes recommended
If lymphangiogram is equivocal and pro- 
posedjtreatment in absence of laparot­
omy would lead to loss of desired 
fe rtility
If splenic findings are equivocal and 
proposed treatment in absence of 
laparotomy would lead to loss of 
desired fe rtility
♦Only considered in patients aged 8 to 65 
years with no medical contraindication.
suits of hematologic and biochemical 
tests, as well as on radionuclide scans 
and lymphangiograms. Staging was 
based, in the earlier years of the study, 
on the Rye classification,2 and in the 
later years on the Ann Arbor clas­
sification.3
The decision to recommend a pa­
tient for staging laparotomy was usual­
ly made by the multidisciplinary lym­
phoma group and was individualized, 
although indications tended to follow 
those set forth in Table I. Operative 
staging was based on the findings 
at laparotomy performed by a 
number of different surgeons pri­
marily at one hospital. This led to 
some variability in approach, although, 
in general, surgeons adhered to the 
CCABC recommendations (Table II).
Findings
The ages of the 506 patients ranged 
from 8 to 74 years, although most 
were adults.
Of 94 patients who underwent lapa­
rotomy, 71 had laparotomy specific­
ally for the staging of Hodgkin’s dis­
ease and they formed the basis of our 
analysis.
Sixty-eight of the 71 patients had 
splenectomy; in 24 (35.3%) of them 
the features of Hodgkin’s disease 
were found. Of the three patients who 
did not undergo splenectomy, one had 
a grossly enlarged spleen that was not 
removed due to technical difficulties 
and two had spleens that grossly ap­
peared normal.
Three liver biopsies (4.2%) showed 
characteristics typical of Hodgkin’s 
disease; all were from patients who 
had splenic disease.
Lymph-node biopsy in 21 patients 
(29.2%) was positive for Hodgkin’s 
disease, and 17 of these patients also 
had splenic disease.
Table II—Operative Protocol for Staging 
Laparotomy
Splenectomy
Liver biopsies—wedge and needle, both 
lobes
Lymph-node biopsies—splenic, porta hepa- 
tis, celiac, para-aortic, iliac and indivi­
dual nodes suggestive of disease on 
lymphangiography 
Oophoropexy in women 
Metal clips at biopsy sites
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Lymphangiograms were obtained 
for 57 patients; 14 were interpreted as 
positive (i.e. showing features typical 
of Hodgkin’s disease), 23 as negative 
and 20 as equivocal. After laparo­
tomy, 9 of the 14 positive lymphangio­
grams were proved positive (64.3% 
accuracy rate) and 19 of the 23 neg­
ative ones were proved negative 
(82.6% accuracy rate). Nine (45%) 
of the 20 equivocal lymphangiograms 
were positive and 11 (55%) were 
negative.
Clinical and pathologic staging were 
compared. Of 22 patients clinically 
identified as having stage I disease, 8 
were “staged up” and none down. Of 
26 patients classified as stage II clinic­
ally, 7 were staged up and none down. 
Of 21 considered clinically to have 
stage III disease, 2 were staged up and 
13 staged down. In 2 who were clinic­
ally stage IV, there was no alteration.
Because of the treatment policies 
at the CCABC, this altered staging 
dictated that we change the course of 
treatment in all except the two 
stage III patients whose disease was 
revised to stage IV. Overall, the re­
sults of laparotomy altered the staging 
in 30 of the 71 cases (42.3%) and 
treatment regimen in 28 (39.4%).
The assessment of complications in 
our series was hindered by the fact 
that some of the operations were per­
formed at smaller community hos­
pitals. Nevertheless, our overall mor­
tality is 0%, and the rate of serious 
complications is 18% (13 of 71 pa­
tients); there were five cases of tran­
sient atelectasis, one of pleural effu­
sion, one of subphrenic abscess, one 
of fistula and five of wound infection.
Discussion
In a review of selected world liter­
ature up to 1976, Kawarada and as­
sociates4 found, in a total of 719 
staging laparotomies from 14 institu­
tions, a mortality of 0.9% and a mor­
bidity of 10%. Major complications 
were wound infection and dehiscence, 
subphrenic abscess, atelectasis, pneu­
monia, pleural effusion, pulmonary 
emboli, intestinal obstruction and pan­
creatitis. In the largest single series 
reported, Cannon and Nelsen5 from 
Stanford University reported on a 
group of 400 patients. The mortality 
was 0%, the rate of major complica­
tions was 3.7% and of minor com­
plications 14%. Since 1952, when 
King and Shumacker6 suggested that 
patients with splenectomy were pre­
disposed to bacterial infection, numer­
ous reports have appeared. Walker7 in 
1976 reviewed 821 splenectomies in
children; the rate of serious infection 
was 6%, most infections occurring in 
children under 3 years of age. How­
ever, Desser and Ultmann8 who 
studied the results of 1170 splenec­
tomies performed on adults, reported 
an infection rate of only 1.4%; all in­
fections occurred after staging lapa­
rotomy. Considering our series results 
of no mortality and an 18% complica­
tion rate, we believe there is good 
evidence for the relative safety of 
staging laparotomy, especially in the 
age groups in which Hodgkin’s dis­
ease is most common.
Without doubt laparotomy in the 
staging of Hodgkin’s disease is the 
most accurate method of identifying 
subdiaphragmatic disease.1'9'10 The dis­
ease most commonly involves the 
spleen, lymph nodes and liver (in our 
series 35.3%, 29.2% and 4.2%, re­
spectively). Therefore, identifying dis­
ease in these organs on a purely clinic­
al basis has been an important ob­
jective.
Preoperative assessment of periaor­
tic lymph nodes by means of lymphan­
giography has steadily improved in 
accuracy. However, while false-neg­
ative results are uncommon, false­
positive results are sufficiently com­
mon that positive findings are un­
reliable. Kawarada and colleagues4 
found an accuracy rate of 72.1% 
among positive lymphangiograms and 
an accuracy rate of 86.7% among 
negative lymphangiograms. This was 
similar to the findings in our series 
of 64.4% and 82.6% respectively.
Liver function tests are unreliable 
predictors of liver involvement.1’9’11'13 
Liver scanning also is of little value.1’13 
Liver involvement is seldom found in 
the absence of splenic disease9’11,13 
therefore the diagnosis of Hodgkin’s 
disease in the spleen is the key. Un­
fortunately, preoperative assessment 
of splenic involvement is equally un­
rewarding.
The clinical impression of spleno­
megaly14 and the findings of splenic 
scanning13,13 have been proved in­
accurate by open biopsy. In one series 
of 443 patients, the accuracy rate of 
clinical diagnosis was only 65%—of 
125 spleens thought clinically to be 
involved only 81 demonstrated fea­
tures of Hodgkin’s disease on his­
tologic examination. Of the 318 
spleens thought clinically to be neg­
ative only 218 (68%) were proved 
negative histologically.13
In addition to the diagnostic ac­
curacy which staging laparotomy af­
fords, there are a number of other 
advantages. The procedure offers the 
opportunity to perform oophoropexy,
thus reducing the possibility of infer­
tility in irradiated women of child­
bearing age. Also, removal of the 
spleen permits a major reduction in 
radiation dosage to the left upper 
quadrant, thus decreasing the like­
lihood of radiation pneumonitis and 
nephritis. Further, as Salzman and 
Kaplan15 found, splenectomized pa­
tients have an appreciably greater 
hematologic tolerance to radiotherapy 
and chemotherapy.
Despite the proven diagnostic ac­
curacy of staging laparotomy, it is 
of no value unless (a) it results in an 
alteration of the clinical staging, (b) 
this alteration in turn dictates a 
change in treatment and (c) this 
change improves long-term survival 
rates.
There is now little doubt that lapa­
rotomy findings appreciably alter the 
staging of Hodgkin’s disease. In a 
review of accumulated series to 1978 
involving 664 patients, Lee Yeu-Tsu 
and associates16 reported that staging 
was altered after laparotomy in 28% 
of patients; in 20% the staging was 
advanced and in 8% it was decreased. 
In the Stanford series5 of 400 patients, 
27.5% had staging altered as a result 
of laparotomy. In our series the rate 
was slightly higher—staging was al­
tered in 42.3%, probably due to the 
highly selected group chosen for study.
The centre of the issue, therefore, is 
whether or not altered staging will 
change the treatment regimen. At 
most institutions a form of combina­
tion chemotherapy is used for all pa­
tients with disease below the dia­
phragm—alone in stage IV and com­
bined with radiotherapy in stage III. 
Unfortunately, chemotherapy is as­
sociated with substantial morbidity. 
Moreover, recent evidence indicates 
that secondary malignant lesions, 
usually a fatal acute leukemia, are 
associated with intensive combined 
therapy. Coleman and associates17 in 
a series of 680 patients followed up 
for 4 to 11 years found that the prob­
ability of fatal leukemia resulting 
from the use of combined chemother­
apy and radiotherapy was between 
2.9% and 3.9%. Clearly, overtreat­
ment should be avoided, and at most 
treatment centres the presence or ab­
sence of abdominal disease is pivotal 
in any decision to introduce chemo­
therapy in association with radio­
therapy.
Although little has been written 
about the long-term survival rates of 
patients who have undergone staging 
laparotomy compared with the results 
of treatment based on clinical staging, 
a few reports have appeared recently.
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The British National Lymphoma 
Group examined patients classified 
clinically as stage I or II who were 
randomly treated either according to 
their clinical stage or according to 
their pathologic stage after they had 
undergone laparotomy. The laparo­
tomy group had a 5% rate of intra­
abdominal relapse, while in the 
clinically staged group the rate was 
31 % ,ls However, the effect of relapse 
on the ultimate prognosis is not yet 
proven. Certainly it is possible to pro­
duce a durable second remission in 
some of these patients.19
Conclusions
Staging laparotomy is a relatively 
safe procedure. At present it is the 
most accurate method of identifying 
Hodgkin’s disease intra-abdominally.
The decision to recommend staging 
laparotomy is best made by a multi­
disciplinary panel of specialists who 
weigh the advantages of laparotomy 
against its known morbidity. Consider­
ation must be given to each institu­
tion’s treatment policies, the poten­
tial for altered treatment plans and 
the potential of increased morbidity 
due to treatment.
The surgeon’s role in staging lapa­
rotomy is diagnostic. Operation should 
therefore be impeccably thorough 
and should be performed by an in­
dividual familiar with the procedure.
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Critique of Item 424 (SESAP III)
Nonfamilial rectal and colonic polyps in children are not premalignant. These juvenile polyps are not 
neoplastic and not adenomatous. They are retention polyps which usually disappear before the patient 
reaches adult life. Juvenile polyps frequently present with blood in the stool, but the commonest cause 
of rectal bleeding in children is an anal fissure, not a polyp. Polyps are rarely the leading point for an 
intussusception in infants. The specific causes of most intussusceptions in infants are not known. There 
is no known relationship between polyps and Hirschsprung’s disease, the latter condition resulting from 
congenital aganglionosis of the distal colon and rectum. Juvenile polyps are not equally distributed 
throughout the colon; 70% to 80% occur in the distal sigmoid and rectum.
Juvenile polyps are not premalignant; consequently, the only indications for their removal are 
recurrent bleeding bleeding or abdominal pain. In the rare cases in which removal is indicated, it is 
best accomplished endoscopically.
Reference
424/1. Shermeta DW, Morgan WW, Eggleson J, et al: Juvenile retention polyps. J Pediatr Surg 
4:211-215, 1969
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THE INJURED ADOLESCENT KNEE.
Edited by J.C. Kennedy. 257 pp. Illust.
The Williams & Wilkins Company,
Baltimore, 1979. Price not stated.
The editor of this volume is an authority 
on sports injuries and has had a lifelong 
interest in the knee. The book includes 
contributions from five other Canadian 
and American surgeons internationally 
recognized in this area of orthopedics.
Seven of the chapters deal separately 
with ligamentous injuries and arthro­
scopy, injuries of the epiphyseal plate, 
osteochondral fractures, osteochondritis 
dissecans, avulsion of the proximal 
tibial epiphysis, dislocation of the patella 
and patellar chondromalacia. Each 
chapter has an extensive list of refer­
ences. The authors have attempted to 
keep abreast of the rapidly evolving con­
cepts of knee injuries, particularly those 
causing ligamentous damage and patellar 
subluxation and have included refer­
ences to new material such as operative 
arthroscopy.
Adolescence is defined by the editor 
as the age group between 12 and 18 
years. Separation of this age group from 
those younger and older is justified by 
statements quoting the very high in­
cidence of injuries in grade school 
athletes in a 1-year study.
The book is of comfortable weight 
and size, well illustrated and brief. Its 
greatest value is as an introduction for 
those having an interest in sports med­
icine or for paramedical people involved 
in sports medicine clinics who wish to 
learn more about the surgical aspects of 
knee injuries in adolescents.
K.S. Morton, md, frcs[c], facs
Division of orthopedics,
The University of British Columbia, 
Vancouver, BC
LES TUMEURS ODDIENNES. Am-
pullomes Vateriens. G. Marchal et J.
Jureau. 180 pp. Illust. Masson, Paris,
1978. Prix non mentionne, broche.
ISBN 2-225-70466-X.
Dans ce livre, les auteurs font l’histori- 
que de la tumeur oddienne et ils en etu- 
dient l’epidemiologie en tenant compte 
des facteurs etiologiques. La troisieme 
partie du livre est consacree a 1’anatomie 
chirurgicale du carrefour bilio-pancreati- 
co-duodenal. On etudie par la suite l’ana- 
tomie pathologique des tumeurs oddien- 
nes, leur diagnostic preoperatoire et leur 
traitement.
Dans l’ensemble, la revue de ce type 
de tumeur est bien couverte et illustree 
de schemas et de photos tres appro- 
pries.
Nous retrouvons ici une excellente 
etude de l’anatomie du carrefour bilio- 
pancreatico-duodenal bien que la des­
cription de l’appareil sphincterien ne 
semble pas claire; il faut reconnaitre 
neanmoins que cette structure est assez
complexe dans son ensemble. Depourvue 
d’implication clinique, la description des 
fibres musculaires de l’appareil d’Oddi 
nous apparait trop minutieuse, ce qui a 
pour effet de surcharger le texte et de 
nuire a sa clarte.
La classification anatomique des tu­
meurs oddiennes est bien donnee et la 
pathologie est tres bien exposee, tant du 
point de vue macroscopique que micro- 
scopique. Le diagnostic preoperatoire est 
bien analyse sauf pour ce qui a trait a 
la digestion des graisses. En effet, les 
auteurs parlent surtout du test a la trio­
leine et a l’acide oleique marque, une 
epreuve quelque peu depassee. A mon 
avis, le dosage quantitatif des graisses 
dans les selles des 24 heures est actuel- 
lement plus approprie.
En ce qui concerne l’aspect radiolo- 
gique, il est tres bien etudie et illustre 
de bonnes photographies. Le traitement 
chirurgical de ce type de tumeur est 
bien explique.
En cours de lecture, j’ai note un usage 
abusif des statistiques. Les auteurs 
auraient pu etre plus selectifs et se 
limiter a celles qui sont les plus signifi- 
catives. Ce volume n’en demeure pas 
moins, a mon avis, recommandable: la 
revue de la tumeur oddienne est excel­
lente et le livre est a conseiller pour les 
etudiants en medecine.
Dans les livres de gastro-enterologie 
courants, les tumeurs oddiennes sont tres 
peu decrites et peu d’auteurs y ont atta­
che autant d’importance que Marchal et 
Hureau. Je crois que l’effort fait ici est 
tres louable et que nous avons beaucoup 
a retirer de la lecture de ce livre.
Yvon G iroux, md, cspq, frcp[c]
Chef du departement de medecine,
Cite de la Sante de Laval,
Laval, PQ
METABOLIC SURGERY. Edited by 
Henry Buchwald and Richard L. 
Varco. 317 pp. Illust. Grune & Strat­
ton, Inc., New York; Longman Canada 
Limited, Don Mills, Ont., 1978. 
$36.90. ISBN 0-8089-1077-9.
This 11-chapter text defines metabolic 
surgery as “the operative manipulation 
of a normal organ or organ system to 
achieve a biological result for a poten­
tial health gain”. Each chapter is written 
by different authors; the editors contri­
bute one chapter. The text discusses 
metabolic consequences of several well 
established procedures in addition to a 
number of new operations designed to 
achieve specific metabolic goals.
The excellent opening chapter by 
Menguy is a thorough, well written re­
view of the results and sequelae of oper­
ations for peptic ulcer disease, and adds 
to what is currently available in stand­
ard texts. The attachment of the afferent 
loop in Fig. 1-5 is incorrect.
The second chapter is a review of 
gastric bypass written by Mason and 
Printen from Iowa. Although the chap­
ter is well written the techniques de­
scribed are out of date. For example, 
retrocolic gastrojejunostomy is no longer 
used and there is no discussion of gas­
troplasty. Also, the weight losses shown 
are not listed as percentages of initial 
weights.
There follows a section on jejunoileal 
bypass. Again, this is a good but out­
dated review. This procedure seems to 
be rapidly disappearing from the sur­
gical literature. The editors, in their 
paper, discuss the cholesterol-atheroscle­
rosis hypothesis in relation to the use of 
partial ileal bypass for managing hyper- 
lipidemias. This is an excellent paper and 
is up to date. It is followed by a chapter 
discussing the metabolic effects of par­
tial and complete pancreatectomy. This 
unique chapter is extremely informative.
The role of splenectomy in treating 
hematologic disorders and the humoral- 
immunologic influences of splenectomy 
are discussed and an extensive biblio­
graphy is included. However, this chap­
ter adds little to information currently 
available.
Putnam and Starzl have contributed 
one chapter on the use of portacaval 
shunts in glycogen storage diseases, type 
2 hyperlipidemia and Gaucher’s disease, 
utilizing the metabolic rather than the 
hemodynamic alterations of portovenous 
diversion. The long article on transplan­
tation in metabolic disease, including 
hormonal deficiencies and inborn errors 
of metabolism, covers a variety of topics 
in this mainly experimental area.
Papers on functional neurosurgery 
and an extremely brief chapter on en­
docrine ablation in benign and malignant 
disease are also included.
The final chapter deals with the de­
velopment and clinical applications of 
pulsing electromagnetic fields, primarily 
in orthopedic surgery. This chapter 
covers 61 pages and includes 152 refer­
ences which amounts to 17% of the total 
book. The author repeatedly promises to 
“simplify the concept for practicing 
surgeons” but never succeeds in doing 
so. The chapter is intriguing and of 
great interest but is hopelessly confusing.
In summary, this is a collection of 11 
interesting and worthwhile articles but 
there is a wide range of interests as well 
as levels of sophistication required of the 
reader. The rationale and usefulness of 
grouping these topics together is un­
clear.
James M. Watters, md
Joel B. Freeman, md, frcs[c], facs
Division of general surgery,
Ottawa General Hospital,
Ottawa, Ont.
PLASTIC SURGERY IN INFANCY  
AND CHILDHOOD. 2nd ed. Edited 
by John Clark Mustarde. 631 pp. Il­
lust. Churchill Livingstone, Edinburgh, 
1979. Price not stated. ISBN 0-443- 
01629-1.
This text is yet another attempt to 
continued on page 498
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As the treatment of the pa­
tient in shock has progressed 
in recent years, various organ 
systems have, in turn, been 
the “ weak link” limiting 
recoversTli^dekeribrMibrj 
often becomes apparentfiEstT 
in the kidney where disrup­
tion of cellular metabolism 
causes acute tubular swelling 
fspujesulting o h g u ^ J l ^
Soon, the pulmonary vascu­
lature begins to exhibif a p  
pattern o f interstitial oedema, 
pooling o f blood in the stag­
nant microcirculation and 
aggregation of the formed ele­
m en ts o f the blood. Diffusion 
of oxygen from the alveoli is 
greatly decreased, commonly 
resulting in arteriovenous 
shunting -  a phenomenon in 
which blood passes through 
the lung without oxygenation.
If the shock state continues, 
lysosomal enzymes injth[ej~ 
anoxic pancreas trigger the 
release of myocardial depres­
sant factor (MDF), a vaso­
active peptide which can 
fiause further deterioration of the microcirculation. J  -L
Although cerebral blood flow 
is maintained early in shock 
at the expense of the other 
organs, this state of adequate 
perfusion does not persist for 
long. Relatively soon, avail­
able oxygen becomes crit­
ically low, and the brain, too, 
turns to anaerobic metabo­
lism. Lactate acid levels rise 
and fluids leak into the in- 
testitial spaces. Continued 
oxygen deprivation threatens 
both the cellular integrity of 
the brain and the central ner­
vous system function.
Once shock has progressed 
beyond its early stage, fluid 
administration alone is usu-
severe shock threatens each link in the body’s chain o f organ systems
Solu-Medrol exerts a protective effect on the cell 
to preserve tissue function and increase survival rates
LUNGS
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ally not sufficient to reverse 
the haemodynamic arid cel- 
lular disruptions.
Solu-Medrol, administered in 
pharmacologic doses as part 
of a comprehensive treatment 
regimen, can reduce vasocon­
striction and increase tissue 
perfusion. The multiphasic 
activity o f Solu-Medrol 
restore haemodynamic bal­
ance, preserve lysosome and 
cell membranes, and protect 
cellular and intracellular 
structures and function. ,..J_
The actions of Solu-Medrol 
affect all of the body’s systems:
• In the kidney, increased per­
fusion reverses the anoxic state 
and improves organ function 
as evidenced clinically by an 
increase in urine outputp
• Improvement in the pulmonary 
vasculature is demonstrated by a 
reduction in shunting and an 
increase in oxygen consumption.2
• The affinity of haemoglobin for 
oxygen is reduced permitting | j  
increased delivery of oxygen by
the blood to the tissues.3
I ■ | 1 I I  I  1  i — — 1 | | j I
• A positive inotropic effect is
exerted on the heart further 
increasing the flow of blood.4
U pjohn
Pancreatic lysosomes are 
stabilized halting the production 
of MDF.5
•  Capillary membranes in the brain 
are stabilized, and capillary 
permeability reduced.6
Through its network of protective 
actions, Solu-Medrol strengthens 
the chain of organ systems and 
increases the shock patient’s 
chances of survival.
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Solu-Medrol
(methylprednisolone sodium succinate)
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present in one volume the facet of plas­
tic surgery that relates to infancy and 
childhood using contributors who are 
well known for their expertise in a 
specific area.
The book is divided into four sections 
—head and neck, trunk, limbs and 
other areas. Some chapters contain an 
addendum in which relevant material 
from sources other than those of the 
main contributor are included. In an 
effort to keep the volume down to prac­
tical size each contributor offers a “blue­
print” rather than an exhaustive study of 
the subject. The book is easy to read 
and the illustrations are adequate.
There are, however, sections of the 
book that appear dated. For example, 
the chapter on facial hemiatrophy still 
recommends the use of tubed pedicle 
flaps all over the body. There is no refer­
ence to the use of microsurgery or free 
flaps, which are becoming more com­
mon in the treatment of this and other 
problems. Also many of the subjects are 
well covered, in many cases by the 
same contributors, in Converse’s seven- 
volume reference work on plastic sur­
gery.
In summary this text presents a little 
about many aspects of plastic surgery 
in childhood in a handy-sized volume 
that is easy to read.
St a n l e y  S. L a bow , m d , f r c s [c]
Department of surgery,
Children’s Hospital of Eastern Ontario, 
Ottawa, Ont.
THE SCIENTIFIC BASIS OF ORTHO­
PAEDICS. Edited by James A. Al­
bright and Richard A. Brank. 493 pp. 
Illust. Appleton-Century-Crofts, New 
York, 1979. $28.50. ISBN 0-8385- 
8503-5.
A series of lectures in basic sciences, 
which was designed originally for resi­
dents in an orthopedic program, has been 
condensed in this book. The structure of 
a cell in detail, its membranes and func­
tions, the basic terms of genetics and the 
patterns of inheritance illustrated by 
clinical conditions known to orthopedic 
surgeons and growth in the musculoske­
letal system occupy the first part of the 
book. This is followed by a section on 
bone, its structure, its mechanical and 
electrical properties, potential for re­
modelling, regulation of biochemical 
changes and processes of repair. The 
rest of the volume deals with joint car­
tilage and lubrication, muscle and nerve 
structure, function, role and relation of 
inflammation and immunology in the 
tissue responses seen in orthopedic 
practice.
The 12 contributors pack all this to­
gether with a large number of clear il­
lustrations into 470 pages. This com­
pression makes for a style that varies
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and, at times, is so concentrated as to 
defy rapid reading.
As a study book for postgraduate 
examinations, it will be popular. But it 
will have a far wider use in bringing the 
practising orthopedic surgeon up to date.
Each of the 14 chapters starts with an 
enjoyable short historical section that 
provides perspective to the study of the 
detailed concepts that follow. Each chap­
ter ends with a list of recommended 
references for the enquirer who wants 
more and who now has the background 
to read further with understanding.
My prediction is that this book will 
become part of the personal library of 
many orthopedic surgeons.
D.A. G ibson, md, frcs[c]
Medical director,
The Ontario Crippled Children’s Centre, 
Toronto, Ont.
SURGICAL GYNECOLOGIC TECH­
NIQUES. Franc Novak. Translated by 
Wilfrido Cameron Curry. 421 pp. II- 
lust. John Wiley & Sons, Inc., New 
York, 1978. $65. ISBN 0-471-04276-5.
First published in 1973, this book 
has since been translated into six lan­
guages of which English is the most re­
cent. In the introduction the author states 
that the purpose of the book is to show 
the beginner a simple and sure path. 
Technically he has accomplished his pur­
pose.
The text is notable for its profuse and 
clear illustrations. There is an interesting, 
but perhaps unattainable, section entitled 
“preparation of the surgeon, scrub nurse 
and assistants”. It would be impossible 
in the university setting in North Amer­
ica to have a surgical team, consisting of 
assistants, each with 10 years operating 
experience. Some of the mentioned suture 
materials (e.g., linen ligatures) and is- 
struments (e.g., ligature carriers) are 
unfamiliar and are not in use on this 
continent.
In spite of the excellent illustrations 
and many useful surgical hints much of 
the information is totally foreign. For 
instance, not many gynecologic surgeons 
would voluntarily use a morcellation 
operation for the elective vaginal removal 
of a fibroid uterus the size of a 16-week 
pregnancy. The Schauta operation for 
stage la carcinoma of the cervix is sim­
ply not done and most assuredly not for 
carcinoma in situ of the cervix as the 
author recommends. Apparently cytology 
and colposcopy in the diagnosis and 
treatment of cervical intraepithelial neo­
plasia have had no impact upon the 
author’s philosophy.
The section on urinary incontinence is 
likewise deficient. There is no mention 
of urodynamic investigation or treatment. 
The discussion of incontinence centres 
around the Kelly operation, along with 
bladder neck and urethral plication and 
bladder suspension. In the light of present 
knowledge, this would be considered woe­
fully inadequate.
A discussion of various radical proce­
dures for malignant disease is given in 
detail. There is very little mention of 
radiotherapy in the treatment of malig­
nant tumours of the pelvis. According to 
the author his institution has no radium 
or radiotherapy and this appears to be 
reflected in his discussion of lymphade- 
nectomy in association with radical hys­
terectomy. However, elsewhere in the 
text he suggests a combination of radio­
therapy and radical surgery for stage II 
carcinoma of the cervix. Once again, this 
is not acceptable in the North American 
context.
Vaginal cesarean section, as mentioned 
here, can only be condemned. The text as 
a whole does not reflect current thought 
on many topics, but could still be a 
useful reference for details of operative 
technique. It would not be useful to the 
postgraduate student in obstetrics and 
gynecology.
H.R. Morgan, md, frcs[c], facog
Department of obstetrics and gynecology, 
McMaster University,
Hamilton, Ont.
SYMPOSIUM ON ATHROSCOPY 
AND ARTHROGRAPHY OF THE 
KNEE. American Academy of Ortho­
paedic Surgeons. 352 pp. Illust. The 
C.V. Mosby Company, Saint Louis, 
1978. $66.25. ISBN 0-8016-0056-1.
Lectures given at several courses spon­
sored by The American Academy of Or­
thopaedic Surgeons on arthrography and 
arthroscopy of the knee have been col­
lected under one cover in this volume. 
This may account for some of the repe­
tition, which could have been eliminated 
by tighter editing. In an effort to be 
systematic and complete for the purpose 
of presenting a “definitive text”, material 
has been included which is irrelevant or 
superfluous. Having mentioned two 
particular types of arthroscope the 
authors either should have dealt with the 
others or should not have named any 
and should simply have discussed large 
and small arthroscopes. Add to this a 
number of split infinitives and faulty 
grammatical construction and the draw­
backs to this book (excepting its high 
price) have been dealt with.
The material is clearly presented in 
text, line drawings, roentgenograms and 
photographs taken through the arthro­
scope. The photographs particularly are 
good; some of the best are those of 
Jackson (chapter 10) which are accom­
panied by line drawings to establish the 
orientation. Since lack of orientation is 
one of the greatest difficulties for the 
beginner arthroscopist, this chapter is 
most important.
Experts tend to move beyond what is 
normally applicable to what is minimally 
useful—that is part of their function. In 
this book there is very little of that and 
usually a cautionary note is presented 
advising against enthusiasm for what 
may be achieved. I object to one state­
ment on page 214 which advises arthro­
scopic excision of a meniscus as a tem­
porary measure to allow an athlete to 
finish playing the season, when the pro­
cedure can then be completed. This is 
representative of a certain attitude of 
many sports medicine physicians to 
whom the athlete is a commodity rather 
than a person.
J.L. Shugar, md, frc,s[c]
Associate editor
THE TREATMENT OF NEUROLOG­
ICAL DISEASE. Edited by Roger N. 
Rosenberg. 613 pp. Illust. SP Medical 
& Scientific Books, Jamaica, NY, 
1979. $45. ISBN 0-89335-062-1.
An ongoing criticism of recent neurologic 
textbooks has been their weak and out­
dated descriptions of treatment. Neuro­
logists have always been accused of over­
diagnosis and undertreatment. With the 
many recent advances in neurologic 
therapy, no single author can claim ex­
pertise in all facets of treatment.
Dr. Rosenberg and his colleagues at 
the University of Texas have done an 
excellent job in producing a textbook of 
neurologic therapy. Its 19 chapters out­
line the up-to-date management of a 
multitude of common and rare neuro­
logic disorders. There are chapters on 
computerized tomography, neurotrans­
mitters and pharmacokinetics. The chap­
ter on vasculitis is particularly good and 
those on subarachnoid hemorrhage, tu­
mours, infections and movement di­
sorders are outstanding.
Some readers will disagree with such 
statements as “parenteral Dilantin is not 
convenient to use” and “lumbar punc­
ture may have a role in the work-up of 
glioma patients before chemotherapy”. 
The discussion as to when anticonvulsant 
drugs should be withdrawn in patients 
who have continuing seizures is poor and 
leaves one with the impression that drugs 
can be withdrawn if the patient has been 
free of seizure for 2 years. In the section 
on myasthenia gravis there is no discus­
sion of the use of transcervical thymec­
tomy.
These are only minor criticisms of an 
excellent work to be highly recom­
mended to medical, neurologic and neu­
rosurgical residents and to the neurol­
ogic practitioner interested in complete 
reviews of treatment of both common 
and unusual neurologic conditions.
J. D avid G rim es, md, frcp[c]
Division of neurology,
Ottawa Civic Hospital,
Ottawa, Ont.
VASCULAR SURGERY. Edited by John 
S. Najarian and John P. Delaney. 627 
pp. Illust. Symposia Specialists Inc., 
Miami; Year Book Medical Publishers, 
Inc., Chicago, III., 1978. Price not 
stated. ISBN 0-88372-103-1.
Many topics of interest to vascular 
surgeons are covered in this well edited 
volume which is the latest in a recent
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series of books on vascular surgery and 
is based on the annual continuation 
courses sponsored by the University of 
Minnesota, department of surgery. The 
first section is devoted to nonoperative 
aspects of vascular disease, from risk 
factors in the development of athero­
sclerosis to noninvasive diagnostic tech­
niques. This followed by a section on op­
erative therapy for arterial occlusive 
disease from aorta to distal limb vessels. 
It includes the choice of bypass ma­
terials and a discussion on vascular 
trauma. Subsequent papers consider vari­
ous visceral vascular diseases, both oc­
clusive and aneurysmal. Other papers 
deal with the surgical aspects of cere­
brovascular disease, renovascular disease 
and the role of the surgeon in its treat­
ment, and aneurysms from the arch 
of the aorta to the popliteal artery. The 
final section of the book deals with the 
principles of coagulation and the treat­
ment of venous thrombosis and its 
complications.
A statement of objectives precedes 
each article, and at the end of each sec-
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Interdisciplinary training in basic 
research and/or clinical investigation 
available. Programs provide oppor­
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tion is a self-evaluation quiz and ex­
panded references and bibliography. The 
editors state that this book is not in­
tended as an exhaustive treatise on vas­
cular surgery but to provide an update 
of the field with emphasis on recent de­
velopments and controversial issues. I 
believe that they have achieved this goal.
This volume will not replace the stand­
ard textbooks of vascular surgery but 
will be a satisfactory addition to the 
library of most vascular surgeons and 
others interested in vascular disease 
because of its informative discussions 
by experienced surgeons and its approach 
to controversial topics. It lacks the depth 
and systematic organization usually 
found in standard texts but does fill a 
gap by expressing opinions about current 
management of vascular problems in a 
personal and lucid fashion.
T .  K e i t h  S c o b if ., m d , f r c s [ c ]
Chief, division of vascular surgery, 
Ottawa Civic Hospital,
Ottawa, Ont.
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